Zhejiang NHU Company Ltd. 2026 Semi-Annual Report
August 2026
Section I Important Notes, Contents, and Definitions
The Board of Directors and its members and senior executives of the Company hereby guarantee that the information presented in this semi-annual report is authentic, accurate, complete and free of false records, misleading statements or material omissions, and they will bear individual and joint liabilities for such information.
Hu Baifan, the Company’s legal representative, Shi Guanqun, the officer in charge of accounting, and Wang Xiaobi, the head of accounting department hereby declare that they guarantee the financial statements in this semi-annual report are authentic, accurate and complete.
All members of the Board of Directors have attended the meeting of the Board of Directors for deliberation of this semi-annual report.
The future plan and other forward-looking information disclosed in this semiannual report shall not be regarded as a substantive commitment to investors. Investors are hereby cautioned to be mindful of investment risks. For a detailed description of potential operational risks of the Company and relevant countermeasures, refer to Item X Risks and Countermeasures under Section III Management’s Discussion and Analysis of this Report. Investors are hereby cautioned to be mindful of investment risks.
The profit distribution proposal reviewed and approved by the Board of Directors at this meeting is as follows: Based tentatively on 3,068,717,398 shares [Note], which is the total share capital of 3,073,421,680 shares as of July 31, 2026 after deducting 4,704,282 repurchased shares held in the special repurchase account, a cash dividend of RMB 2.00 (tax inclusive) per 10 shares will be distributed to all shareholders. No bonus shares (tax inclusive) will be issued, and no capitalization of capital reserves will be made.
[Note] The Company currently has a total share capital of 3,073,421,680 shares, of which 4,704,282 shares are held in the special repurchase account. In accordance with the Rules on Share Repurchases by Listed Companies, shares held in the special repurchase account are not entitled to profit distribution or capitalization of capital reserve.
If the total share capital of the Company changes prior to the implementation of the distribution plan due to factors such as conversion of convertible bonds, share repurchases, exercise of equity incentive options, or listing of new shares from refinancing, the total amount to be distributed will be adjusted accordingly while the distribution ratio per share remains unchanged.
This Semi-Annual Report is an English translation ofthe Chinese Semi-Annual Report. In case the English version does no conform to the Chinese version, the Chinese version prevails.
Contents
Section I Important Notes, Contents, and Definitions....1
Section II Company Profile and Key Financial Indicators....6
Section III Management Discussion and Analysis....9
Section IV Corporate Governance, Environmental and Society....21
Section V Significant Events....25
Section VI Movements in Share Capital and Shareholders....36
Section VII Bonds....42
Section VIII Financial Report....44
Documents Available for Reference
I. Financial statements signed and sealed by the Company’s legal representative, officer in charge of accounting, and head of accounting department;
II. Originals of all the Company’s documents and announcements published in newspapers designated by CSRC during the reporting period;
III. Other documents for reference.
Definitions
| Abbreviations | Refers to | Contents of definitions |
| The Company, NHU | Refers to | ZHEJIANG NHU CO., LTD. |
| CSRC | Refers to | China Securities Regulatory Commission |
| PPS | Refers to | Polyphenylene Sulfide |
Section II Company Profile and Key Financial Indicators
I. Company profile
| Stock abbreviation | NHU | Stock code | 002001 |
| Stock Exchange | Shenzhen Stock Exchange | ||
| Company Name in Chinese | 浙江新和成股份有限公司 | ||
| Company Abbreviation in Chinese | 新和成 | ||
| Company name in foreign language (if any) | ZHEJIANG NHU COMPANY LTD. | ||
| Company Abbreviation in foreign language (if any) | NHU | ||
| Legal representative | Hu Baifan | ||
II. Contact information
| Items | Board secretary | Securities affairs representative |
| Name | 石观群(Shi Guanqun) | 曾淑颖 (Zeng Shuying) |
| Contact address | No.418 Xinchang Dadao West Road, Xinchang, Zhejiang, P.R.China | No.418 Xinchang Dadao West Road, Xinchang, Zhejiang, P.R.China |
| Tel. | +86 575 86017157 | +86 575 86017157 |
| Fax | +86 575 86125377 | +86 575 86125377 |
| E-mail address | sgq@cnhu.com | 002001@cnhu.com |
III. Other Information
1. Company’s Contact Information
Whether the Company’s registered address, office address, zip code, website and e-mail address has changed during the reporting period
Applicable Not applicable
The Company’s registered address, office address, zip code, website and e-mail address have not changed during the reporting period, which can be found in the 2025 Annual Report.
2. Information Disclosure and Location of Documents for Public Inspection
Whether information disclosure and location of documents for public inspection has changed during the reporting period ApplicableNot applicable
The name of the Company’s selected information disclosure newspaper, the URL of the website designated by the CSRC where the semi-annual report is posted, and the place where the Company’s semi-annual report is available have not changed during the reporting period, which can be found in the 2025 Annual Report.
3. Other relevant Information
Whether other relevant information has changed during the reporting period
Applicable Not applicable
IV. Key accounting data and financial indicators
Whether the Company needs to perform a retroactive adjustment or restatement on the financial data of prior years Yes No
| Items | Current Reporting Period | Prior-Year Period | YoY Change(%) |
| Operating revenue (yuan) | 13,129,300,260.89 | 11,100,632,836.78 | 18.28 |
| Net profit attributable to shareholders of the listed company (yuan) | 4,010,733,454.55 | 3,603,323,979.16 | 11.31 |
| Net profit attributable to shareholders of the listed company after deducting non-recurring profit or loss (yuan) | 3,918,936,563.72 | 3,678,562,540.56 | 6.53 |
| Net cash flows from operating activities (yuan) | 3,640,144,282.94 | 3,242,727,802.31 | 12.26 |
| Basic earnings per share (yuan/share) | 1.30 | 1.17 | 11.11 |
| Diluted earnings per share (yuan/share) | 1.30 | 1.17 | 11.11 |
| Weighted average return on equity | 11.39% | 11.87% | -0.48pp |
| Items | June 30, 2026 | December 31, 2025 | Change(%) |
| Total assets (yuan) | 46,685,231,500.76 | 45,606,449,805.48 | 2.37 |
| Net assets attributable to shareholders of the listed company (yuan) | 34,880,103,504.10 | 32,805,654,181.90 | 6.32 |
V. Differences in Accounting Data Under Chinese Accounting Standards and Overseas Accounting Standards
1. Difference in Net Profit and Net Assets in Financial Reports Disclosed Respectively Under IFRS Standards and Chinese Accounting Standards
Applicable Not applicable
During the reporting period, the Company has no difference in net profit or net assets in financial reports disclosed respectively under IFRS Standards and Chinese accounting standards.
2. Difference in Net Profit and Net Assets in Financial Reports Disclosed Respectively Under Overseas Accounting Standards and Chinese Accounting Standard
Applicable Not applicable
During the reporting period, the Company has no difference in net profit or net assets in financial reports disclosed respectively under overseas accounting standards and Chinese accounting standards
VI. Non-Recurring Profit or Loss
Applicable Not applicable
Unit: RMB Yuan
| Items | Amount | Remarks |
| Gains or losses on disposal of non-current assets, including write-off of provision for impairment | -35,306,533.70 | |
| Government grants included in profit or loss (excluding those closely related to operating activities of the Company, satisfying government policies and regulations, enjoyed based on certain standards, and having a continuing impact on the Company's profit or loss) | 37,824,754.25 | |
| Gains or losses on changes in fair value of financial assets and financial liabilities held by non-financial enterprises and gains or losses arising from disposal of financial assets and financial liabilities, excluding those arising from effective hedging business related to the Company's normal operating activities | 101,306,033.08 | |
| Gains or losses on assets consigned to the third party for investment or management | 16,602,412.40 | |
| Other non-operating revenue or expenditures | -8,309,061.39 | |
| Less: Enterprise income tax affected | 20,142,157.25 | |
| Non-controlling interest affected (after tax) | 178,556.56 | |
| Total | 91,796,890.83 |
Remarks on other profit or loss satisfying the definition of non-recurring profit or loss:
Applicable Not applicable
The Company has no other profit or loss satisfying the definition of non-recurring profit or loss.
Remarks on defining non-recurring profit or loss listed in the “Interpretation Pronouncement on Information Disclosure Criteria for Public Companies No. 1 – Non-Recurring Profit or Loss” as recurring profit or loss
Applicable Not applicable
The Company has no situation of defining non-recurring profit or loss listed in the “Interpretation Pronouncement on Information Disclosure Criteria for Public Companies No. 1 – Non-Recurring Profit or Loss” as recurring profit or loss.
Section III Management Discussion and Analysis
I. Principal Business Activities During the Reporting Period
There were no material changes to the Company's core business operations during the reporting period. For details, please refer to the company's 2025 annual report.
II. Core Competitiveness analysis
There were no material changes to the Company’s core competitiveness during the reporting period. For details, please refer to the Company’s 2025 annual report.
III. Principal Business Activities Analysis
Overview
In the first half of the year, guided by the operating principle of “expanding markets and increasing sales, pursuing innovative development, empowering with smart manufacturing, and improving quality and efficiency,” the Company actively responded to the complex and changing domestic and international environment, seized development opportunities, and achieved steady growth in key operating indicators. During the reporting period, the Company achieved operating revenue of RMB 13.13 billion, representing a year-on-year increase of 18.28%; total profit of RMB 4.70 billion, an increase of 11.06% year-on-year; and net profit attributable to shareholders of the listed company of RMB 4.01 billion, an increase of 11.31% year-on-year
1. Steady growth of operating indicators
During the reporting period, the Company coordinated production, sales, and procurement to continuously improve operating quality and efficiency. On the sales side, the Company actively seized product market opportunities, continued to expand highvalue application fields, and achieved good results in developing “Four-New” markets. The market demand and price of methionine, a key product in the nutrition segment, rose significantly, and the methionine business achieved growth in both volume and price. Other segments also showed stable and improving sales. On the production side, the Company continued to promote cost reduction and efficiency improvement through measures such as shared-line production, centralized startup and shutdown, and high output with low consumption. On the procurement side, the Company accurately judged market conditions and effectively strengthened its supply chain risk defense.
2. Orderly advancement of project construction
During the reporting period, the Company upheld the philosophy of innovation-driven development and growth through market competition, and key projects progressed in an orderly manner. The civil construction of the Tianjin New Materials Nylon Industry Chain Project was basically completed and handed over for installation, with equipment arriving and installation commencing. The PPS Phase IV project began construction. The civil works for HA Phase II started smoothly. Other technical upgrading and management improvement projects advanced steadily, while reserve projects and new project planning were carried out in an orderly manner.
3. Innovation subjects enhance endogenous driving force
During the reporting period, the Company consistently adhered to innovation-driven development. On the one hand, it continued to deepen the research and development of new products, steadily advanced new product research subjects, and continuously expanded product categories. On the other hand, it reviewed special subjects on improving the competitiveness of existing products, continued to improve and innovate, and continuously enhanced product competitiveness. Through building a technology resource library and a unit technology database, the Company continued to strengthen technology platform capabilities, laying a
solid foundation for technological innovation.
4. Continuous improvement of globalization capabilities
During the reporting period, the Company continued to advance its global layout. Sales, R&D, and other overseas operations are accelerating localization. The Japan Research Institute was completed and put into use. At the same time, the Company continued to improve its international management system, promoted the construction of overseas warehousing resources in key regions, improved its overseas talent introduction and development mechanisms, and deepened employer brand building, laying a solid foundation for the Company’s internationalization strategy.
5. Risk prevention improves management effectiveness
During the reporting period, the Company continued to deepen full-process risk management, promoted confidentiality system development, consolidated supply chain security, upgraded information protection capabilities, and enhanced systemic risk contro capabilities. Meanwhile, the Company continued to improve internal control management, strengthened risk prevention and process management, and comprehensively ensured compliant and efficient operation, laying a solid foundation for long-term sustainable development.
6. Accelerating digital and intelligent transformation
During the reporting period, the Company relied on digital and intelligent transformation to achieve refined management, focusing on three major areas—smart factories, smart operations, and artificial intelligence-enabled management—and steadily advanced the digital and intelligent construction of each base. The smart operation system continued to iterate, and self-developed platform were continuously optimized, pushing the digital and intelligent transformation from “point-based pilots” to “full-domain empowerment” and injecting digital momentum into the Company’s high-quality development.
Year-on-year Changes in Key Financial Data
Unit: RMB Yuan
| Item | Current Reporting Period | Prior-Year Period | YoY Change(%) | Reasons for Changes |
| Operating Revenue | 13,129,300,260.89 | 11,100,632,836.78 | 18.28 | |
| Operating Cost | 7,323,675,460.81 | 6,006,367,357.09 | 21.93 | |
| Sales Expenses | 88,987,069.94 | 88,602,406.65 | 0.43 | |
| Administration Expenses | 292,591,830.68 | 309,618,405.74 | -5.50 | |
| Financial Expenses | 257,803,128.41 | -178,098,697.47 | 244.75 | It was mainly due to increased exchange loss caused by exchange rate fluctuations during the reporting period. |
| Income Tax Expenses | 669,297,246.91 | 607,906,795.85 | 10.10 | |
| R&D Expenses | 605,728,077.64 | 522,723,563.18 | 15.88 | |
| Net Cash Flows from Operating Activities | 3,640,144,282.94 | 3,242,727,802.31 | 12.26 | |
| Net Cash Flows from Investing Activities | -1,643,359,986.70 | -1,108,314,695.05 | -48.28 | It was mainly due to an increase in land payments during the reporting period. |
| Net Cash Flows from Financing Activities | -2,427,781,067.80 | -2,154,111,363.13 | -12.70 | |
| Net Increase in Cash and Cash Equivalents | -423,489,717.70 | -12,707,478.21 | -3,232.60 | It was mainly due to an increase in land payments and dividenddistributions during the reporting period. |
| Taxes and surcharges | 147,102,530.45 | 126,138,622.06 | 16.62 |
Significant changes in the composition of the Company’s profit or sources of profit during the reporting period Applicable Not applicable No significant changes in the composition of the Company’s profit or sources of profit during the reporting period.
Composition of Operating Revenue Unit: RMB Yuan
| Items | Current Reporting Period | Prior-Year Period | YoY Change(%) | ||
| Amount | % to operating revenue | Amount | % to operating revenue | ||
| Total operating revenue | 13,129,300,260.89 | 100% | 11,100,632,836.78 | 100% | 18.28% |
| By industry | |||||
| Pharmaceutical chemicals | 11,900,862,959.74 | 90.64% | 10,015,550,568.46 | 90.23% | 18.82% |
| Others | 1,228,437,301.15 | 9.36% | 1,085,082,268.32 | 9.77% | 13.21% |
| By product | |||||
| Nutrition | 8,805,591,681.68 | 67.07% | 7,199,720,687.58 | 64.86% | 22.30% |
| Aroma chemicals | 2,022,263,282.57 | 15.40% | 2,104,560,598.28 | 18.96% | -3.91% |
| New materials | 1,165,989,510.74 | 8.88% | 1,038,207,401.78 | 9.35% | 12.31% |
| Others | 1,135,455,785.90 | 8.65% | 758,144,149.14 | 6.83% | 49.77% |
| By region | |||||
| Domestic sales | 5,457,466,507.97 | 41.57% | 4,657,675,802.41 | 41.96% | 17.17% |
| Overseas sales | 7,671,833,752.92 | 58.43% | 6,442,957,034.37 | 58.04% | 19.07% |
| By sales model | |||||
| Direct selling | 9,952,153,084.05 | 75.80% | 8,176,473,106.34 | 73.66% | 21.72% |
| Agent sales | 3,177,147,176.84 | 24.20% | 2,924,159,730.44 | 26.34% | 8.65% |
☑ Applicable Not applicable
Unit: RMB Yuan
| Items | Operating revenue | Operating cost | Gross rate | Growth rate of operating revenue | Growth rate of operating cost | Growth rate of gross rate |
| By industry | ||||||
| Pharmaceutical chemicals | 11,900,862,959.74 | 6,496,275,217.07 | 45.41% | 18.82% | 23.32% | -2.00pp |
| By product | ||||||
| Nutrition | 8,805,591,681.68 | 4,678,820,058.45 | 46.87% | 22.30% | 24.46% | -0.92pp |
| Aroma chemicals | 2,022,263,282.57 | 1,032,127,702.98 | 48.96% | -3.91% | 6.64% | -5.05pp |
| By region | ||||||
| Domestic sales | 5,457,466,507.97 | 3,430,671,277.53 | 37.14% | 17.17% | 25.63% | -4.23pp |
| Overseas sales | 7,671,833,752.92 | 3,893,004,183.28 | 49.26% | 19.07% | 18.85% | 0.10pp |
In case the statistical caliber of the Company’s main business data was adjusted during the reporting period, the Company’s main business data of the preceding period adjusted according to the caliber at the end of the reporting period shall be indicated
Applicable Not applicable
IV. Non-Main Business Analysis
Applicable Not applicable
Unit: RMB Yuan
| Items | Amount | % to total profit before tax | Reason for balance | Whether has continuity |
| Investment income | 204,498,489.13 | 4.35% | It was mainly due to an increase in investment income from associates and financial products during the reporting period. | No |
| Gains on changes in fair value (or less: losses) | 65,993,991.83 | 1.40% | It was mainly due to changes in fair value of forward foreign exchange settlement and sales during the reporting period. | No |
| Assets impairment loss (or less: losses) | -29,423,561.32 | -0.63% | It was mainly due to impairment losses arising from provisions for inventory write-downs and asset impairment made during the reporting period. | No |
| Non-operating revenue | 2,189,167.24 | 0.05% | It was mainly due to compensation income. | No |
| Non-operating expenditures | 47,056,112.99 | 1.00% | It was mainly due to losses on retirement of assets and donation expenditures during the reporting period. | No |
| Other income | 120,757,490.82 | 2.57% | It was mainly due to government grants received during the reporting period. | No |
| Credit impairment loss (or less: losses) | -34,278,518.19 | -0.73% | It was mainly due to an increase in accounts receivable during the reporting period, which led to an increase in the provision for bad debts. | No |
V. Assets and Liabilities Analysis
1. Significant Changes in Asset Composition
Unit: RMB Yuan
| Items | Current Reporting Period | Prior-Year Period | Percentage of change | Remarks on significant changes | ||
| Amount | % to total assets | Amount | % to total assets | |||
| Cash and bank balances | 7,458,042,805.72 | 15.98% | 7,966,270,131.17 | 17.47% | -1.49pp | |
| Accounts receivable | 3,769,816,701.75 | 8.07% | 3,331,434,677.27 | 7.30% | 0.77pp | |
| Inventories | 4,769,240,242.26 | 10.22% | 4,648,749,467.43 | 10.19% | 0.03pp | |
| Long-term equity investments | 1,144,592,243.55 | 2.45% | 965,350,549.43 | 2.12% | 0.33pp | |
| Fixed assets | 19,538,428,936.53 | 41.85% | 20,298,898,673.14 | 44.51% | -2.66pp | |
| Construction in progress | 1,006,512,957.55 | 2.16% | 745,117,350.86 | 1.63% | 0.53pp | |
| Right-of-use assets | 8,544,176.48 | 0.02% | 9,116,717.87 | 0.02% | Unchanged | |
| Short-term borrowings | 962,032,277.99 | 2.06% | 675,172,682.37 | 1.48% | 0.58pp | |
| Contract liabilities | 351,344,836.57 | 0.75% | 294,819,090.20 | 0.65% | 0.10pp | |
| Long-term borrowings | 3,170,163,350.48 | 6.79% | 4,187,178,569.02 | 9.18% | -2.39pp | |
| Lease liabilities | 2,307,786.86 | 0.00% | 2,500,183.66 | 0.01% | -0.01pp | |
| Trading financial assets | 2,583,641,120.21 | 5.53% | 2,168,275,092.55 | 4.75% | 0.78pp | |
| Non current liabilities due within one year | 2,745,428,550.04 | 5.88% | 3,165,413,873.49 | 6.94% | -1.06pp | |
2. Major overseas assets
Applicable Not applicable
3. Assets and Liabilities at Fair Value
Applicable Not applicable
Unit: RMB Yuan
| Items | Opening balance | Gains on changes in fair value in the current period | Accumulated changes in fair value included in equity | Provision for impairment made in the current period | Amount purchased during the reporting period | Amount sold during the reporting period | Other changes | Closing balance |
| Financial assets | ||||||||
| 1. Held-for-trading financial assets (derivative financial assets excluded) | 2,155,061,842.34 | -1,385,852.99 | 400,000,000.00 | 2,553,675,989.35 | ||||
| 2. Derivative financial assets | 13,213,250.21 | 16,751,880.65 | 29,965,130.86 | |||||
| Subtotal of financial assets | 2,168,275,092.55 | 16,751,880.65 | -1,385,852.99 | 400,000,000.00 | 2,583,641,120.21 | |||
| Total | 2,168,275,092.55 | 16,751,880.65 | -1,385,852.99 | 400,000,000.00 | 2,583,641,120.21 | |||
| Financial liabilities | 0.00 | 1,663,300.90 | 1,663,300.90 | |||||
Remarks on other changes: None Whether the Company has significant changes in the measurement attributes of its main assets during the reporting period Yes No
4.Restrictions on Assets as of the End of the Reporting Period
Unit: RMB Yuan
| Items | Closing book balance | Closing carrying amount | Type of restriction | Reasons for restrictions |
| Cash and bank balances | 12,939,755.86 | 12,939,755.86 | Pledged | Deposit for bank acceptance |
| 3,498,310.00 | 3,498,310.00 | Pledged | Deposit for letter of guarantee | |
| 3,883,550.00 | 3,883,550.00 | Pledged | Deposit for customs duty | |
| 19,750,000.00 | 19,750,000.00 | Pledged | Deposit for letters of credit | |
| 1,064,122.78 | 1,064,122.78 | Pledged | Security deposits for tap water fees | |
| 852,203.92 | 852,203.92 | Pledged | Deposit for project labor wage | |
| 18,500.00 | 18,500.00 | Pledged | Deposit for ETC | |
| 1,885.57 | 1,885.57 | Pledged | Deposit for emission rights | |
| 595,346.15 | 595,346.15 | Pledged | Deposit for futures | |
| 19,221,359.13 | 19,221,359.13 | Pledged | Deposit investment funds | |
| 1.00 | 1.00 | Pledged | Deposit for Yipaike platform | |
| Receivables financing | 114,794,927.96 | 114,794,927.96 | Pledged | Establish bank acceptance bill pledge |
| Fixed assets | 98,344,608.36 | 75,698,163.27 | Mortgage | Mortgaged for bank borrowings |
| Intangible assets | 108,525,632.40 | 85,879,187.31 | Mortgage | Mortgaged for bank borrowings |
| Total | 383,490,203.13 | 338,197,312.95 |
VI. Investment Status Analysis
1. Overall Information
Applicable Not applicable
| Investments during the reporting period (yuan) | Investments of the preceding period (yuan) | Percentage of change |
| 588,745,723.05 | 817,601,567.39 | -27.99% |
2. Significant equity investments made during the reporting period
Applicable Not Applicable
3. Significant non-equity investments in progress during the reporting period
Applicable Not Applicable
4. Investments in financial assets
(1) investments in securities
Applicable Not Applicable
There is no investment in securities during the reporting period.
(2) Investments in Derivatives
Applicable Not applicable
1) Derivative Investments for Hedge Purposes During the Reporting Period
Applicable Not applicable
Unit:RMB'0,000
| Categories of derivative investments | Initial investment amount | Opening balance | Gains on changes in fair value in the current period | Accumulated changes in fair value included in equity | Amount purchased during the reporting period | Amount sold during the reporting period | Closing balance | Proportion of investments to net assets at the end of the reporting period |
| Forward contracts | 126,083.85 | 126,083.85 | 5,707.23 | 0 | 1,010,263.24 | 721,432.90 | 414,914.19 | 11.84% |
| Structured forward contracts | 34,800.50 | 34,800.50 | 313.29 | 0 | 44,717.05 | 79,517.55 | 0 | 0.00% |
| Futures | 0 | 0 | -102.94 | 0 | 1,383.61 | 205.94 | 1,177.67 | 0.03% |
| Total | 160,884.35 | 160,884.35 | 5,917.58 | 0 | 1,056,363.90 | 801,156.39 | 416,091.86 | 11.87% |
| Remarks on whether there were significant changes in the | The Company accounts for the hedge business conducted in accordance with the relevant provisions and guidelines of the Ministry of Finance's "CASBE 22 — Financial Instruments: Recognition and Measurement", "CASBE 23 — Transfer of Financial Assets", and "CASBE 37 — Presentation of Financial Instruments". There were no significant changes in accounting policies and specific principles of accounting compared with the previous reporting period. | |||||||
| accounting policies and specific accounting principles for the Company's hedging business during the reporting period compared to the previous reporting period | ||||||||
| Explanation of actual profit or loss for the reporting period | In order to reduce the impact of exchange rate fluctuations on the Company's operating results, the Company carried out foreign exchange hedging business in accordance with a certain percentage of its export business, with business varieties mainly including forward exchange settlement and other foreign exchange derivative products, all of which were within the expected scale of sales business, and the actual gain on derivatives at the end of the reporting period was 79.5826 million yuan.In order to reduce the impact of material prices fluctuations on the Company's operating results, the Company carried out material futures hedging business in accordance with a certain percentage of its procurement business,with business varieties mainly including the bulk raw materials required for the daily production of the company, all of which were within the expected scale of procurement business.The loss of futures instruments was 183,000 yuan,and the floating loss of positions was 1.0294 million yuan. | |||||||
| Explanation of hedge effectiveness | The Company conducts foreign exchange hedge business and material futures hedging business to reduce exchange rate risk arising from exchange rate fluctuations and material prices risks from material prices fluctuations, aiming to reduce foreign exchange losses and effectively control operating risks. | |||||||
| Fund source | Own funds. | |||||||
| Remarks on risk analysis and control measures for holding derivative positions during the reporting period (including but not limited to market risk, liquidity risk, credit risk, operational risk, legal risk, etc.) | In order to prevent exchange rate risks and material prices risks, the Company and its subsidiaries carried out derivative instrument businesses. The Company and its subsidiaries strictly implemented the Management Measures on Foreign Exchange Hedging Business and Material Futures Hedging Business. | |||||||
| In the case of changes in market prices or fair value of investedderivatives during the reporting period, the analysis on fair value of derivatives shall disclose the specific methods for their uses, and the setting of relevant assumptions and parameters | Fair value gains on derivatives as at period-end amounted to 59.1758 million yuan. | |||||||
| Conditions of involved lawsuits (if applicable) | None | |||||||
| Disclosure date of the Board of Directors announcement for the approval of derivatives investment (if any) | April 16, 2026; April 29, 2026 | |||||||
2) Derivative Investments for Speculative Purposes During the Reporting Period
Applicable Not applicable
The Company had no derivative investments for speculative purposes during the reporting period.
5. Use of Proceeds from Fundraising
Applicable Not applicable
The Company did not utilize any proceeds from fundraising activities during the reporting period.
VII. Sale of Major Assets and Equities
1. Sale of Major Assets
Applicable Not applicable
There is no sale of major assets during the reporting period.
2. Significant Sale of Equities
Applicable ☑ Not applicable
VIII. Major Entities Controlled or Invested by the Company
Applicable Not applicable
Major subsidiaries and associates accounting for more than 10% of the Company’s net profit
Unit:RMB'0,000
| Name of companies | Categories | Main businesses | Registered capital | Total assets | Net assets | Operating revenue | Operating profit | Net profit |
| Shandong NHU Amino-acids Co., Ltd. | Subsidiary | Production and sales of methionine | 110,000 | 1,600,737.62 | 1,481,128.89 | 482,580.09 | 233,858.20 | 201,264.80 |
| Shandong NHU Fine Chemical Science and Technology Co., Ltd. | Subsidiary | Production and sales of feed additives | 90,000 | 599,925.58 | 465,695.08 | 198,858.72 | 75,335.05 | 61,925.57 |
| Shandong NHU Pharmaceutical Co., Ltd. | Subsidiary | Production and sales of fragrances | 59,000 | 666,425.60 | 596,578.94 | 213,404.44 | 81,788.04 | 70,559.90 |
Details of the acquisition and disposal of subsidiaries during the reporting period
Applicable Not applicable
| Name of companies | Method for acquisition and disposal of subsidiaries during the reporting period | Effect on the overall production, operation, and performance |
| NHU Life Science North America LLC | Investment and establishment | No significant effect at the initial stage. |
| Shandong Xinshuang'an Biotechnology Co., Ltd. | Deregistered | No significant effect at the initial stage. |
Remarks on major holding investees
Not applicable
IX.Structured entities controlled by the Company
Applicable Not applicable
X. The risks faced by the Company and the countermeasures
(1)Macroeconomic Risk
The international environment remains complex and volatile, with intensifying geopolitical rivalry and unresolved regiona conflicts contributing to uncertainties in the global macroeconomy. The Company will accelerate its internationalization process and expedite its global strategic layout. It will strengthen localized operations and service capabilities to ensure steady progress in its international expansion. The Company will continue to improve its global innovation, sales, and information centers, and build diversified innovation chains, supply chains, and customer bases to promote sound and sustainable development.
(2)Industry and Market Competition Risk
The Company faces competition from peers in both domestic and international markets. Competitors continue to enhance their overall competitiveness in terms of technology, capital, talent reserves, and sales channels. The transition between old and new production capacity has further intensified market competition, presenting greater challenges to the Company within the industry. In the future, the Company will continue to strengthen its R&D and innovation capabilities, focus on core strategic directions, deepen its industrial chain layout, upgrade product technology and service levels, improve management efficiency, enhance value creation capabilities, and increase its overall competitiveness.
(3)Raw Material Price Fluctuation Risk
Geopolitical conflicts have heightened uncertainties in global raw material supply and increased price volatility. As raw material costs account for a relatively high proportion of the Company’s total costs, fluctuations in raw material prices may affect the Company’s profitability. In the future, the Company will mitigate the adverse effects of raw material price fluctuations b strengthening market research and analysis, establishing strategic partnerships with suppliers, and improving raw material utilization efficiency.
(4) Risks of Product Market Price Fluctuation
Due to changes in market supply and demand and other factors, the market prices of the Company's products fluctuate, which has a certain impact on the Company's operating performance. The Company will continuously strengthen market expansion, deepen its industrial-chain layout, optimize its product architecture, improve quality and efficiency, fully tap potential, enhance product value and application, and service capabilities. It will also build technological and cost moats and reduce the risks posed by market price fluctuations.
(5) Exchange Rate and Trade Risks
The current international environment has grown increasingly complex, with rising uncertainty in global geopolitical risks and more variable trade and tariff policies, which may have a certain impact on the Company's sales revenue and profitability. Going forward, the Company will strengthen market assessment, closely monitor changes in the international situation, and mitigate risks through the use of hedge instruments and by advancing the Company’s international market expansion, striving to consolidate the Company’s international market position and actively explore new sources of economic growth.
(6) Risks of Changes in Environmental Protection Policies
With the increased social awareness of environmental protection, the promotion of the ecological civilization construction of the CPC Central Committee, and the strategic goal of "carbon emission peak and carbon neutrality", the requirements for energy conservation, emission reduction, safety, and environmental protection in the chemical and pharmaceutical manufacturing industr in which the Company operates are stricter than before. The Company will operate with higher standards, fully integrate ESG and carbon reduction requirements into the management framework, and explore more environmentally friendly ways of production to achieve sustainable development.
XI. Development and implementation of market value management system and valuation enhancement plan
Whether the Company has formulated a market value management system.
Yes No
Whether the Company has disclosed the valuation enhancement plan.
Yes No
The Company considered and passed the Market Value Management System at the Eleventh Meeting of the Ninth Session of the Board of Directors of the Company held on April 11, 2025, which specifies the institutions and responsibilities of market value management, the main methods of market value management, the monitoring and early warning mechanism and the contingency measures, etc., as detailed in the announcement of the Company published on the CNINFO (http://www.cninfo.com.cn) on Apri 15, 2025.
XII. Implementation of the “Quality-Return dual improvement” action plan
Whether the Company disclosed the “quality-return dual improvement” action plan.
Yes No
In line with the guiding principles set forth at the meeting of the Political Bureau of the CPC Central Committee to “revitalize the capital market and boost investor confidence,” and at the State Council executive meeting to “vigorously enhance the quality and investment value of listed companies, and adopt more effective measures to stabilize the market and bolster confidence,” and with a view to safeguarding the rights and interests of all shareholders, strengthening investor confidence, and promoting the Company’s long-term sustainable development, the Company disclosed the Announcement on the Action Plan for “Dua Enhancement of Quality and Return” (2024-002) on March 9, 2024. The Action Plan focuses on four key areas: “Innovation‑Driven Development and Core Business Excellence,” “Contributor‑ Oriented Approach and Sharing the Fruits of Development,” “Deepening Corporate Governance and Enhancing Standardized Operations,” and “Compliant Information Disclosure and Sincere Two‑ Way Communication.”
During the reporting period, the Company actively advanced and implemented the “Quality and Return Dual Enhancement” Action Plan, continued to deepen the execution of various measures, consolidated and improved its operational quality and governance standards, and placed strong emphasis on shareholder returns and the communication of corporate value. Remarkable results have been achieved in multiple aspects. For details, please refer to the Announcement on the Implementation Progress o the “Quality and Return Dual Enhancement” Action Plan (2026-036) published by the Company on August 20, 2026 in designated information disclosure media and on the CNINFO((http://www.cninfo.com.cn).
Section IV Corporate Governance, Environmental and Society
I.Changes of directors and senior executives
Applicable Not applicable
The Company’s directors and senior executives remains unchanged during the current reporting period, please refer to the 2025 Annual Report for details.
II. Profit distribution and conversion of capital reserve into share capital
Applicable Not applicable
| Bonus Shares per 10 shares (shares) | 0 |
| Dividends per 10 shares (yuan) (tax included) | 2 |
| Total Shares as Base for Distribution Plan (shares) | 3,068,717,398 |
| Cash Dividend Amount (yuan, pre-tax) | 613,743,479.60 |
| Cash Distributed via Other Methods (e.g., Share Repurchase) (yuan) | 0 |
| Total Cash Distribution (Including Other Methods) (yuan) | 613,743,479.60 |
| Distributable Profit (yuan) | 5,826,201,879.72 |
| Proportion of total cash dividends (including those by other methods) to total profit distribution | 100% |
| Cash Dividend Policy Requirement | |
| For companies in the growth phase with significant capital expenditure arrangements, the cash dividend ratio shall account for at least 20% of the total profit distribution. | |
| Details on proposals on profit distribution or conversion of capital reserve into share capital | |
| The profit distribution proposal reviewed and approved by the Board of Directors at this meeting is as follows: Based tentatively on 3,068,717,398 shares [Note], which is the total share capital of 3,073,421,680 shares as of July 31, 2026 after deducting 4,704,282 repurchased shares held in the special repurchase account, a cash dividend of RMB 2.00 (tax inclusive) per 10 shares will be distributed to all shareholders. No bonus shares (tax inclusive) will be issued, and no capitalization of capital reserves will be made.Note: The Company currently has a total share capital of 3,073,421,680 shares, of which 4,704,282 shares are held in the special repurchase account. In accordance with the Rules on Share Repurchases by Listed Companies, shares held in the special repurchase account are not entitled to profit distribution or capitalization of capital reserve.If the total share capital of the Company changes prior to the implementation of the distribution plan due to factors such as conversion of convertible bonds, share repurchases, exercise of equity incentive options, or listing of new shares from refinancing, the total amount to be distributed will be adjusted accordingly while the distribution ratio per share remains unchanged. | |
III. Implementation of equity incentive plans, employee stock ownership plans or other employee incentive programs
Applicable Not applicable
1. Equity incentive
Not applicable.
2. Implementation of employee stock ownership plans
Applicable Not applicable
All active employee stock ownership plans during the reporting period
| Scope of employees | Number of employees | Total shares held | Changes | Proportion to total share capital of the Company | Sources of fund to implement the plan |
| The fifth phase of employee stock ownership plan: directors, senior executives, eligible regular employees of the Company and its holding subsidiaries or wholly-owned subsidiaries who meet the criteria | 602 | 21,454,310 | N/A | 0.70% | Legal remuneration of the employees, self-raised funds and other methods permitted by laws and administrative regulations |
Shareholdings of directors and senior executives in the employee stock ownership plan during the reporting period
| Name | Position | Number of shares held at the beginning of the reporting period | Number of shares held at the end of the reporting period | Proportion to total share capital of the Company |
| The fifth phase of employee stock ownership plan:Hu Baifan, Hu Baishan, Shi Guanqun, Wang Xuewen, Wang Zhengjiang, Zhou Guiyang, Yu Hongwei, Zhang Liying | Directors and senior executives | 0 | 5,481,601 | 0.18% |
Changes in asset management agency during the reporting period
Applicable Not applicable
Changes in equity during the reporting period due to disposal of shares by holders
Applicable Not applicable
Exercise of shareholders’ rights during the reporting period
Pursuant to the Fifth Phase of Employee Stock Ownership Plan , such plan voluntarily waives the voting rights of holding shares in the Board of Shareholders of the Company, while shares acquired through the employee stock ownership plan carry no voting rights in the Board of Shareholders. During the reporting period, the employee stock ownership plan did not exercise the voting rights of holding shares in the Board of Shareholders, but still enjoyed the right to profit distribution.
Other relevant situations and remarks of the employee stock ownership plan during the reporting period
Applicable Not applicable
Change in membership of the management committee of employee stock ownership plan
Applicable Not applicable
The second holders’ meeting of the Company’s Fifth Phase Employee Stock Ownership Plan was held on June 23,
2026 by means of communication voting. In view of the work adjustment of Ms. Liu Fanglu, one of the management committee members of the Fifth Phase Employee Stock Ownership Plan of Zhejiang NHU Co., Ltd., and in order to better safeguard the overall interests of the employee stock ownership plan, this holders’ meeting elected Ms. Wang Xiaobi as a member of the management committee of the Fifth Phase Employee Stock Ownership Plan. Together with Ms. Xi Chun, Mr. Cao Ying, Mr. Yu Weiguo and Ms. Zeng Shuying elected at the first holders’ meeting, they jointly form the management committee of the Company’s Fifth Phase Employee Stock Ownership Plan, with a term of office equal to the duration of the Company’s Fifth Phase Employee Stock Ownership Plan.
Financial impact of employee stock ownership plan on the Company in the reporting period and related accounting treatments
Applicable Not applicable
Termination of employee stock ownership plan during the reporting period
Applicable Not applicable
Other Notes:
The number of shares held by directors and senior management in the employee stock ownership plan is calculated based on the proportion of the holders’ shares to the total shares of the employee stock ownership plan.
3.Other employee incentive programs
Applicable Not applicable
IV. Environmental Information Disclosure
Whether the listed company and its major subsidiaries are included in the list of enterprises required to disclose environmental information in accordance with the law
Applicable Not applicable
| Number of enterprises included in the list of enterprises required to disclose environmental information in accordance with the law (number of companies) | ||
| No. | Company name | Reference index for environmental information disclosure reports |
| 1 | Zhejiang NHU Co., Ltd. | Zhejiang Enterprise Environmental Information Disclosure System, website:https://mlzj.sthjt.zj.gov.cn/eps/index/enterprise-list?input=%E6%B5%99%E6%B1%9F%E6%96%B0%E5%92%8C%E6%88%90%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8&area= |
| 2 | Shangyu NHU Bio-Chem Co., Ltd. | Zhejiang Enterprise Environmental Information Disclosure System, website:https://mlzj.sthjt.zj.gov.cn/eps/index/enterprise-list?input=%E4%B8%8A%E8%99%E6%96%B0%E5%92%8C%E6%88%90%E7%94%9F%E7%89%A9%E5%8C%96%E5%B7%A5%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8&area= |
| 3 | Zhejiang NHU Pharmaceutical Co., Ltd. | Zhejiang Enterprise Environmental Information Disclosure System, website:https://mlzj.sthjt.zj.gov.cn/eps/index/enterprise-list?input=%E6%B5%99%E6%B1%9F%E6%96%B0%E5%92%8C%E6%88%90%E8%8D%AF%E4%B8%9A%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8&area= |
| 4 | Zhejiang NHU Specialty Materials Co., Ltd. | Zhejiang Enterprise Environmental Information Disclosure System, website:https://mlzj.sthjt.zj.gov.cn/eps/index/enterprise-list?input=%E6%B5%99%E6%B1%9F%E6%96%B0%E5%92%8C%E6%88%90%E7%89%B9%E7%A7%8D%E6%9D%90%E6%96%99%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8&area= |
| 5 | Shaoxing Yuchen New Materials Co., Ltd. | Zhejiang Enterprise Environmental Information Disclosure System, website:https://mlzj.sthjt.zj.gov.cn/eps/index/enterprise-list?input=%E7%BB%8D%E5%85%B4%E8%A3%95%E8%BE%B0%E6%96%B0%E6%9D%90%E6%96%99%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8&area= |
| 6 | Shandong NHU Pharmaceutical Co., Ltd. | Shandong Enterprise Environmental Information Disclosure System, website:http://221.214.62.226:8090/EnvironmentDisclosure/enterpriseRoster/openEnterpriseDetails?comDetailFrom=0&id=91370700665726586C |
| 7 | Shandong NHU Amino-acids Co., Ltd. | Shandong Enterprise Environmental Information Disclosure System, website:http://221.214.62.226:8090/EnvironmentDisclosure/enterpriseRoster/openEnterpriseDetails?comDetailFrom=0&id=91370700068724427K |
| 8 | Shandong NHU Fine Chemical Science and Technology Co., Ltd. | Shandong Enterprise Environmental Information Disclosure System, website:http://221.214.62.226:8090/EnvironmentDisclosure/enterpriseRoster/openEnterpriseDetails?comDetailFrom=0&id=91370700MA3DJKFLX8 |
| 9 | Shandong NHU Fine Chemical Science and Technology Co., Ltd. Vitamins Branch | Shandong Enterprise Environmental Information Disclosure System, website:http://221.214.62.226:8090/EnvironmentDisclosure/enterpriseRoster/openEnterpriseDetails?comDetailFrom=0&id=91370700MAE7CDAE8F |
| 10 | Weifang Haicheng Thermal Power Co., Ltd. | Shandong Enterprise Environmental Information Disclosure System, website:http://221.214.62.226:8090/EnvironmentDisclosure/enterpriseRoster/openEnterpriseDetails?comDetailFrom=0&id=91370700MA3M9W2793 |
| 11 | Heilongjiang Xinhao Thermal Power Co., Ltd. | Heilongjiang Enterprise Environmental Information Disclosure System, website:http://111.40.190.123:8082/eps/index/enterprise-list?input=%E9%BB%91%E9%BE%99%E6%B1%9F%E6%96%B0%E6%98%8A&area= |
| 12 | Heilongjiang NHU Biotechnology Co., Ltd. | Heilongjiang Enterprise Environmental Information Disclosure System, website:http://111.40.190.123:8082/eps/index/enterprise-list?input=%E9%BB%91%E9%BE%99%E6%B1%9F%E6%96%B0%E5%92%8C%E6%88%90&area= |
V. Social responsibilities
Not applicable
Section V Significant Events
I. Commitment performance fulfilled during the reporting period and overdue commitments as of the end of the reporting period by parties related to commitments including the actual controller of the Company, shareholders, related parties, acquirers and the Company itself.
Applicable Not applicable
| Commitments | Parties making commitments | Types of commitments | Content of commitments | Time of commitment | Term of commitment | Performance |
| Commitments to shares reform | None | None | None | None | None | |
| Commitments made in reports on acquisition and changes in equity | None | None | None | None | None | |
| Commitments made in asset restructuring | None | None | None | None | None | |
| Commitments made in IPO or refinancing | NHU Holding Group Co., Ltd. and Zhang Pingyi, Shi Cheng, Yuan Yizhong, Hu Baishan, Shi Guanqun, Wang Xuewen, Cui Xinrong, Wang Xulin | Commitments on horizontal competition, related party transactions and occupation of funds | The signing of "Commitment on No Engagement in Horizontal Competition" and commitments on no engagement in business activities result in horizontal competition with operations of the Company after listing | June 25, 2004 | Long-term | Strictly performed |
| Hu Baifan; Hu Baishan; Shi Guanqun; Wang Xuewen; Cui Xinrong; Wang Zhengjiang; Zhou Guiyang | The Company's directors, senior management committed to perform their duties faithfully and diligently to safeguard the legitimate rights and interests of the Company and shareholders, and make the following commitmentsin accordance with the relevant provisions of the CSRC for the full performance of measures on filling immediate returns: 1. not to transfer benefits to other entities or individuals without compensation or on unfair terms, and not to use other means to harm benefits of the Company; 2. to impose restrictions on duty consumption of member of the Board of Directors and senior management; 3. not to use assets of the Company to engage in investment or consumption activities not related to duty performance; 4. to link remuneration system formulated by the Board of Directors or remuneration committee to the implementation of measures on filling immediate returns; 5. tolink vesting conditions of equity incentive to be published in the future to the implementation of measures on filling immediate returns. | January 12, 2017 | Long-term | Strictly performed | ||
| Hu Baifan; NHU Holding Group Co., Ltd. | Not to interfere in the Company's business and management activities in excess of authority; not to encroach on the benefits of the Company; to perform measures on filling immediate returns in a practical way. | January 12, 2017 | Long-term | Strictly performed | ||
| Commitments to equity incentive | None | None | None | None | None | |
| Other commitments to minority shareholders of the Company | None | None | None | None | None | |
| Other commitments | None | None | None | None | None | |
| Whether commitments are performed on time | Yes | |||||
| If commitment performance is not fulfilled on time, please explain detailed reasons for it and the next work plans. | Not applicable | |||||
II. Non-operating occupation of funds over listed companies by controlling shareholders and other related parties
Applicable Not applicable
There is no non-operating occupation of funds over listed companies by controlling shareholders and other related parties during the reporting period.
III. Illegal external guarantees
Applicable ☑ Not applicable
There is no illegal external guarantee during the reporting period.
IV.Engagement and dismissal of accounting firms
Whether the semi-annual report has been audited or not
Yes No
The semi-annual report has not been audited.
V. Statements by the Board of Directors on the “Modified Auditor’s Report” issued by the accounting firm during the reporting period
Applicable ☑ Not applicable
VI. Explanations by the Board of Directors on the “Modified Auditor’s Report” issued by the accounting firm last year
Applicable Not applicable
VII. Matters related to bankruptcy and restructuring
Applicable Not applicable
There are no matters related to bankruptcy and restructuring during the reporting period.
VIII. Lawsuits
Significant lawsuits and arbitration Applicable ☑ Not applicable There is no significant lawsuit and arbitration during the reporting period. Other lawsuits Applicable Not applicable IX. Penalties and rectification Applicable ☑ Not applicable
There is no instance of penalty or rectification for the Company during the reporting period.
X. Integrity of the Company, its controlling shareholders and the actual controller
Applicable Not applicable
XI. Significant related party transactions
1. Related party transactions relevant to daily operations
Applicable Not applicable
There is no related party transaction relevant to daily operations during the reporting period.
2. Related party transactions in purchase or sale of assets or equities
Applicable ☑ Not applicable
There is no related party transaction in purchase or sale of assets or equities during the reporting period.
3. Related party transactions in joint external investments
Applicable Not applicable
There is no related party transaction in joint external investments during the reporting period.
4. Related party creditor’s rights and debts
Applicable Not applicable
There is no related creditor’s rights or debts during the reporting period.
5. Transactions with related financial companies
Applicable ☑ Not applicable
There is no business of deposits, loans, credit granting or other financial businesses between the Company and its related financial companies.
6. Transactions between financial companies controlled by the Company and the Company’s related parties
Applicable ☑ Not applicable
There is no business of deposits, loans, credit granting or other financial businesses between financial companies controlled by the Company and the Company’s related parties.
7. Other significant related party transactions
Applicable Not applicable
There is no other material connected transactions during the reporting period.
XII. Significant contracts and performance
1. Matters of trusteeship, contracting and leases
(1) Trusteeship
Applicable Not applicable
There is no trusteeship during the reporting period.
(2) Contracting
Applicable ☑ Not applicable
There is no contracting during the reporting period.
(3) Leases
Applicable ☑ Not applicable
There is no lease during the reporting period.
2. Significant Guarantees
Applicable Not applicable
Unit:RMB'0,000
| External guarantees by the Company and its subsidiaries to third parties (guarantees to subsidiaries are excluded) | ||||||||||
| Guaranteed parties | Announcement date of disclosure of amount guaranteed | Amount guaranteed | Actual commencement date | Actual amount guaranteed | Types of guarantees | Collateral s (if any) | Counter guarantees (if any) | Period of guarantee | Whether the guarantee is mature | Whether guarantee for related parties |
| None | ||||||||||
| Total amount of external guarantees approved during the reporting period (A1) | 0 | Total amount of actual external guarantees during the reporting period (A2) | 0 | |||||||
| Total amount of external guarantees approved at the end of the reporting period (A3) | 0 | Total balance of actual external guarantees at the end of the reporting period (A4) | 0 | |||||||
| The Company's guarantees to subsidiaries | ||||||||||
| Guaranteed parties | Announcement date of disclosure of amount guaranteed | Amount guaranteed | Actual commencement date | Actual amount guaranteed | Types of guarantees | Collateral s (if any) | Counter guarantees (if any) | Period of guarantee | Whether the guarantee is mature | Whether guarantee for related parties |
| Xinchang NHU Vitamins Co., Ltd. | 4/22/2021 | 40,000 | 12/16/2021 | 29,000 | Joint and several liability guarantee | 0 | 0 | 2021.12.16-2026.12.25 | No | No |
| Zhejiang NHU Pharmaceutical Co., Ltd. | 5/11/2022 | 60,000 | 6/24/2022 | 55,000 | Joint and several liability guarantee | 0 | 0 | 2022.06.24-2027.06.23 | No | No |
| Xinchang NHU Vitamins Co., Ltd. | 5/11/2022 | 20,000 | 10/14/2022 | 18,000 | Joint and several liability guarantee | 0 | 0 | 2022.10.14-2027.10.14 | No | No |
| Shandong NHU Fine Chemical Science and Technology | 5/20/2023 | 58,600 | 6/06/2023 | 58,600 | Joint and several liability guarantee | 0 | 0 | 2023.03.30-2028.03.29 | No | No |
| Co., Ltd. | ||||||||||
| NHU (Hong Kong) Trading Co., Ltd. | 5/20/2023 | 100,000 | 11/20/2023 | 54,487.2 | Joint and several liability guarantee | 0 | 0 | 2023.11.08-2026.11.08 | No | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/16/2024 | 50,000 | 8/01/2024 | 34,054.5 | Joint and several liability guarantee | 0 | 0 | 2024.08.01-2027.08.01 | No | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/09/2025 | 50,000 | 5/19/2025 | 7,491.99 | Joint and several liability guarantee | 0 | 0 | 2025.05.19-2026.05.08 | Yes | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/09/2025 | 50,000 | 6/13/2025 | 11.38 | Joint and several liability guarantee | 0 | 0 | 2025.06.13-2026.02.26 | Yes | No |
| Zhejiang NHU Import & Export Co., Ltd. | 5/09/2025 | 15,000 | 7/08/2025 | 15,000 | Joint and several liability guarantee | 0 | 0 | 2025.07.08-2026.07.07 | No | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/09/2025 | 50,000 | 8/06/2025 | 6,810.9 | Joint and several liability guarantee | 0 | 0 | 2025.08.06-2026.05.15 | Yes | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/09/2025 | 50,000 | 10/28/2025 | 24.89 | Joint and several liability guarantee | 0 | 0 | 2025.10.28-2026.03.04 | Yes | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/09/2025 | 50,000 | 11/27/2025 | 4.22 | Joint and several liability guarantee | 0 | 0 | 2025.11.27-2026.04.08 | Yes | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/09/2025 | 50,000 | 01/22/2026 | 9.66 | Joint and several liability guarantee | 0 | 0 | 2026.01.22-2026.06.04 | Yes | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/09/2025 | 50,000 | 03/03/2026 | 67.85 | Joint and several liability guarantee | 0 | 0 | 2026.03.03-2026.07.14 | No | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/15/2026 | 50,000 | 06/10/2026 | 6,810.9 | Joint and several liability guarantee | 0 | 0 | 2026.06.10-2027.06.20 | No | No |
| NHU (Hong Kong) Trading Co., Ltd. | 5/15/2026 | 50,000 | 06/15/2026 | 4.82 | Joint and several liability guarantee | 0 | 0 | 2026.06.15-2026.09.02 | No | No |
| Total amount of guarantees approved for subsidiaries during the reporting period (B1) | 80,000 | Total amount actually guaranteed for subsidiaries during the reporting period (B2) | 6,893.23 | |||||||
| Total amount of guarantees approved for subsidiaries at the end of the reporting period (B3) | 344,209.55 | Total balance of actual external guarantees for subsidiaries at the end of the reporting period (B4) | 271,025.27 | |||||||
| Guarantees by subsidiaries to subsidiaries | ||||||||||
| Guaranteed parties | Announcement date of disclosure of amount guaranteed | Amount guaranteed | Actual commencement date | Actual amount guaranteed | Types of guarantees | Collateral s (if any) | Counter guarantees (if any) | Period of guarantee | Whether the guarantee is mature | Whether guarantee for related parties |
| None | ||||||||||
| Total amount of guarantees approved for subsidiaries during the reporting period (C1) | 0 | Total amount actually guaranteed for subsidiaries during the reporting period (C2) | 0 | |||||||
| Total amount of guarantees approved for subsidiaries at the end of the reporting period (C3) | 0 | Total balance of actual external guarantees for subsidiaries at the end of the reporting period (C4) | 0 | |||||||
| Total amount guaranteed by the Company (namely, the sum of the above three items) | ||||||||||
| Total amount of guarantees approved during the reporting period (A1+B1+C1) | 80,000 | Total amount actually guaranteed during the reporting period (A2+B2+C2) | 6,893.23 | |||||||
| Total amount of guarantees approved at the end of the reporting period (A3+B3+C3) | 344,209.55 | Total balance of actual guarantees at the end of the reporting period (A4+B4+C4) | 271,025.27 | |||||||
| Proportion of the total guarantee balance (A4+B4+C4) to net assets of the Company | 7.77% | |||||||||
| Including: | ||||||||||
| Balance of guarantees for shareholders, the actual controller and its related parties (D) | 0 | |||||||||
| Balance of debt guarantee directly or indirectly for guaranteed parties with debt to asset ratio exceeding 70% (E) | 157,425.27 | |||||||||
| The amount of the total amount guaranteed exceeding 50% of net assets (F) | 0 | |||||||||
| Total amount guaranteed of three items above (D+E+F) | 157,425.27 | |||||||||
| Remarks on unexpired guarantee contracts with guarantee liabilities incurred or evidence indicating the possibility of undertaking joint liquidation liabilities during the reporting period (if applicable) | None | |||||||||
| Remarks on external guarantee in violation of provisions (if applicable) | None | |||||||||
Specific description of the use of composite guarantees: None
3. Entrusted Cash Assets Management
☑ Applicable Not applicable
Unit:RMB'0,000
| Product category | Risk characteristics | Balance of entrusted financing during the reporting period | Amount overdue and not recovered |
| Bank financial products | Low risk type with high security and good liquidity | 255,000 | 0 |
Details of the Company's activities, as the sole entruster, in commissioning financial institutions to conduct asset management, or investments in high-risk entrusted wealth-management products that have lower safety and poorer liquidit
Applicable Not applicable
4. Other Significant Contracts
Applicable ☑ Not applicable
There is no other significant contract during the reporting period.
XIII. Research, Communications, and Interviews Received by the Company During the Reporting Period
Applicable Not applicable
| Date of reception | Reception site | Way of reception | Type of visitor | Visitors | Major contents of the conversation and information provided | Index for basic information of the investigation |
| January 22-23, 2026 | Shanghai Pudong Shangri-La Hotel; Company Headquarters Meeting Room | Field research | Institution | Participating organizations: For details, please refer to the disclosures on CNINFO (http://www.cninfo.com.cn). | Introduce the operating conditions of the Company and answer questions from investors | Please refer to the Investor Relations Activities Record Sheet on January 22-23, 2026, published at the website http://irm.cninfo.com.cn/ssessgs/S002001 for details. |
| March 18-19, 2026 | China World Hotel, Beijing; Wanda Reign Wuhan | Field research | Institution | Participating organizations: For details, please refer to the disclosures on CNINFO (http://www.cninfo.com.cn). | Introduce the operating conditions of the Company and answer questions from investors | Please refer to the Investor Relations Activities Record Sheet on March 18-19, 2026, published at the website http://irm.cninfo.com.cn/ssessgs/S002001 for details. |
| April 29, 2026 | Shenzhen Stock Exchange,"Interactive Easy" platform, "Cloud Interview": http://irm.cninfo.com.cn | Network platform online communication | Others | Participating organizations: For details, please refer to the disclosures on CNINFO (http://www.cninfo.com.cn). | Introduce the operating conditions of the Company and answer questions from investors | Please refer to the Investor Relations Activities Record Sheet on April 29, 2026, published at the website http://irm.cninfo.com.cn/ssessgs/S002001 for details. |
| May 15, 2026 | Company Headquarters 2nd Floor Lecture Hall. | Field research | Institution | Participating organizations: For details, please refer to the disclosures on CNINFO (http://www.cninfo.com.cn). | Introduce the operating conditions of the Company and answer questions from investors | Please refer to the Investor Relations Activities Record Sheet on May 15, 2026, published at the website http://irm.cninfo.com.cn/ssessgs/S002001 for details. |
XIV. Other significant matters
☑ Applicable Not applicable
1. Progress of the Fifth Phase Employee Stock Ownership Plan
The Company held the 16th meeting of the Ninth Board of Directors and the 11th meeting of the Ninth Supervisory Board on December 10, 2025, and the third extraordinary general meeting of 2025 on December 26, 2025, at which it reviewed and approved the employee stock ownership plan-related proposals, including the Draft of the Fifth Phase Employee Stock Ownership Plan of Zhejiang NHU Co., Ltd. and Its Summary, and agreed to implement the Fifth Phase Employee Stock Ownership Plan. The Fifth Phase Employee Stock Ownership Plan was actually subscribed by 602 participants, with actual subscription funds of RMB 259.49 million. The controlling shareholder, NHU Holding Group Co., Ltd., provided a matching loan of RMB 259.49 million, and the total funds of the Fifth Phase Employee Stock Ownership Plan amounted to RMB 518.98 million. As of January 26, 2026, the Company received the Securities Transfer Registration Confirmation issued by the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited. The 21,454,310 shares of the Company held in the Company’s special repurchase securities account were transferred by way of non-trading transfer to the dedicated securities account of “Zhejiang NHU Co., Ltd. – Fifth Phase Employee Stock Ownership Plan” on January 23, 2026, accounting for 0.6981% of the Company’s total share capital, at a transfer price of RMB 24.19 per share. The lock-up period for the underlying shares acquired by the Fifth Phase Employee Stock Ownership Plan is 12 months, calculated from the date on which the Company announced the registration and transfer of the last batch of underlying shares to the name of the Plan, i.e., from January 27, 2026 to January 26, 2027. The duration of the underlying shares acquired under this Employee Stock Ownership Plan is 24 months, calculated from the date on which the Company announced the registration and transfer of the last batch of underlying shares to the name of the Plan. For details, please refer to the relevant announcements published by the Company on the designated information disclosure media and CNINFO (http://www.cninfo.com.cn).
The second holders’ meeting of the Company’s Fifth Phase Employee Stock Ownership Plan was held on June 23, 2026 by means o communication voting. In view of the work adjustment of Ms. Liu Fanglu, one of the management committee members of the Fifth Phase Employee Stock Ownership Plan of Zhejiang NHU Co., Ltd., and in order to better safeguard the overall interests of the employee stock ownership plan, this holders’ meeting elected Ms. Wang Xiaobi as a member of the management committee of the Fifth Phase Employee Stock Ownership Plan. Together with Ms. Xi Chun, Mr. Cao Ying, Mr. Yu Weiguo and Ms. Zeng Shuying elected at the first holders’ meeting, they jointly form the management committee of the Company’s Fifth Phase Employee Stock Ownership Plan, with a term of office equal to the duration of the Company’s Fifth Phase Employee Stock Ownership Plan.. Fo details, please see the Announcement on Adjustment of Members of the Management Committee for the Fifth Phase Employee Stock ‑ ownership Plan disclosed on June 24, 2026 via designated information disclosure media and CNINFO (http://www.cninfo.com.cn).
2. Progress of Share Repurchase
At the 20th meeting of the Ninth Board of Directors held on June 23, 2026, the Company reviewed and approved the Proposal on the Share Repurchase Plan, agreeing to use its own funds to repurchase part of the Company’s publicly issued shares through centralized bidding transactions, for the purpose of implementing equity incentive plans or employee stock ownership plans. The repurchase amount is in the range of RMB 300 million to RMB 600 million, and the repurchase price shall not exceed RMB 45.50 per share The specific number of repurchased shares and its proportion to the total share capital shall be subject to the actual number of shares repurchased upon expiration of the repurchase period. For details, please refer to the Announcement on the Company’s Share Repurchase Plan(2026-027) published by the Company on the designated information disclosure media and CNINFO (http://www.cninfo.com.cn).
As of June 30, 2026, the Company had not yet commenced the share repurchase. For details, please refer to the Announcement on the Progress of Share Repurchase and the First Share Repurchase of the Company (2026-031) published by the Company on the designated information disclosure media and CNINFO (http://www.cninfo.com.cn).
XV. Significant matters of the subsidiaries of the Company
Applicable ☑ Not applicable
Section VI Movements in Share Capital and Shareholders
I. Movements in Share
1. Details
Unit: Share
| Items | Before | Movements | After | ||||||
| Quantity | % to total | Issue of new shares | Bonus shares | Conversion of capital reserve into shares | Others | Subtotal | Quantity | % to total | |
| I. Restricted shares | 36,559,752 | 1.19% | 9,000 | 9,000 | 36,568,752 | 1.19% | |||
| 1. State-owned shares | |||||||||
| 2. Held by state-owned legal persons | |||||||||
| 3. Held by other domestic parties | 36,559,752 | 1.19% | 9,000 | 9,000 | 36,568,752 | 1.19% | |||
| Including: Held by domestic legal persons | |||||||||
| Held by domestic natural persons | 36,559,752 | 1.19% | 9,000 | 9,000 | 36,568,752 | 1.19% | |||
| 4. Held by overseas parties | |||||||||
| Including: Held by overseas legal persons | |||||||||
| Held by overseas natural persons | |||||||||
| II. Unrestricted shares | 3,036,861,928 | 98.81% | -9,000 | -9,000 | 3,036,852,928 | 98.81% | |||
| 1. RMBordinary shares | 3,036,861,928 | 98.81% | -9,000 | -9,000 | 3,036,852,928 | 98.81% | |||
| 2. Domestically listed foreign shares | |||||||||
| 3. Overseas listed foreign shares | |||||||||
| 4. Others | |||||||||
| III. Total shares | 3,073,421,680 | 100.00% | 3,073,421,680 | 100.00% | |||||
Reason for movements
Applicable Not applicable
During the reporting period, there is no change in the total share capital of the Company. As the supervisory board had been cancelled in the previous period, the lock-up shares attributable to the resigned supervisors (as part of the senior management lockup shares) changed accordingly, resulting in corresponding changes in restricted shares. Approval on movements in shares Applicable ☑ Not applicable Transfer of shares Applicable ☑ Not applicable Actual progress of share repurchase Applicable Not applicable
The 20th meeting of the Ninth Board of Directors of the Company held on June 23, 2026, deliberated and approved the Proposal on the Share Repurchase Scheme. It was approved that the Company would repurchase part of its publicly held shares using its own funds through centralized bidding transactions, for the purpose of implementing an equity incentive plan or an employee stock ownership plan, with the total repurchase amount ranging from RMB 300 million to RMB 600 million. As of June 30, 2026, the Company had not yet commenced the implementation of the share repurchase.
Implementation progress of shareholding reduction for shares repurchased through centralized bidding
Applicable Not applicable
Effect of changes in shares on financial indicators of preceding year and preceding period such as basic EPS and diluted EPS, net assets per share attributable to shareholders of ordinary shares
Applicable Not applicable
Other contents the Company considered as necessary or securities regulatory institutions required disclosure
Applicable Not applicable
2.Movement in Restricted Stocks
Applicable Not applicable
Unit: Share
| Shareholders | Opening balance | Increase | Decrease due to unlocking | Closing balance | Reason for restriction | Date of unlocking |
| Others | 0 | 0 | 9,000 | 9,000 | Executive lock-in | Managed in accordance with the relevant provisions on locked-up shares of senior executives. |
| Total | 0 | 0 | 9,000 | 9,000 | -- | -- |
Note: The shares listed under the “Others” column of shareholders in the table represent the shares held by the company’s former supervisors.
II. Issuance and listing of securities
Applicable ☑ Not applicable
III. Number of shareholders of the Company and their shareholding conditions
Unit: Share
| Total number of ordinary shareholders at the end of the reporting period | 78,891 | Total number of preferred shareholders whose voting rights were restored at the end of the reporting period | 0 | |||||
| Shareholders with holding proportion over 5% or the top 10 shareholders with largest holding proportions | ||||||||
| Shareholders | Nature of shareholders | Holding proportion | Quantity of ordinary shares at the end of the reporting period | Movements during the reporting period | Quantity of restricted shares | Quantity of unrestricted shares | Shares pledged, marked or frozen | |
| Condition | Quantity | |||||||
| NHU Holding Group Co., Ltd. | Domestic non-state-owned legal person | 50.08% | 1,539,232,431 | 0 | 0 | 1,539,232,431 | N/A | 0 |
| Hong Kong Securities Clearing Company Limited | Overseas legal person | 6.02% | 184,907,234 | 5,973,646 | 0 | 184,907,234 | N/A | 0 |
| National Social Security Fund No.503 Portfolio | Others | 0.87% | 26,600,007 | -1,400,073 | 0 | 26,600,007 | N/A | 0 |
| China Construction Bank Corporation - E Fund CSI 300 Healthcare ETF | Others | 0.81% | 24,983,011 | 4,460,629 | 0 | 24,983,011 | N/A | 0 |
| Zhejiang NHU Co., Ltd. - Fifth Employee StockOwnership Plan | Others | 0.70% | 21,454,310 | 21,454,310 | 0 | 21,454,310 | N/A | 0 |
| Hu Baishan | Domestic natural person | 0.47% | 14,595,929 | 0 | 10,946,947 | 3,648,982 | N/A | 0 |
| Hu Baifan | Domestic natural person | 0.45% | 13,922,998 | 0 | 10,442,248 | 3,480,750 | N/A | 0 |
| China Universal Asset Management Co., Ltd. - Social Security Fund Portfolio 16032 | Others | 0.38% | 11,765,192 | 11,765,192 | 0 | 11,765,192 | N/A | 0 |
| Zhejiang Baofang Printing and Dyeing Co., Ltd. | Domestic non-state-owned legal person | 0.36% | 11,048,410 | 3,982,200 | 0 | 11,048,410 | N/A | 0 |
| Yu Baomu | Domestic natural person | 0.36% | 10,934,700 | 385,800 | 0 | 10,934,700 | N/A | 0 |
| Strategic investors or ordinary legal persons that became one of the top 10 shareholders due to the allotment of new shares | N/A | |||||||
| Remarks on relationships or concerted action between the top 10 shareholders with largest holding proportions | The above shareholder, Hu Baifan is the chairman, general manager, and actual controller of NHU Holding Group Co., Ltd.; Hu Baishan is a director of NHU Holding Group Co., Ltd. Hu Baifan and Hu Baishan are brothers. Hu Baifan and Hu Baishan have an affiliated relationship with Zhejiang NHU Co., Ltd. - Fifth Employee Stock Ownership Plan due to their participation in the employee stock ownership plan. The Company does not know whether other shareholders have relationships and whether they are persons acting in concert as defined in “Administration of the Takeover of Listed Companies Procedures”. | |||||||
| Remarks on proxy voting and waiver of voting right of the above shareholders | N/A | |||||||
| Special remarks on top 10 shareholders with special repurchase accounts | N/A | |||||||
| Top 10 shareholders with unrestricted shares (excluding shares lent through transfer facility and shares locked up by executives) | ||||||||
| Shareholders | Quantity of unrestricted shares at the end of the reporting period | Category of shares | ||||||
| Category | Quantity | |||||||
| NHU Holding Group Co., Ltd. | 1,539,232,431 | RMB ordinary shares | 1,539,232,431 | |||||
| Hong Kong Securities Clearing Company Limited | 184,907,234 | RMB ordinary shares | 184,907,234 | |||||
| National Social Security Fund No.503 Portfolio | 26,600,007 | RMB ordinary shares | 26,600,007 | |||||
| China Construction Bank Corporation - E Fund CSI 300 Healthcare ETF | 24,983,011 | RMB ordinary shares | 24,983,011 | |||||
| Zhejiang NHU Co., Ltd. - Fifth Employee Stock Ownership Plan | 21,454,310 | RMB ordinary shares | 21,454,310 | |||||
| China Universal Asset Management Co., Ltd. - Social Security FundPortfolio 16032 | 11,765,192 | RMB ordinary shares | 11,765,192 | |||||
| Zhejiang Baofang Printing and Dyeing Co., Ltd. | 11,048,410 | RMB ordinary shares | 11,048,410 | |||||
| Yu Baomu | 10,934,700 | RMB ordinary shares | 10,934,700 | |||||
| Industrial and Commercial Bank of China Limited - China Universal Value Selected Mixed Securities Investment Fund | 10,859,600 | RMB ordinary shares | 10,859,600 | |||||
| Wu Wenping | 10,512,214 | RMB ordinary shares | 10,512,214 | |||||
| Remarks on relationships or concerted action between the top 10 shareholders with unrestricted shares, and between the top 10 shareholders with unrestricted shares and the top 10 shareholders with largest holding proportions. | Hu Baifan is the chairman, general manager, and actual controller of NHU Holding Group Co., Ltd.; Hu Baishan is a director of NHU Holding Group Co., Ltd. The Company does not know whether other shareholders have relationships and whether they are persons acting in concert as defined in “Administration of the Takeover of Listed Companies Procedures”. | |||||||
| Remarks on top 10 shareholders of ordinary shares participating in securities margin trading | Zhejiang Baofang Printing and Dyeing Co., Ltd. holds 7,066,210 shares through the customer credit transaction collateral securities account of Guotai Haitong Securities Co., Ltd.; Yu Baomu holds 10,718,900 shares through the customer credit transaction collateral securities account of Guotai Haitong Securities Co., Ltd.; Wu Wenping holds 10,512,214 shares through the customer credit transaction collateral securities account of Caitong Securities Co., Ltd. | |||||||
The participation of shareholders holding more than 5% of shares, the top 10 shareholders and the top 10 shareholders with unlimited shares in circulation in lending of shares in the transfer and financing business
Applicable ☑ Not applicable
Top 10 shareholders and top 10 shareholders with unlimited shares outstanding Change from the previous period due to lending/returning of convertible bond
Applicable Not applicable
Did the top 10 common shareholders and the top 10 unrestricted common shareholders of the company engage in any agreed repurchase transactions during the reporting period
Yes No
The top 10 common shareholders and the top 10 unrestricted common shareholders of the company did not engage in any agreed repurchase transactions during the reporting period.
IV.Changes in shareholdings of directors and senior executives
Applicable Not applicable
The shareholdings of the company’s directors and senior management personnel did not change during the reporting period. For details, please refer to the 2025 Annual Report.
V. Changes in controlling shareholders or actual controllers
If the Company has previously disclosed that its actual controller is planning a change of control but the change has not yet been completed, please describe the progress of the change of control
Applicable ☑ Not applicable
Changes of holding shareholders during the reporting period
Applicable Not applicable
The Company has no changes of holding shareholders during the reporting period.
Changes of actual controller within the reporting period
Applicable Not applicable
The Company has no changes in actual controller within the reporting period.
VI. Details of Preferred Stock
Applicable Not applicable
The Company has no preferred shares during the reporting period.
Section VII Bonds
Applicable Not applicable
I. Enterprise Bond
Applicable Not applicable
During the reporting period, the Company had no outstanding enterprise bonds.
II. Corporate Bond
Applicable Not applicable
During the reporting period, the Company had no outstanding corporate bonds.
III. Non-financial Enterprise Debt Financing Instruments
Applicable Not applicable
1. Basic Information on Non-financial Enterprise Debt Financing Instruments
Unit: RMB Yuan
| Bond Full Name | Bond Short Name | Bond Code | Issuance Date | Interest Commencement Date | Maturity Date | Outstanding Bond Balance | Coupon Rate | Repayment and Interest Payment Method | Trading Venue |
| Zhejiang NHU Company Ltd. technology innovation bond in the first phase of 2026 | 26 NHU Stock SCP001 (Sci-Tech Innovation Bond) | 012680341.IB | February 1,2026 | February 2,2026 | October 30,2026 | 500,000,000 | 1.57% | Lump-sum repayment of principal and interest upon maturity | Inter-bank Bond Market |
| Investor Suitability Arrangements (if applicable) | Qualified institutional investors in the inter-bank bond market (excluding those prohibited from purchasing by national laws and regulations) | ||||||||
| Applicable Trading Mechanism | Trading Mechanisms of China's Inter-bank Bond Market | ||||||||
| Risk of delisting (if applicable) and Countermeasures | None | ||||||||
Overdue Unpaid Bonds
Applicable Not applicable
2. Triggering and Implementation of Issuer’s or Investor’s Option Clauses and Investor Protection Clauses
Applicable ☑ Not applicable
3. Adjustments to Credit Rating Results during the Reporting Period
Applicable Not applicable
4. Implementation and Changes of Guarantees, Debt Repayment Plans and Other Debt Repayment Safeguard Measures during the Reporting Period and Their Impact on Bond Investors’ Rights and Interests
Applicable ☑ Not applicable
IV. Convertible Corporate Bonds
Applicable Not applicable
During the reporting period, the Company had no outstanding convertible corporate bonds.
V. Loss in consolidated scope during the reporting period exceeding 10% of net assets at end of prior year
Applicable Not applicable
VI. As of the end of the reporting period, the company's main accounting data and financial indicators for the past two years
| Items | Closing balance | Opening balance | YoY growth rate |
| Current Ratio | 2.69 | 2.63 | 2.28% |
| Debt-to-Assets Ratio | 24.96% | 27.73% | -2.77pp |
| Acid-test Ratio | 2.01 | 1.97 | 2.03% |
| Items | Current period | Prior period | YoY growth rate |
| Net Profit Excluding Non-recurring Gains and Losses (Unit:RMB'0,000) | 391,893.66 | 367,856.25 | 6.53% |
| EBITDA-to-Total Debt Ratio | 270.00% | 179.00% | 91.00pp |
| Interest Coverage Ratio | 61.55 | 38.39 | 60.33% |
| Cash-based Interest Coverage Ratio | 67.58 | 39.95 | 69.16% |
| EBITDA Interest Coverage Ratio | 239.93 | 141.00 | 70.16% |
| Loan Repayment Ratio | 100.00% | 100.00% | Unchanged |
| Interest Payment Ratio | 100.00% | 100.00% | Unchanged |
Section VIII Financial Report
I. Audit Reports
Has the semi-annual report been audited
Yes No
The Company’s semi-annual report has not been audited.
II. Financial Statements
The monetary unit of the financial statements is Renminbi (RMB) Yuan.
1. Consolidated balance sheet
Prepared by Zhejiang NHU Co., Ltd.
June 30, 2026 Unit: RMB Yuan
| Items | June 30, 2026 | January 1, 2026 |
| Current assets: | ||
| Cash and bank balances | 7,458,042,805.72 | 7,966,270,131.17 |
| Deposit reservation for balance | ||
| Lending to banks and other financial institutions | ||
| Trading Financial Assets | 2,583,641,120.21 | 2,168,275,092.55 |
| Derivative financial assets | ||
| Notes receivable | ||
| Accounts receivable | 3,769,816,701.75 | 3,331,434,677.27 |
| Receivables financing | 920,577,788.17 | 813,062,385.73 |
| Prepayments | 296,698,192.81 | 178,450,145.87 |
| Insurance premium receivable | ||
| Reinsurance accounts receivable | ||
| Reserves for reinsurance contract receivable | ||
| Other receivables | 261,081,058.41 | 274,052,669.41 |
| Including: Interest receivable | ||
| Dividends receivable | ||
| Financial assets purchased under resale agreement | ||
| Inventories | 4,769,240,242.26 | 4,648,749,467.43 |
| Among them: data resources | ||
| Contracted assets | ||
| Assets held for sale | ||
| Non-current assets due within one year | ||
| Other current assets | 86,282,299.41 | 55,037,719.63 |
| Total current assets | 20,145,380,208.74 | 19,435,332,289.06 |
| Non-current assets: | ||
| Granting of loans and advances | ||
| Debt investments | ||
| Other debt investments | ||
| Long-term receivables | ||
| Long-term equity investments | 1,144,592,243.55 | 965,350,549.43 |
| Other equity instrument investment | 22,446,147.55 | 60,126,147.55 |
| Other non-current financial assets | ||
| Investment property | ||
| Fixed assets | 19,538,428,936.53 | 20,298,898,673.14 |
| Construction in progress | 1,006,512,957.55 | 745,117,350.86 |
| Productive biological assets | ||
| Oil and gas assets | ||
| Right-of-use assets | 8,544,176.48 | 9,116,717.87 |
| Intangible assets | 3,626,997,348.57 | 2,590,073,891.40 |
| Among them: data resources | ||
| Development expenditure | ||
| Among them: data resources | ||
| Goodwill | 3,622,704.97 | 3,622,704.97 |
| Long-term deferred expenses | 14,079,928.37 | 19,477,100.43 |
| Deferred tax assets | 5,030,160.91 | 2,692,450.99 |
| Other non-current assets | 1,169,596,687.54 | 1,476,641,929.78 |
| Total non-current assets | 26,539,851,292.02 | 26,171,117,516.42 |
| Assets in total | 46,685,231,500.76 | 45,606,449,805.48 |
| Current liabilities: | ||
| Short-term borrowings | 962,032,277.99 | 675,172,682.37 |
| Borrowings from the central bank | ||
| Borrowing from banks and financial institutions | ||
| Financial liabilities held for trading | 1,663,300.90 | |
| Derivative financial liabilities | ||
| Notes payable | 43,197,229.37 | 70,054,101.63 |
| Accounts payable | 1,889,531,581.58 | 1,780,307,765.08 |
| Advance receipts | ||
| Contract liabilities | 351,344,836.57 | 294,819,090.20 |
| Financial assets sold for repurchase | ||
| Deposits and interbank deposits received | ||
| Receiving from Vicariously Traded Securities | ||
| Receiving from Vicariously Sold Securities | ||
| Employee compensation payable | 307,941,186.16 | 511,515,144.15 |
| Taxes and fees payable | 530,467,264.25 | 669,468,878.66 |
| Other payables | 96,098,501.09 | 131,685,145.99 |
| Including: Interests payable | ||
| Dividends payable | ||
| Charges and commissions payable | ||
| Reinsurance accounts payable | ||
| Liabilities held for sale | ||
| Non-current liabilities due within one year | 2,745,428,550.04 | 3,165,413,873.49 |
| Other current liabilities | 562,644,066.41 | 99,358,351.24 |
| Total current liabilities | 7,490,348,794.36 | 7,397,795,032.81 |
| Non-current liabilities: | ||
| Provision for insurance contracts | ||
| Long-term borrowings | 3,170,163,350.48 | 4,187,178,569.02 |
| Bonds payable | ||
| Including: Preferred stocks | ||
| Perpetual bonds | ||
| Lease liabilities | 2,307,786.86 | 2,500,183.66 |
| Long-term accounts payable | ||
| Long-term payroll payable | ||
| Estimated liabilities | ||
| Deferred income | 848,203,512.02 | 906,007,748.59 |
| Deferred income tax liabilities | 140,244,113.07 | 152,052,864.16 |
| Other non-current liabilities | ||
| Total non-current liabilities | 4,160,918,762.43 | 5,247,739,365.43 |
| Liabilities in total | 11,651,267,556.79 | 12,645,534,398.24 |
| Owner’s equity: | ||
| Share capital | 3,073,421,680.00 | 3,073,421,680.00 |
| Other equity instruments | ||
| Including: Preferred stocks | ||
| Perpetual bonds | ||
| Capital reserve | 3,171,219,081.42 | 3,135,683,253.49 |
| Less: Treasury stock | 70,972,212.67 | 556,161,195.70 |
| Other comprehensive income | 52,359,128.04 | 67,743,496.72 |
| Special reserves | 176,658,517.35 | 162,056,373.58 |
| Surplus reserves | 1,545,453,678.00 | 1,545,453,678.00 |
| General risk reserve | ||
| Undistributed profits | 26,931,963,631.96 | 25,377,456,895.81 |
| Total owners’ equity attributed to parent company | 34,880,103,504.10 | 32,805,654,181.90 |
| Minority shareholders’ equity | 153,860,439.87 | 155,261,225.34 |
| Total owner's equity | 35,033,963,943.97 | 32,960,915,407.24 |
| Total liabilities and owners' equity | 46,685,231,500.76 | 45,606,449,805.48 |
Legal Representative: Hu Baifan Chief Accountant in Charge: Shi Guanqun Chief of Accounting Institution: Wang Xiaobi
2. Balance Sheet of the Parent Company
Unit: RMB Yuan
| Items | June 30, 2026 | January 1, 2026 |
| Current assets: | ||
| Cash and bank balances | 923,654,750.93 | 1,555,965,210.51 |
| Trading Financial Assets | 150,517,808.22 | 451,800,000.01 |
| Derivative financial assets | ||
| Notes receivable | ||
| Accounts receivable | 1,105,033,234.29 | 1,092,272,295.09 |
| Receivables financing | 148,138,925.57 | 270,401,584.88 |
| Prepayments | 19,799,719.62 | 3,263,824.89 |
| Other receivables | 227,803,286.35 | 476,588,831.47 |
| Including: Interest receivable | ||
| Dividends receivable | ||
| Inventories | 344,403,780.03 | 311,443,142.04 |
| Among them: data resources | ||
| Contracted assets | ||
| Assets held for sale | ||
| Non-current assets due within one year | ||
| Other current assets | 12,823,637.94 | 14,680,703.63 |
| Total current assets | 2,932,175,142.95 | 4,176,415,592.52 |
| Non-current assets: | ||
| Debt investments | ||
| Other debt investments | ||
| Long-term receivables | ||
| Long-term equity investments | 13,825,651,896.58 | 12,816,459,007.72 |
| Other equity instrument investment | 72,446,147.55 | 110,126,147.55 |
| Other non-current financial assets | ||
| Investment property | ||
| Fixed assets | 694,097,657.13 | 723,262,231.62 |
| Construction in progress | 81,115,219.68 | 60,024,286.84 |
| Productive biological assets | ||
| Oil and gas assets | ||
| Right-of-use assets | 2,228,119.48 | 2,308,653.88 |
| Intangible assets | 149,338,474.14 | 155,849,630.44 |
| Among them: data resources | ||
| Development expenditure | ||
| Among them: data resources | ||
| Goodwill | ||
| Long-term deferred expenses | ||
| Deferred tax assets | ||
| Other non-current assets | 523,308,060.09 | 524,620,404.55 |
| Total non-current assets | 15,348,185,574.65 | 14,392,650,362.60 |
| Assets in total | 18,280,360,717.60 | 18,569,065,955.12 |
| Current liabilities: | ||
| Short-term borrowings | 71,376,375.00 | 170,756,694.44 |
| Financial liabilities held for trading | 1,029,440.00 | |
| Derivative financial liabilities | ||
| Notes payable | ||
| Accounts payable | 608,082,792.55 | 449,516,671.19 |
| Advance receipts | ||
| Contract liabilities | 8,867,748.92 | 6,104,710.14 |
| Employee compensation payable | 59,052,823.84 | 101,012,594.64 |
| Taxes and fees payable | 26,364,904.89 | 38,789,811.12 |
| Other payables | 23,022,867.07 | 24,009,833.99 |
| Including: Interests payable | ||
| Dividends payable | ||
| Liabilities held for sale | ||
| Non-current liabilities due within one year | 1,316,998,077.29 | 2,110,742,905.69 |
| Other current liabilities | 498,434,598.56 | 4,863,857.53 |
| Total current liabilities | 2,613,229,628.12 | 2,905,797,078.74 |
| Non-current liabilities: | ||
| Long-term borrowings | 2,296,471,907.76 | 2,560,775,206.87 |
| Bonds payable | ||
| Including: Preferred stocks | ||
| Perpetual bonds | ||
| Lease liabilities | 2,307,786.86 | 2,486,246.32 |
| Long-term accounts payable | ||
| Long-term payroll payable | ||
| Estimated liabilities | ||
| Deferred income | 15,732,662.72 | 15,536,053.20 |
| Deferred income tax liabilities | 16,063,817.31 | 18,965,367.73 |
| Other non-current liabilities | ||
| Total non-current liabilities | 2,330,576,174.65 | 2,597,762,874.12 |
| Liabilities in total | 4,943,805,802.77 | 5,503,559,952.86 |
| Owner’s equity: | ||
| Share capital | 3,073,421,680.00 | 3,073,421,680.00 |
| Other equity instruments | ||
| Including: Preferred stocks | ||
| Perpetual bonds | ||
| Capital reserve | 2,906,255,131.36 | 2,871,264,474.99 |
| Less: Treasury stock | 70,972,212.67 | 556,161,195.70 |
| Other comprehensive income | 20,444,554.43 | 36,492,554.43 |
| Special reserves | 35,750,203.99 | 29,335,599.82 |
| Surplus reserves | 1,545,453,678.00 | 1,545,453,678.00 |
| Undistributed profits | 5,826,201,879.72 | 6,065,699,210.72 |
| Total owner's equity | 13,336,554,914.83 | 13,065,506,002.26 |
| Total liabilities and owners' equity | 18,280,360,717.60 | 18,569,065,955.12 |
Legal Representative: Hu Baifan ChiefAccountant in Charge: Shi Guanqun Chief ofAccounting Institution: Wang Xiaobi
3. Consolidated income statement
Unit: RMB Yuan
| Items | 2026 Semi-Annual | 2025 Semi-Annual |
| I. Total operating income | 13,129,300,260.89 | 11,100,632,836.78 |
| Including: Operating revenue | 13,129,300,260.89 | 11,100,632,836.78 |
| Interest income | ||
| Earned premiums | ||
| Service charge and commission income | ||
| II. Total Operating Cost | 8,715,888,097.93 | 6,875,351,657.25 |
| Including: Operating cost | 7,323,675,460.81 | 6,006,367,357.09 |
| Interest expenses | ||
| Handling charge and commission expenses | ||
| Surrender value | ||
| Net claims paid | ||
| Net Amount of Withdrawn Reserve for Insurance Liability Contract | ||
| Policyholder Dividend Expense | ||
| Reinsurance cost | ||
| Taxes and surcharges | 147,102,530.45 | 126,138,622.06 |
| Selling expenses | 88,987,069.94 | 88,602,406.65 |
| Administrative expenses | 292,591,830.68 | 309,618,405.74 |
| R&D expenses | 605,728,077.64 | 522,723,563.18 |
| Financial expenses | 257,803,128.41 | -178,098,697.47 |
| Including: Interest expenses | 77,290,550.93 | 112,615,701.07 |
| Interest income | 33,892,368.94 | 39,620,525.39 |
| Add: Other income | 120,757,490.82 | 121,765,131.08 |
| Investment income ( “-” for loss) | 204,498,489.13 | 18,237,922.39 |
| Including: Income from investment in associates and joint ventures | 152,851,395.37 | 24,632,875.74 |
| Income recognized at the termination of financial assets measured at amortized cost | ||
| Exchange gains ( “-” for loss) | ||
| Net-exposure hedging income ( “-” for loss) | ||
| Incomes from changes in fair value (“-” for loss) | 65,993,991.83 | -106,860,384.44 |
| Credit impairment losses (“-” for loss) | -34,278,518.19 | 7,613,141.39 |
| Assets impairment loss (“-” for loss) | -29,423,561.32 | -33,272,405.82 |
| Gains from asset disposal ("-” for loss) | 1,251,350.66 | -1,582,139.69 |
| III. Operating Profit ("-” for loss) | 4,742,211,405.89 | 4,231,182,444.44 |
| Add: Non-operating income | 2,189,167.24 | 1,218,592.90 |
| Less: Non-operating expenses | 47,056,112.99 | 2,998,696.24 |
| IV. Total Profit Before Tax (“-” for total losses) | 4,697,344,460.14 | 4,229,402,341.10 |
| Less: Income tax expense | 669,297,246.91 | 607,906,795.85 |
| V. Net Profit (“-” for net loss) | 4,028,047,213.23 | 3,621,495,545.25 |
| (I) Classification by business continuity | ||
| 1. Net profit from continuing operations (“-” for net loss) | 4,028,047,213.23 | 3,621,495,545.25 |
| 2. Net profit from discontinued operations (“-” for net loss) | ||
| (II) Classification by ownership | ||
| 1. Net profit attributable to shareholders of the parent company | 4,010,733,454.55 | 3,603,323,979.16 |
| 2. Profit or loss of minority shareholders | 17,313,758.68 | 18,171,566.09 |
| VI. Net Amount after Tax of Other Comprehensive Income | -34,098,912.83 | -19,129,756.45 |
| Net amount of other comprehensive income after tax attributed to the owners of parent company | -15,384,368.68 | -18,585,337.91 |
| (I) Other comprehensive income that cannot be reclassified into profit or loss | -16,048,000.00 | |
| 1. Amount of changes in the defined benefit plan due to re-measurement | ||
| 2. Other comprehensive income that can not be converted into profits and losses under the equity method | ||
| 3. Changes in the fair value of investment in other equity instruments | -16,048,000.00 | |
| 4. Changes in the fair value of the enterprise's own credit risk | ||
| 5. Other | ||
| (II) Other comprehensive income that will be reclassified into profit or loss | 663,631.32 | -18,585,337.91 |
| 1. Other comprehensive income that can be converted to profit or loss under the equity method | ||
| 2. Change in fair value for other investments on bonds | ||
| 3. Amount of financial assets reclassified into other comprehensive income | ||
| 4. Provisions for the credit impairment of investment in other creditor's rights | ||
| 5. Cash flow hedge reserve | ||
| 6. Difference of foreign currency financial statement translation | 663,631.32 | -18,585,337.91 |
| 7. Other | ||
| Net amount of other comprehensive income after tax attributed to minority shareholders | -18,714,544.15 | -544,418.54 |
| VII. Total Comprehensive Income | 3,993,948,300.40 | 3,602,365,788.80 |
| Total comprehensive income attributable to owners of the parent company | 3,995,349,085.87 | 3,584,738,641.25 |
| Total comprehensive income attributable to minority shareholders | -1,400,785.47 | 17,627,147.55 |
| VIII. Earnings per Share | ||
| (I) Basic earnings per share | 1.30 | 1.17 |
| (II) Diluted earnings per share | 1.30 | 1.17 |
Legal Representative: Hu Baifan Chief Accountant in Charge: Shi Guanqun Chief of Accounting Institution: Wang Xiaobi The net profit realized by the merged entity before the combination in the current period where a same-control business combination occurred is: RMB 0.00, and the net profit realized in the prior period is: RMB 0.00.
4. Income Statement of the Parent Company
Unit: RMB Yuan
| Items | 2026 Semi-Annual | 2025 Semi-Annual |
| I. Operating revenue | 2,338,627,557.40 | 2,288,910,353.91 |
| Less: Operating cost | 1,789,112,272.04 | 1,621,351,248.43 |
| Taxes and surcharges | 13,699,998.31 | 17,236,515.74 |
| Selling expenses | 29,087,591.81 | 21,103,533.89 |
| Administrative expenses | 77,289,076.08 | 89,152,501.14 |
| R&D expenses | 124,508,073.92 | 124,532,788.27 |
| Financial expenses | 38,336,635.53 | 45,720,895.39 |
| Including: Interest expenses | 52,205,734.84 | 65,621,366.30 |
| Interest income | 15,399,257.26 | 19,823,918.91 |
| Add: Other income | 7,954,559.07 | 20,424,472.11 |
| Investment income (“-” for loss) | 1,973,669,970.26 | 1,793,286,828.79 |
| Including: Income from investment in associates and joint ventures | 167,993,008.36 | 17,307,279.63 |
| Gains from derecognition of financial assets measured at amortized cost (“-” for loss) | ||
| Net-exposure hedging income (“-” for loss) | ||
| Incomes from changes in fair value (“-” for loss) | -480,460.93 | |
| Credit impairment losses (“-” for loss) | 10,196,246.05 | 10,852,149.30 |
| Assets impairment loss ( “-” for loss) | -1,463,709.32 | -15,460,631.24 |
| Gains from asset disposal ( "-" for loss) | -2,533,390.86 | -643,654.25 |
| II. Operating Profit ( “-” for loss) | 2,253,937,123.98 | 2,178,272,035.76 |
| Add: Non-operating income | 175,749.42 | 202,867.23 |
| Less: Non-operating expenses | 1,834,943.97 | 215,135.17 |
| III. Total profit ( “-” for total loss) | 2,252,277,929.43 | 2,178,259,767.82 |
| Less: Income tax expense | 35,548,542.03 | 50,709,150.24 |
| IV. Net Profit ( “-” for net loss) | 2,216,729,387.40 | 2,127,550,617.58 |
| (I) Net Profit as a Going Concern (Mark "-" for Net Loss) | 2,216,729,387.40 | 2,127,550,617.58 |
| (II) Net Profit of Discontinued Operation (Mark "-" for Net Loss) | ||
| V. Net Amount of Other Comprehensive Incomes After Tax | -16,048,000.00 | |
| (I) Other comprehensive income that cannot be reclassified into profit or loss | -16,048,000.00 | |
| 1. Amount of changes in the defined benefit plan due to re-measurement | ||
| 2. Other comprehensive income that can not be converted into profits and losses under the equity method | ||
| 3. Changes in the fair value of investment in other equity instruments | -16,048,000.00 | |
| 4. Changes in the fair value of the enterprise's own credit risk | ||
| 5. Other | ||
| (II) Other comprehensive income that will be reclassified into profit or loss | ||
| 1. Other comprehensive income that can be converted to profit or loss under the equity method | ||
| 2. Change in fair value for other investments on bonds | ||
| 3. Amount of financial assets reclassified into other comprehensive income | ||
| 4. Provisions for the credit impairment of investment in other creditor's rights | ||
| 5. Cash flow hedge reserve | ||
| 6. Difference of foreign currency financial statement translation | ||
| 7. Other | ||
| VI. Total Comprehensive Income | 2,200,681,387.40 | 2,127,550,617.58 |
| VII. Earnings Per Share | ||
| (I) Basic earnings per share | ||
| (II) Diluted earnings per share |
5. Consolidated cash flow statement
Unit: RMB Yuan
| Items | 2026 Semi-Annual | 2025 Semi-Annual |
| I. Cash flows generated from operating activities: | ||
| Cash received from the sale of commodities and rendering of labor services | 11,935,154,736.56 | 11,266,097,495.55 |
| Net increase in deposit from customers and interbank | ||
| Net increase in borrowing from central bank | ||
| Net increase in borrowings from other financial institutions | ||
| Cash receipts from premiums under direct insurance contracts | ||
| Net Amount Arising from Reinsurance Business | ||
| Net Increase in Deposits and Investments from Policyholders | ||
| Cash Arising from Interests, Service Charges and Commissions | ||
| Net Increase in Borrowings from Banks and Other Financial Institutions | ||
| Net increase in repurchase business capital | ||
| Net Amount of Cash Received from the Vicariously Traded Securities | ||
| Tax Refund | 456,665,226.07 | 460,059,989.38 |
| Cash received relating to other operating activities | 106,192,435.92 | 104,830,537.50 |
| Subtotal of cash inflows from operating activities | 12,498,012,398.55 | 11,830,988,022.43 |
| Cash payments for goods acquired and services received | 5,818,976,439.30 | 5,656,926,781.96 |
| Net increase in customer loans and advances | ||
| Net increase in deposits in central bank and interbank | ||
| Cash payments for original insurance contract claims | ||
| Net increase in lending funds from banks and other financial institutions | ||
| Cash payments for interest, fee, and commission | ||
| Cash payments for insurance policyholder dividends | ||
| Cash paid to and on behalf of employees | 1,349,611,411.25 | 1,260,472,740.56 |
| Cash payments for taxes | 1,502,033,083.17 | 1,144,724,413.30 |
| Other cash payments relating to operating activities | 187,247,181.89 | 526,136,284.30 |
| Subtotal of cash outflows from operating activities | 8,857,868,115.61 | 8,588,260,220.12 |
| Net cash flows from operating activities | 3,640,144,282.94 | 3,242,727,802.31 |
| II. Cash Flows from Investing Activities: | ||
| Cash receipts from investment withdrawal | 1,708,000.00 | |
| Cash receipts from returns on investments | 45,236,351.03 | 26,149,305.22 |
| Net cash receipts from disposals of fixed assets, intangible assets and other long-term assets | 120,800.00 | |
| Net cash received from disposal of subsidiaries and other business units | ||
| Other cash receipts relating to investing activities | 2,251,950,000.00 | 2,150,000,000.00 |
| Subtotal of cash inflows from investing activities | 2,297,186,351.03 | 2,177,978,105.22 |
| Cash Paid for the Purchase and Construction of Fixed Assets, Intangible Assets, and Other Long-term Assets | 1,370,546,337.73 | 634,342,800.27 |
| Cash payments for investment | ||
| Net increase in pledged loans | ||
| Net Cash Paid for Acquisition of Subsidiaries and Other Business Units | ||
| Other Paid Cashes Related to Investment Activities | 2,570,000,000.00 | 2,651,950,000.00 |
| Subtotal of cash outflows from investing activities | 3,940,546,337.73 | 3,286,292,800.27 |
| Net cash flows from investing activities | -1,643,359,986.70 | -1,108,314,695.05 |
| III. Cash Flows from Financing Activities: | ||
| Cash received from capital contributions | ||
| Including: Cash received from investment of minority shareholder from subsidiary | ||
| Cash received from borrowings | 2,314,460,068.77 | 1,737,092,525.26 |
| Other cash receipts relating to financing activities | 518,979,758.90 | |
| Subtotal of cash inflows from financing activities | 2,833,439,827.67 | 1,737,092,525.26 |
| Cash repayments of amounts borrowed | 2,714,144,297.40 | 1,305,624,740.38 |
| Cash payments for distribution of dividends, profits, or cash payments for interest expenses | 2,546,662,425.93 | 2,276,198,922.57 |
| Including: Dividends and profits paid to minority shareholders by subsidiaries | ||
| Other cash paid related to financing activities | 414,172.14 | 309,380,225.44 |
| Subtotal of cash outflows from financing activities | 5,261,220,895.47 | 3,891,203,888.39 |
| Net cash flows from financing activities | -2,427,781,067.80 | -2,154,111,363.13 |
| IV. Effect of foreign exchange rate changes on cash and cash equivalents | 7,507,053.86 | 6,990,777.66 |
| V. Net Increase in Cash and Cash Equivalents | -423,489,717.70 | -12,707,478.21 |
| Add: Beginning balance of cash and cash equivalents | 7,819,707,489.01 | 5,521,452,666.47 |
| VI. Closing Balance of Cash and Cash Equivalents | 7,396,217,771.31 | 5,508,745,188.26 |
Legal Representative: Hu Baifan Chief Accountant in Charge: Shi Guanqun Chief of Accounting Institution: Wang Xiaobi
6. Cash Flow Statement of the Parent Company
Unit: RMB Yuan
| Items | 2026 Semi-Annual | 2025 Semi-Annual |
| I. Cash flows generated from operating activities: | ||
| Cash received from the sale of commodities and rendering of labor services | 2,400,001,550.91 | 2,612,605,837.48 |
| Tax Refund | 105,938,944.72 | 87,585,823.10 |
| Cash received relating to other operating activities | 33,165,784.53 | 52,796,332.31 |
| Subtotal of cash inflows from operating activities | 2,539,106,280.16 | 2,752,987,992.89 |
| Cash payments for goods acquired and services received | 1,600,121,729.63 | 1,822,628,821.22 |
| Cash paid to and on behalf of employees | 260,289,180.60 | 235,325,982.05 |
| Cash payments for taxes | 54,607,219.18 | 37,783,744.06 |
| Other cash payments relating to operating activities | 62,434,507.80 | 69,964,013.58 |
| Subtotal of cash outflows from operating activities | 1,977,452,637.21 | 2,165,702,560.91 |
| Net cash flows from operating activities | 561,653,642.95 | 587,285,431.98 |
| II. Cash Flows from Investing Activities: | ||
| Cash receipts from investment withdrawal | 1,708,000.00 | |
| Cash receipts from returns on investments | 1,826,491,810.94 | 1,766,219,371.71 |
| Net cash receipts from disposals of fixed assets, intangible assets and other long-term assets | 120,800.00 | |
| Net cash received from disposal of subsidiaries and other business units | ||
| Other cash receipts relating to investing activities | 1,186,100,000.00 | 2,417,850,000.00 |
| Subtotal of cash inflows from investing activities | 3,012,591,810.94 | 4,185,898,171.71 |
| Cash Paid for the Purchase and Construction of Fixed Assets, Intangible Assets, and Other Long-term Assets | 47,123,229.09 | 67,230,055.13 |
| Cash payments for investment | 840,000,000.00 | 288,000,000.00 |
| Net Cash Paid for Acquisition of Subsidiaries and Other Business Units | ||
| Other Paid Cashes Related to Investment Activities | 561,000,000.00 | 1,794,550,000.00 |
| Subtotal of cash outflows from investing activities | 1,448,123,229.09 | 2,149,780,055.13 |
| Net cash flows from investing activities | 1,564,468,581.85 | 2,036,118,116.58 |
| III. Cash Flows from Financing Activities: | ||
| Cash received from capital contributions | ||
| Cash received from borrowings | 1,200,000,000.00 | 999,000,000.00 |
| Other cash receipts relating to financing activities | 518,979,758.90 | |
| Subtotal of cash inflows from financing activities | 1,718,979,758.90 | 999,000,000.00 |
| Cash repayments of amounts borrowed | 1,857,000,000.00 | 829,000,000.00 |
| Cash payments for distribution of dividends, profits, or cash payments for interest expenses | 2,505,659,195.73 | 2,220,631,198.81 |
| Other cash paid related to financing activities | 159,248.33 | 309,231,676.57 |
| Subtotal of cash outflows from financing activities | 4,362,818,444.06 | 3,358,862,875.38 |
| Net cash flows from financing activities | -2,643,838,685.16 | -2,359,862,875.38 |
| IV. Effect of foreign exchange rate changes on cash and cash equivalents | -801,154.25 | 414,212.64 |
| V. Net Increase in Cash and Cash Equivalents | -518,517,614.61 | 263,954,885.82 |
| Add: Beginning balance of cash and cash equivalents | 1,416,902,595.01 | 1,700,342,936.46 |
| VI. Closing Balance of Cash and Cash Equivalents | 898,384,980.40 | 1,964,297,822.28 |
7. Consolidated statement of changes in owners’ equity
Amount of the current period
Unit: RMB Yuan
| Items | 2026 Semi-Annual | ||||||||||||||
| Equity attributable to owners of the parent company | Minority shareholders' equity | Total owner's equity | |||||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | General risk reserve | Undistributed profits | Others | Subtotal | |||||
| Preferred stocks | Perpetual bonds | Others | |||||||||||||
| I. Balance at the end of the period of previous year | 3,073,421,680.00 | 3,135,683,253.49 | 556,161,195.70 | 67,743,496.72 | 162,056,373.58 | 1,545,453,678.00 | 25,377,456,895.81 | 32,805,654,181.90 | 155,261,225.34 | 32,960,915,407.24 | |||||
| Add: Changes to accounting policies | |||||||||||||||
| Correction of errors from previous periods | |||||||||||||||
| Others | |||||||||||||||
| II. Opening balance of this year | 3,073,421,680.00 | 3,135,683,253.49 | 556,161,195.70 | 67,743,496.72 | 162,056,373.58 | 1,545,453,678.00 | 25,377,456,895.81 | 32,805,654,181.90 | 155,261,225.34 | 32,960,915,407.24 | |||||
| III. Increase or decrease in the current period (“-” for decrease) | 35,535,827.93 | -485,188,983.03 | -15,384,368.68 | 14,602,143.77 | 1,554,506,736.15 | 2,074,449,322.20 | -1,400,785.47 | 2,073,048,536.73 | |||||||
| (I) Total comprehensive income | -15,384,368.68 | 4,010,733,454.55 | 3,995,349,085.87 | -1,400,785.47 | 3,993,948,300.40 | ||||||||||
| (II) Capital injection and reduction by owners | 33,790,775.87 | -485,188,983.03 | 518,979,758.90 | 518,979,758.90 | |||||||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2026 Semi-Annual | ||||||||||||||
| Equity attributable to owners of the parent company | Minority shareholders' equity | Total owner's equity | |||||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | General risk reserve | Undistributed profits | Others | Subtotal | |||||
| Preferred stocks | Perpetual bonds | Others | |||||||||||||
| 1. Common stock invested by the owner | |||||||||||||||
| 2. Capital contributed by holders of other equity instruments | |||||||||||||||
| 3. Amount of share-based payments recorded into the owners' equity | |||||||||||||||
| 4. Others | 33,790,775.87 | -485,188,983.03 | 518,979,758.90 | 518,979,758.90 | |||||||||||
| (III) Profit distribution | -2,456,226,718.40 | -2,456,226,718.40 | -2,456,226,718.40 | ||||||||||||
| 1. Appropriation of surplus reserve | |||||||||||||||
| 2. Appropriation of general risk reserve | |||||||||||||||
| 3. Distribution to owners (or shareholders) | -2,456,226,718.40 | -2,456,226,718.40 | -2,456,226,718.40 | ||||||||||||
| 4. Others | |||||||||||||||
| (iv) Internal transfers of owner's equity | |||||||||||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2026 Semi-Annual | ||||||||||||||
| Equity attributable to owners of the parent company | Minority shareholders' equity | Total owner's equity | |||||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | General risk reserve | Undistributed profits | Others | Subtotal | |||||
| Preferred stocks | Perpetual bonds | Others | |||||||||||||
| 1. Conversion of capital reserves to increased capital (or capital stock) | |||||||||||||||
| 2. Conversion of surplus reserves to increased capital (or capital stock) | |||||||||||||||
| 3. Recovery of losses by surplus reserves | |||||||||||||||
| 4. Amount of changes in the defined benefit plan carried over to the retained earnings | |||||||||||||||
| 5. Other comprehensive income carried over to retained earnings | |||||||||||||||
| 6. Others | |||||||||||||||
| (v) Special reserves | 14,602,143.77 | 14,602,143.77 | 14,602,143.77 | ||||||||||||
| 1. Withdrawal in current period | 69,820,553.97 | 69,820,553.97 | 69,820,553.97 | ||||||||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2026 Semi-Annual | ||||||||||||||
| Equity attributable to owners of the parent company | Minority shareholders' equity | Total owner's equity | |||||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | General risk reserve | Undistributed profits | Others | Subtotal | |||||
| Preferred stocks | Perpetual bonds | Others | |||||||||||||
| 2. Use in the current period | -55,218,410.20 | -55,218,410.20 | -55,218,410.20 | ||||||||||||
| (VI) Others | 1,745,052.06 | 1,745,052.06 | 1,745,052.06 | ||||||||||||
| IV. Balance at the End of This Period | 3,073,421,680.00 | 3,171,219,081.42 | 70,972,212.67 | 52,359,128.04 | 176,658,517.35 | 1,545,453,678.00 | 26,931,963,631.96 | 34,880,103,504.10 | 153,860,439.87 | 35,033,963,943.97 | |||||
Amount of the previous period Unit: RMB Yuan
| Items | 2025 Semi-Annual | ||||||||||||||
| Equity attributable to owners of the parent company | Minority shareholders' equity | Total owner's equity | |||||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | General risk reserve | Undistributed profits | Others | Subtotal | |||||
| Preferred stocks | Perpetual bonds | Others | |||||||||||||
| I. Balance at the end of the period of previous year | 3,073,421,680.00 | 3,132,519,968.42 | 91,513,343.50 | 106,348,864.91 | 1,545,453,678.00 | 21,375,740,194.12 | 29,324,997,728.95 | 120,552,533.98 | 29,445,550,262.93 | ||||||
| Add: Changes to accounting policies | |||||||||||||||
| Correction of errors from previous periods | |||||||||||||||
| Others | |||||||||||||||
| II. Opening balance of this | 3,073,421,680.00 | 3,132,519,968.42 | 91,513,343.50 | 106,348,864.91 | 1,545,453,678.00 | 21,375,740,191.12 | 29,324,997,728.95 | 120,552,533.98 | 29,445,550,262.93 | ||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2025 Semi-Annual | ||||||||||||||
| Equity attributable to owners of the parent company | Minority shareholders' equity | Total owner's equity | |||||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | General risk reserve | Undistributed profits | Others | Subtotal | |||||
| Preferred stocks | Perpetual bonds | Others | |||||||||||||
| year | |||||||||||||||
| III. Increase or decrease in the current period (“-” for decrease) | 11,681.07 | 309,134,899.57 | -18,585,337.91 | 35,207,710.56 | 1,452,562,653.16 | 1,160,061,807.31 | 17,627,147.55 | 1,177,688,954.86 | |||||||
| (I) Total comprehensive income | -18,585,337.91 | 3,603,323,979.16 | 3,584,738,641.25 | 33,066,557.55 | 3,617,805,198.80 | ||||||||||
| (II) Capital injection and reduction by owners | 309,134,899.57 | -309,134,899.57 | -309,134,899.57 | ||||||||||||
| 1. Common stock invested by the owner | |||||||||||||||
| 2. Capital contributed by holders of other equity instruments | |||||||||||||||
| 3. Amount of share-based payments recorded into the owners' equity | |||||||||||||||
| 4. Others | 309,134,899.57 | -309,134,899.57 | -309,134,899.57 | ||||||||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2025 Semi-Annual | ||||||||||||||
| Equity attributable to owners of the parent company | Minority shareholders' equity | Total owner's equity | |||||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | General risk reserve | Undistributed profits | Others | Subtotal | |||||
| Preferred stocks | Perpetual bonds | Others | |||||||||||||
| (III) Profit distribution | -2,150,761,326.00 | -2,150,761,326.00 | -15,439,410.00 | -2,166,200,736.00 | |||||||||||
| 1. Appropriation of surplus reserve | |||||||||||||||
| 2. Appropriation of general risk reserve | |||||||||||||||
| 3. Distribution to owners (or shareholders) | -2,150,761,326.00 | -2,150,761,326.00 | -15,439,410.00 | -2,166,200,736.00 | |||||||||||
| 4. Others | |||||||||||||||
| (iv) Internal transfers of owner's equity | |||||||||||||||
| 1. Conversion of capital reserves to increased capital (or capital stock) | |||||||||||||||
| 2. Conversion of surplus reserves to increased capital (or capital stock) | |||||||||||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2025 Semi-Annual | ||||||||||||||
| Equity attributable to owners of the parent company | Minority shareholders' equity | Total owner's equity | |||||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | General risk reserve | Undistributed profits | Others | Subtotal | |||||
| Preferred stocks | Perpetual bonds | Others | |||||||||||||
| 3. Recovery of losses by surplus reserves | |||||||||||||||
| 4. Amount of changes in the defined benefit plan carried over to the retained earnings | |||||||||||||||
| 5. Other comprehensive income carried over to retained earnings | |||||||||||||||
| 6. Others | |||||||||||||||
| (v) Special reserves | 35,207,710.56 | 35,207,710.56 | 35,207,710.56 | ||||||||||||
| 1. Withdrawal in current period | 59,342,545.02 | 59,342,545.02 | 59,342,545.02 | ||||||||||||
| 2. Use in the current period | -24,134,834.46 | -24,134,834.46 | -24,134,834.46 | ||||||||||||
| (VI) Others | 11,681.07 | 11,681.07 | 11,681.07 | ||||||||||||
| IV. Balance at the End of This Period | 3,073,421,680.00 | 3,132,531,649.49 | 309,134,899.57 | 72,928,005.59 | 141,556,575.47 | 1,545,453,678.00 | 22,828,302,847.28 | 30,485,059,536.26 | 138,179,681.53 | 30,623,239,217.79 | |||||
8. Statement of Changes in Owners' Equity of the Parent Company
Amount of the current period
Unit: RMB Yuan
| Items | 2026 Semi-Annual | |||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury shares | Other comprehensive income | Special reserve | Surplus reserve | Undistributed profit | Others | Total equity | |||
| Preferred stocks | Perpetual bonds | Others | ||||||||||
| I. Balance at the end of the period of previous year | 3,073,421,680.00 | 2,871,264,474.99 | 556,161,195.70 | 36,492,554.43 | 29,335,599.82 | 1,545,453,678.00 | 6,065,699,210.72 | 13,065,506,002.26 | ||||
| Add: Changes to accounting policies | ||||||||||||
| Correction of errors from previous periods | ||||||||||||
| Others | ||||||||||||
| II. Opening balance of this year | 3,073,421,680.00 | 2,871,264,474.99 | 556,161,195.70 | 36,492,554.43 | 29,335,599.82 | 1,545,453,678.00 | -6,065,699,210.72 | 13,065,506,002.26 | ||||
| III. Increase or decrease in the current period (“-” for decrease) | 34,990,656.37 | -485,188,983.03 | -16,048,000.00 | 6,414,604.17 | -239,497,331.00 | 271,048,912.57 | ||||||
| (I) Total comprehensive income | -16,048,000.00 | 2,216,729,387.40 | 2,200,681,387.40 | |||||||||
| (II) Capital injection and reduction by owners | 33,790,775.87 | -485,188,983.03 | 518,979,758.90 | |||||||||
| 1. Common stock invested by the owner | ||||||||||||
| 2. Capital contributed by holders of other equity instruments | ||||||||||||
| 3. Amount of share-based payments recorded into the owners' equity | ||||||||||||
| 4. Others | 33,790,775.87 | -485,188,983.03 | 518,979,758.90 | |||||||||
| (III) Profit distribution | -2,456,226,718.40 | -2,456,226,718.40 | ||||||||||
| 1. Appropriation of surplus reserve | ||||||||||||
| 2. Distribution to owners (or shareholders) | -2,456,226,718.40 | -2,456,226,718.40 | ||||||||||
| 3. Others | ||||||||||||
| (iv) Internal transfers of owner's equity | ||||||||||||
| 1. Conversion of capital reserves to | ||||||||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2026 Semi-Annual | |||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury shares | Other comprehensive income | Special reserve | Surplus reserve | Undistributed profit | Others | Total equity | |||
| Preferred stocks | Perpetual bonds | Others | ||||||||||
| increased capital (or capital stock) | ||||||||||||
| 2. Conversion of surplus reserves to increased capital (or capital stock) | ||||||||||||
| 3. Recovery of losses by surplus reserves | ||||||||||||
| 4. Amount of changes in the defined benefit plan carried over to the retained earnings | ||||||||||||
| 5. Other comprehensive income carried over to retained earnings | ||||||||||||
| 6. Others | ||||||||||||
| (v) Special reserves | 6,414,604.17 | 6,414,604.17 | ||||||||||
| 1. Withdrawal in current period | 7,598,974.74 | 7,598,974.74 | ||||||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2026 Semi-Annual | |||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury shares | Other comprehensive income | Special reserve | Surplus reserve | Undistributed profit | Others | Total equity | |||
| Preferred stocks | Perpetual bonds | Others | ||||||||||
| 2. Use in the current period | -1,184,370.57 | -1,184,370.57 | ||||||||||
| (VI) Others | 1,199,880.50 | 1,199,880.50 | ||||||||||
| IV. Balance at the End of This Period | 3,073,421,680.00 | 2,906,255,131.36 | 70,972,212.67 | 20,444,554.43 | 35,750,203.99 | 1,545,453,678.00 | 5,826,201,879.72 | 13,336,554,914.83 | ||||
Amount of the previous period
Unit: RMB Yuan
| Items | 2025 Semi-Annual | |||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | Undistributed profits | Others | Total owner's equity | |||
| Preferred stocks | Perpetual bonds | Others | ||||||||||
| I. Balance at the end of the period of previous year | 3,073,421,680.00 | 2,871,231,553.94 | 506,954.43 | 19,478,463.14 | 1,545,453,678.00 | 6,481,153,549.07 | 13,991,245,878.58 | |||||
| Add: Changes to accounting policies | ||||||||||||
| Correction of errors from previous periods | ||||||||||||
| Others | ||||||||||||
| II. Opening balance of this year | 3,073,421,680.00 | 2,871,231,553.94 | 506,954.43 | 19,478,463.14 | 1,545,453,678.00 | 6,481,153,549.07 | ||||||
| III. Increase or decrease in the current period (“-” fordecrease) | 11,681.07 | 309,134,899.57 | 5,785,520.09 | -23,210,708.42 | -326,548,406.83 | |||||||
| (I) Total comprehensive income | 2,127,550,617.58 | 2,127,550,617.58 | ||||||||||
| (II) Capital injection and reduction by owners | 309,134,899.57 | -309,134,899.57 | ||||||||||
| 1. Common stock invested by the owner | ||||||||||||
| 2. Capital contributed by holders of other equity instruments | ||||||||||||
| 3. Amount of share-based payments recorded into the owners' equity | ||||||||||||
| 4. Others | 309,134,899.57 | -309,134,899.57 | ||||||||||
| (III) Profit distribution | -2,150,761,326.00 | -2,150,761,326.00 | ||||||||||
| 1. Appropriation of surplus reserve | ||||||||||||
| 2. Distribution to owners (or shareholders) | -2,150,761,326.00 | -2,150,761,326.00 | ||||||||||
| 3. Others | ||||||||||||
| (iv) Internal transfers of owner's equity | ||||||||||||
| 1. Conversion of capital reserves to increased capital (or capital stock) | ||||||||||||
| 2. Conversion of surplus reserves to increased capital (or capital stock) | ||||||||||||
| 3. Recovery of losses by surplus reserves | ||||||||||||
| 4. Amount of changes in the defined benefit plan carried over to the retained earnings | ||||||||||||
| 5. Other comprehensive income carried over to retained earnings | ||||||||||||
| 6. Others | ||||||||||||
| (v) Special reserves | 5,785,520.09 | 5,785,520.09 | ||||||||||
2026 Semi-Annual Report of Zhejiang NHU Co., Ltd.
| Items | 2025 Semi-Annual | |||||||||||
| Share capital | Other equity instruments | Capital reserve | Less: Treasury stock | Other comprehensive income | Special reserves | Surplus reserves | Undistributed profits | Others | Total owner's equity | |||
| Preferred stocks | Perpetual bonds | Others | ||||||||||
| 1. Withdrawal in current period | 7,156,485.65 | 7,156,485.65 | ||||||||||
| 2. Use in the current period | -1,370,965.56 | -1,370,965.56 | ||||||||||
| (VI) Others | 11,681.07 | 11,681.07 | ||||||||||
| IV. Balance at the End of This Period | 3,073,421,680.00 | 2,871,243,235.01 | 309,134,899.57 | 506,954.43 | 25,263,983.23 | 1,545,453,678.00 | 6,457,942,840.65 | 13,664,697,471.75 | ||||
III. Basic Information about the Company
Zhejiang NHU Co., Ltd. (hereinafter referred to as the Company or this Company) was established with the approval of the former Securities Committee of the People's Government of Zhejiang Province under document Zhe Zheng Wei [1999] No. 9. It was jointly established by Xinchang Synthetic Chemical Plant (renamed NHU Holding Group Co., Ltd. on November 17, 2009) together with nine individuals: Zhang Pingyi, Yuan Yizhong, Shi Cheng, Hu Baiyan, Shi Guanqun, Wang Xuewen, Shi Sanfu, Cui Xinrong, and Wang Xulin. The Company was registered with the Zhejiang Provincial Administration for Industry and Commerce on April 5, 1999, and is headquartered in Shaoxing City, Zhejiang Province. The Company currently holds a business license with unified social credit code 91330000712560575G, registered capital RMB 3,073,421,680.00, and a total of 3,073,421,680 shares (par value of RMB 1 per share). Among them, outstanding shares A subject to sale restrictions: 36,568,752 shares; outstanding shares A not subject to sale restrictions: 3,036,852,928 shares. The Company's shares were listed and began trading on the Shenzhen Stock Exchange on June 25, 2004.
The Company is in the pharmaceutical manufacturing industry. The main operating activities are research and development, production, and sales of nutritional products, aroma chemicals, and new polymer materials.
These financial statements have been approved for external disclosure by the Company at the 21st meeting of the ninth session of the Board of Directors on August 18, 2026.
IV. Basis for Preparing the Financial Statement
1. Basis for the preparation
The financial statements of the Company are prepared on the basis of a going concern.
2. Going concern
There are no events or circumstances that would give rise to major concerns as to the Company's capability to continue as a going concern for 12 months from the end of the reporting period.
V. Significant Accounting Policies and Accounting Estimates
Notes to specific accounting policies and accounting estimates:
The Company has established specific accounting policies and accounting estimates for transactions or matters such as impairment of financial instruments, inventories, depreciation of fixed assets, construction in progress, intangible assets, and revenue recognition based on the characteristics of its actual production and operations.
1. Statement on compliance with Accounting Standards for Business Enterprises
The financial statements prepared by the Company conform to the requirements of the accounting standards for business enterprises, and truly and completely reflect the relevant information of the Company, such as its financial status, operating results, and cash flow.
2. Accounting period
The fiscal year starts from January 1 to December 31 of the Gregorian calendar.
3. Operating cycle
Except for the real estate industry, the business cycle of the Company is short, and 12 months is taken as the liquidity division criteria for assets and liabilities. The operating cycle in the real estate industry, from property development to realization through sale, generally exceeds 12 months. The specific cycle is determined based on the circumstances of the development project, and the operating cycle is used as the criterion for classifying the liquidity of assets and liabilities.
4. Recording currency
The Company and its domestic subsidiaries use RMB as their currency for accounting purposes. Overseas subsidiaries such as NHU (Hong Kong) Trading Co., Ltd., NHU EUROPE GMBH, NHU Singapore Pte. Ltd., NHU/Chr.Olesen Latin America A/S, NHU LIFE SCIENCE GmbH, CONG TY TNHH NHU VIETNAM, NHU Japan Co., Ltd., NHU North America LLC, and NHU BESLENME GIDA SANAYi VE TiCARET LiMiTED SIRKETI conduct overseas operations and have chosen the currency of the primary economic environment in which they operate as their currency for accounting purposes.
5. Determination method and selection basis of importance standards
Applicable □ Not applicable
| Items | Importance standards |
| Significant write-offs of accounts receivable | The amount of a single item exceeds 0.5% of the total assets |
| Important prepayments with an aging of more than one year | The amount of a single item exceeds 0.5% of the total assets |
| Important construction in progress projects | The amount of a single item exceeds 0.5% of the total assets |
| Important accounts payable with an aging of more than one year | The amount of a single item exceeds 0.5% of the total assets |
| Other important accounts payable with an aging of more than one year | The amount of a single item exceeds 0.5% of the total assets |
| Important contract liabilities aged above 1 year | The amount of a single item exceeds 0.5% of the total assets |
| Significant changes in the carrying amount of contract liabilities | The amount of a single item exceeds 0.5% of the total assets |
| Significant cash flows from investing activities | The cash flow amount from a single investing activity exceeds 10% of the total assets |
| Important overseas businesses | Total assets/total revenue/total profit exceed the corresponding items in the consolidated financial statements by 15%. |
| Important subsidiary and non-wholly-owned subsidiary | Total assets/total revenue/total profit exceed the corresponding items in the consolidated financial statements by 15%. |
| Important associates and joint ventures | The carrying amount of a single long-term equity investment exceeds 15% of the Group's net assets / The investment income of a single investment accounted for under the equity method exceeds 15% of the Group's total profit |
6. The accounting treatment of business combinations involving enterprises under common control and business combinations not involving enterprises under common control
(1) The accounting treatment of business combinations involving enterprises under common control
For a business combination under common control, the acquirer measures the assets and liabilities of the acquiree obtained in the combination at the carrying amounts of the acquiree in the consolidated financial statements of the ultimate controlling party as of the date of the combination. The difference between the carrying amount of the consideration transferred in a business combination and the carrying amount of the net assets acquired in the combination is adjusted to capital reserve; if the capital reserve is insufficient to offset it, retained earnings are adjusted.
Business combination under common control achieved in stages through multiple transactions
The assets and liabilities of the acquiree obtained in the consolidation are measured at their carrying amounts in the ultimate controlling party’s consolidated financial statements on the acquisition date; the difference between the sum of the carrying amount of the investment held before the consolidation and the carrying amount of the consideration newly paid on the acquisition date and the carrying amount of the net assets acquired in the consolidation adjusts capital reserve; if the capital reserve is insufficient to offset the difference, retained earnings are adjusted. The long-term equity investment held by the merging party prior to the acquisition of the control right of the merged party, and the relevant profits and losses, other comprehensive income and other changes in owners’ equity have been confirmed from the later date on which the original equity is acquired and the merging party and the merged party are under common control to the date of merger are offset against the beginning retained earnings or current profits and losses of the comparative statement period respectively.
(2) The accounting treatment of business combinations not involving enterprises under common control
Business combination involving entities not under common control: The cost of combination is the fair value of the assets paid, the liabilities incurred or assumed, and the equity securities issued to acquire the control of the acquiree on the date of acquisition. On the acquisition date, the assets, liabilities, and contingent liabilities acquired from the acquiree are recognized at fair value.
Where the cost of combination is higher than the fair value of the identifiable net assets acquired from the merging party in business combination, such difference shall be recognized as goodwill, subsequently measured at cost less accumulated impairment losses.; where the cost of combination is less than the fair value of the identifiable net assets acquired from the merging party in business combination, such difference shall be charged to the profit or loss for the period after review.
Business combination under non‑common control achieved through multiple transactions in stages
The cost of a business combination is the sum of the consideration transferred on the purchase date and the fair value on the purchase date of the equity interests in the acquiree that were already held before the purchase date. For equity interests in the acquiree that were held before the acquisition date, remeasure those equity interests at their fair value at the acquisition date; the difference between fair value and their carrying amount is recognized in investment income for the current period. If the acquiree's pre‑acquisition equity holdings relate to other comprehensive income or other changes in owners' equity that are reclassified to income on the acquisition date, those amounts are reclassified to income for the current period, except for other comprehensive income arising from remeasurement of the investee's defined benefit plan net liability or net asset and except for other comprehensive income related to non‑trading equity instrument investments that were originally designated at fair value with changes recognized in other comprehensive income.
(3) Treatment of transaction costs in business combinations
Acquisition-related costs including auditing fees, legal services fees, valuation advice fees and other relevant management fees are generally recognized in profit or loss as incurred. The transaction costs of equity securities or debt securities issued as the consideration of combination are included in the initial recognition amount of equity securities or debt securities.
7. Criteria for Judging Control and Method for Preparing the Consolidated Financial Statement
(1) Assessment of control
The scope of consolidation of the consolidated financial statements is determined on the basis of control. Control means that the investor has the power with respect to the Company to obtain variable returns by engaging in relevant activities of the invested entity, and has the ability to influence the amount of its returns by applying its power with respect to the invested entity. Once any changes in relevant facts and circumstances cause the changes in relevant elements concerned in the definition of control, a reassessment shall be made by the Company.
When determining whether to include a structured entity within the scope of consolidation, the Company assesses whether it controls that structured entity based on all facts and circumstances, including evaluating the structured entity’s purpose and design, identifying the types of variable returns, and whether it is exposed to some or all of the variability of those returns through its involvement in the relevant activities.
(2) Preparation method of consolidated financial statements
The Company prepares its consolidated financial statements based on the financial statements of the Company and its subsidiaries, as well as other relevant information prepared by the Company. When preparing the consolidated financial statements, the
Company and its subsidiaries are required to maintain consistent accounting policies and accounting periods, and significant intercompany transactions and balances are eliminated.
During the reporting period, subsidiaries and businesses added as a result of business combinations under common control are treated as having been included in the Company's consolidated scope from the date they came under the common control of the ultimate controlling party; their operating results and cash flows from that date are included, respectively, in the consolidated income statement and the consolidated cash flow statement.
During the reporting period, subsidiaries and businesses added through business combinations not under common control have their revenue, expenses, and profit from the acquisition date to the end of the reporting period included in the consolidated income statement, and their cash flows included in the consolidated cash flow statement.
The portion of a subsidiary's shareholders' equity that is not owned by the Company is presented separately as non-controlling interests under shareholders' equity on the consolidated balance sheet; the portion of the subsidiary's net profit or loss for the period attributable to minority shareholders is presented under the net profit item on the consolidated income statement as the "profit or loss of minority shareholders" item. Where losses of a subsidiary attributable to the minority shareholders exceed the minority shareholders' interest entitled in the owners’ equity of the subsidiary at the beginning of the period, the remaining balance is allocated against the minority shareholders’ interest.
(3) Purchase of minority equity of subsidiaries
If there is a difference between the cost of the newly acquired long-term equity investment as a result of the purchase of minority shares and the share of the subsidiary's net assets continuously calculated from the purchase date or the merger date based on the increased shareholding ratio, and without losing control, if there is a difference between the disposal price of partial disposal of the equity investment in the subsidiary and the corresponding share of the subsidiary's net assets continuously calculated from the acquisition date or the merger date of the long-term equity investment disposal, the capital reserves in the consolidated balance sheet shall be adjusted. Where the capital reserve is insufficient to offset, retained earnings are adjusted.
(4) Treatment of loss of control of a subsidiary
If control over a former subsidiary is lost due to disposal of part of an equity investment or for other reasons, the remaining equity interest shall be remeasured at its fair value on the date control is lost; the difference between the sum of the consideration received for the disposed equity and the fair value of the remaining equity, and the sum of the portion of the former subsidiary’s net assets’ carrying amount attributable based on the original shareholding proportion and measured from the acquisition date, together with goodwill, shall be recognized as investment income in the period in which control is lost.
Other comprehensive income related to equity investments in the former subsidiary shall, upon loss of control, be accounted for on the same basis as the direct disposal of the assets or liabilities related to the former subsidiary. Other changes in owners' equity related to the former subsidiary that arise under the equity method shall be transferred to profit or loss for the current period upon loss of control.
8. Classification of joint arrangement and accounting treatment methods for joint operation
A joint arrangement is an arrangement that is jointly controlled by two or more parties. Joint venture arrangements of the Company are classified into joint operations and joint ventures.
(1) Joint operation
Joint operation means the joint venture arrangement in which the Company has the assets and assumes the liabilities related to such arrangement.
The Company recognizes the following items related to its interest in the joint operation and carries out accounting treatment in accordance with relevant accounting standards for business enterprises:
① The assets separately held by the Company and assets jointly held as recognized by its share;
② The liabilities separately assumed by the Company and liabilities jointly assumed as recognized by its share;
③ Income from selling the share of the Company in the output of the joint operation;
④ Income from joint operation of the sold output as recognized by its share;
⑤ The expenses separately incurred and expenses jointly incurred as recognized by its share;
(2) Joint venture
A joint venture is a joint arrangement where the Company has rights only to the net assets of the arrangement.
The Company accounts for its investment in associates in accordance with the equity method of accounting for long-term investments.
9. Criteria for determining cash and cash equivalents
Cash shown in the cash flow statement refers to the cash on hand and the deposits that can be used for payment at any time. Cash equivalents mean the investments held by the Company that are short-term, highly liquid, easy to convert into known amounts of cash, and have little risk of value change.
10. Conversion of transactions and financial statements denominated in foreign currencies
(1) Foreign currency transactions
The Company translates foreign-currency transactions into the currency in which the accounts are kept using exchange rates determined by the system through a reasonable method that approximate the spot exchange rates on the transaction date.
The monetary items of foreign currency on the balance sheet date shall be converted by adoption of the spot exchange rate on the balance sheet date. The exchange difference arising from the difference between the spot exchange rate on the balance sheet date and that at the time of initial recognition or the previous balance sheet date shall be included into the current profits and losses; The non-monetary items of foreign currency measured at historical cost shall still be converted at the approximate spot exchange rate on the transaction date; The non-monetary items of foreign currency measured at fair value shall be converted at the spot exchange rate of the fair value on the recognition date. The difference between the converted and original amount of recording currency shall be included into the current profits and losses, or other comprehensive income for the current period, depending on the nature of the non-monetary item.
(2) Translation of foreign currency financial statements
On the balance sheet date, when the foreign currency financial statement of overseas subsidiaries is converted, the items of assets and liabilities in the balance sheet shall be converted at the spot exchange rate on the balance sheet date, while the item of shareholders’ equity, excluding the item of "undistributed profit", shall be converted at the spot exchange rate on the date of occurrence.
Items of income and expenses in the income statement are converted at a rate similar to the spot rate on the date of occurrence of the transaction determined in a systematic and reasonable manner
All items in the statement of cash flows are converted using exchange rates determined by a systematic and reasonable method that approximate the spot exchange rates on the dates the cash flows occur. The influence of changes in exchange rate on cash shall be taken as adjustment items, and it shall be separately presented and reflected in the item of "influence of changes in exchange rate on cash and cash equivalents" in the cash flow statement.
The difference arising from financial statement conversion shall be reflected in the item of "other comprehensive income" under the item of “shareholders’ equity” in the balance sheet.
When the Group disposes of, and loses control over, an overseas operation, exchange differences from translation which are presented in “equity” of the balance sheet and related to the overseas operation are, all or based on the disposal proportion, transferred to the profit or loss of the period of disposal.
11. Financial instruments
Financial instruments mean the contracts that form the financial assets of one Party and the financial liabilities or equity instruments of the other Party.
(1) Recognition and derecognition of financial instruments
A financial asset or financial liability shall be recognized when the Company becomes a party to a financial instrument contract.
In case of meeting one of the following conditions, the financial assets shall be derecognized: ① The contractual right of collecting the cash flow of such financial assets is terminated; ② The financial assets have been transferred and comply with the following derecognition conditions for the transfer of financial assets.
If all or partial current obligations of financial liabilities have been cancelled, such financial liabilities or part of such financial liabilities shall be derecognized. If the Company (debtor) signs an agreement with the creditor, so as to replace the existing financial liabilities in the way of undertaking the new financial liabilities, and the contract clauses regarding the new financial liabilities are substantially different from those regarding the existing financial liabilities, the existing financial liabilities shall be derecognized, and meanwhile, the new financial liabilities shall be recognized.
If the financial assets are transacted in a conventional manner, accounting recognition and derecognition shall be conducted on the transaction date.
(2) Classification and measurement of financial assets
Pursuant to the business model of managing financial assets and the contractual cash flow characteristics of financial assets upon initial recognition, the financial assets are classified into three categories as below: Financial assets measured at amortized cost, financial assets measured at fair value with changes included in other comprehensive income, and financial assets measured at fair value with changes included in the current profits and losses.
When financial assets are initially recognized, they shall be measured at their fair values. For the financial assets measured at fair value through profit and loss, the related transaction costs shall be included directly in the current profits and losses. For the financial assets or financial liabilities of other categories, the related transaction costs shall be included in the initially recognized amount. For receivables arising from the sale of products or the provision of labor services, which do not include or consider major financing components, the amount of consideration that the Company is expected to be entitled to be taken as the initial confirmation amount.
1) Financial assets measured at amortized cost
The financial assets which satisfy the following conditions, and are not designated as financial assets at fair value through profit or loss will be classified by the Company as financial assets at amortized cost:
① The Company's business model for managing the financial asset is aimed at collecting the contractual cash flows;
② The contractual terms of the financial assets specify that the cash flow generated on a specific date is only the payment of principal and interest based on the amount of outstanding principal.
After initial recognition, the amortized cost is applied for measurement with the effective interest rate method with respect to these financial assets. The profits and losses, arising from a financial asset which is measured at the amortized cost and is not a part of any hedging relationship shall be included in the current profits and losses when it is terminated from recognition, or is amortized according to the actual interest rate method, or is recognized as impaired.
2) Financial assets measured at fair value with changes recorded in other comprehensive income
The financial assets which satisfy the following conditions, and are not designated as financial assets at fair value through profit or loss will be classified by the Company as the financial assets at fair value through other comprehensive income:
① The Company manages the financial asset under a business model that has both the objective of collecting contractual cash flows and the objective of selling the financial asset;
② The contractual terms of the financial assets specify that the cash flow generated on a specific date is only the payment of principal and interest based on the amount of outstanding principal.
After initial recognition, the financial assets are subsequently measured at fair value. The interest, impairment loss or gain, and exchange gain or loss calculated by the effective interest rate method are included in current profits and losses, while other gains or losses are included in other comprehensive income. Upon the termination of recognition, the accumulated gains or losses previously included in other comprehensive income shall be transferred out of other comprehensive income and included in the current profits and losses.
3) Financial assets measured at fair value through profit and loss
Except for the financial assets at amortized cost, and financial assets at fair value through other comprehensive income, all the remaining financial assets are classified as the financial assets at fair value through profit or loss. At initial recognition, to eliminate or significantly reduce the accounting mismatch, the Company may irrevocably designate part of the financial assets measured at amortized cost, or the financial assets measured at fair value with changes included in other comprehensive income, as those measured at fair value with changes included in the current profits and losses.
After initial recognition, the financial assets are subsequently measured at fair value. The gains or losses generated (including interest and dividend income) shall be included in the current profits and losses, unless such financial assets are part of the hedging relationship.
The business model for managing financial assets refers to how the Company manages financial assets to generate cash flows. The business model determines whether the cash flows of the financial assets managed by the Company are derived from collecting contractual cash flows, from selling financial assets, or from both. The Company determines the business model for managing financial assets based on objective facts and on the specific business objectives for managing financial assets determined by key management personnel.
The Company assesses the contractual cash flow characteristics of financial assets to determine whether, on a specified date, the contractual cash flows of the relevant financial assets are solely payments of principal and interest on the outstanding principal amount. Among them, principal refers to the fair value of the financial asset at initial recognition; interest includes consideration for the time value of money, the credit risk associated with the amount of principal outstanding over a specific period, and other basic lending risks, costs, and profits. In addition, the Company assesses contractual terms that could result in changes to the timing or amount of the contractual cash flows of a financial asset to determine whether they meet the requirements of the contractual cash flow characteristics described above.
Reclassification shall occur only when the Company changes the business model for managing financial assets. In such cases, all affected financial assets shall be reclassified on the first day of the first reporting period after the change in business model; otherwise, financial assets shall not be reclassified after initial recognition.
(3) Classification and measurement of financial liabilities
The financial liabilities of the Company, when initially recognized, are classified as: financial liabilities at fair value through profit or loss and financial liabilities at amortized cost. For the financial liabilities unclassified to be those measured at fair value and changes of which are included into the current profits and losses, the relevant transaction expenses shall be included into the initial recognition amount.
1) Financial liabilities measured at fair value through profit or loss
The financial liabilities measured at fair value with changes recorded in the current profits and losses when initially recognized shall include transaction financial liabilities and financial liabilities designated as those measured at fair value through profit or loss. For such financial liabilities subsequently measured at fair value, gains or losses generated from changes in fair value, and the dividends and interest expenses related to the financial liabilities are included in the current profits and losses.
2) Financial liabilities measured at amortized cost
For other financial liabilities, the subsequent measurement shall be conducted by adoption of the effective interest rate method at the amortized cost, and the gains or losses arising from derecognition or amortization shall be included into the current profits and losses.
3) Distinction between financial liabilities and equity instruments
Financial liabilities are liabilities that meet one or more of the following conditions:
① a contractual obligation to deliver cash or another financial asset to another.
② a contractual obligation to exchange financial assets or financial liabilities with another under conditions that are potentially unfavorable to the Company.
③ a contract that will or may be settled in the Company's own equity instruments, and a non-derivative instrument for which the enterprise will be obliged to deliver a variable number of its own equity instruments.
④ a contract that is a derivative instrument that will or may be settled in the enterprise's own equity instruments, other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the enterprise's own equity instruments.
Equity instruments refer to the contract which can prove that certain enterprise holds the residual equity of the assets after the deduction of all liabilities.
If the Company fails to avoid performing a contractual obligation with cash payment or other financial assets unconditionally, then the contractual obligation complies with the definition of financial liabilities.
Where a financial instrument will or may be settled in the Company's own equity instrument, considerations shall be given to whether the enterprise's own equity instrument as used to settle the financial instrument is a substitute of cash or another financial asset or for the purpose of entitling the holders of the financial instrument to the residual interests in the issuer's assets less all of its liabilities. If the former, this instrument is the financial liabilities of the Company; If the latter, this instrument is the equity instrument of the Company.
(4) Derivative financial instruments and embedded derivative instruments
The derivative financial instruments of the Company shall include forward foreign exchange contracts and foreign exchange option contracts, etc. It shall be initially measured at fair value on the date when the derivative transaction contract is signed and subsequently measured at its fair value. The derivative financial instrument with positive fair value shall be recognized as an asset, and that with negative fair value shall be recognized as a liability. The gains or losses which do not comply with the hedge accounting provisions arising from changes in fair value shall be directly included into the current profits and losses.
For hybrid instruments that contain embedded derivatives, where the host contract is a financial asset, the hybrid instrument as a whole shall be subject to the relevant provisions on the classification of financial assets. If the host contract is not a financial asset, and the hybrid instrument is not measured at fair value with changes recognized in profit or loss, and the embedded derivative is not closely related to the economic characteristics and risks of the host contract, and a standalone instrument with the same terms as the embedded derivative meets the definition of a derivative, the embedded derivative is separated from the hybrid instrument and accounted for as a standalone derivative financial instrument. If it is impossible to conduct separate measurement to the embedded derivative instrument when it is obtained or on the subsequent balance sheet date, the hybrid instrument shall be designated entirely as the financial assets or financial liabilities measured at fair value and changes of which are included into the current profits and losses.
(5) Fair value of financial instruments
The methods for determining the fair value of financial assets and financial liabilities are set out in Note 12 of Section V of the financial report.
(6) Impairment of financial assets
The Company measures impairment and recognizes loss allowances for the following items on the basis of expected credit losses:
① Financial assets measured at amortized cost;
② Receivables and investments in debt instruments measured at fair value with changes recorded in through other comprehensive income;
③ Contracted assets as defined in the Accounting Standards for Business Enterprises No. 14 - Revenue;
④ Lease receivables;
⑤ Financial guarantee contracts (except for those measured at fair value with changes recognized in profit or loss, or those arising from transfers of financial assets that do not meet the conditions for derecognition or from continuing involvement in transferred financial assets).
Measurement of expected credit loss
The “expected credit loss” refers to the weighted average of the credit losses of financial instruments weighted by the risk of default. The “credit loss” means the difference between all contractual cash flows receivable by the Company under a contract and discounted at the original actual interest rate, and all cash flows expected to be received, i.e., the present value of all cash shortages. Taking into the reasonable and well-grounded information including past matters, current situation and prediction of future economic conditions, the Company calculates the possibly weighted amount of the present value of the difference between the cash flows receivable under the contract and the cash flows expected to be received, taking the risk of default as the weight, and recognizes the expected credit loss.
The Company measures the expected credit losses for financial instruments at different stages separately. If the credit risk has not increased significantly since the initial recognition of the financial instruments and has been in the first stage, its loss provision is measured by the Company according to the amount equivalent to the expected credit loss in the next 12 months. In the second stage, if there is a significant increase in credit risk since initial recognition of the financial instruments but there is no credit impairment, its loss provision is measured by the Company according to the amount equivalent to the expected credit loss of the instruments throughout the duration. In the third stage, if there have been credit-impaired financial assets since initial recognition of the financial instruments, its loss provision is measured by the Company according to the amount equivalent to the expected credit loss of the instruments throughout the duration.
For financial instruments with relatively low credit risks on the balance sheet date, the Company assumes that their credit risks have not increased significantly since the initial recognition, and measures the provision for loss based on the expected credit loss within the next 12 months.
Lifetime expected credit losses refer to the expected credit losses resulting from all possible default events that may occur over the entire expected life of a financial instrument. Expected credit losses over the next 12 months refer to anticipated credit losses resulting from potential default events on financial instruments that may occur within 12 months after the balance sheet date (or the expected life of the financial instruments if it is less than 12 months). These losses form part of the expected credit losses over
the entire duration.
When measuring expected credit losses, the Company shall consider the longest contractual period over which it is exposed to credit risk (including consideration of renewal options).
For financial instruments in the first stage and the second stage, as well as those with lower credit risk, the Company calculates interest income based on the gross carrying amount before impairment provisions and the effective interest rate. For financial instruments in the third stage, interest income is calculated based on the amortized cost after impairment provisions have been deducted and the effective interest rate.
For notes receivable, accounts receivable, receivables financing, other receivables, contract assets, and other receivable items, if a customer's credit risk characteristics are significantly different from those of other customers in the portfolio, or if that customer's credit risk characteristics change significantly, the Company individually recognizes an allowance for doubtful accounts for that receivable. Except for receivables for which allowance for doubtful accounts is recognized individually, the Company classifies receivables into portfolios based on credit risk characteristics and calculates the allowance for doubtful accounts on a portfolio basis.
Notes receivable, accounts receivable, and contract assets
For notes receivable, accounts receivable, and contracted assets, regardless of whether there exist significant financing components, the Company always measures the loss reserve according to the amount equivalent to the expected credit loss in the entire duration. When it is impossible to assess the expected credit losses of a single financial asset or contracted asset based on reasonable costs, the Company will, according to the feature of credit risks, classify notes receivable, accounts receivable, and contracted assets into different portfolios, measure the expected credit loss on a portfolio basis, and determine the basis of the portfolios as below:
①Notes receivable
Notes receivable portfolio 1 - bank acceptance bill
Notes receivable portfolio 2 - commercial acceptance bills
②Accounts receivable
Accounts receivable portfolio 1: Aging composition
For notes receivable classified as portfolio, the expected credit loss shall be calculated in light of the current conditions and forecasts of future economic condition, by referring to historical credit loss experience and through default risk exposure and expected credit loss rate throughout the life.
For account receivable portfolio, the expected credit loss shall be calculated in light of the current conditions and forecasts of future economic condition, by referring to historical credit loss experience and preparing the comparison table between aging of the accounts receivable and expected credit loss rate throughout the life. The aging of accounts receivable is calculated from the
date of recognition.
Other receivables
The Company will, according to the feature of credit risks, classify accounts receivable into portfolios, measure the expected credit loss on portfolio basis and determine the portfolios as follows:
① Other receivables portfolio 1: Tax refund receivables
② Other receivables portfolio 2: Land deposit receivables portfolio
③ Other receivables portfolio 3: Guarantee deposits receivable from customs and tax authorities
④ Other receivables portfolio 4: Special capital injection funds group
⑤ Other receivables portfolio 5: Other receivables
For other receivables classified as portfolio, the expected credit loss shall be calculated by the Company using the default risk exposure and the expected credit loss rate in the next 12 months or throughout the life. For other receivables grouped by aging, the aging is calculated from the date of recognition.
Debt investments, and other debt investments
For debt investments and other debt investments, the Company calculates expected credit losses based on the nature of the investments and the various types of counterparties and risk exposures, by applying the default risk exposure and the expected credit loss rates within the next 12 months or over the entire remaining life.
(7) Transfer of financial assets
Transfer of financial assets refers to that the financial assets are transferred or delivered to the other party (transferee) other than the issuer of such financial assets.
If the Company has transferred nearly all of the risks and remunerations related to the ownership of financial assets to the transferee, such financial assets shall be derecognized; if nearly all the risks and remunerations related to the ownership of financial assets are retained, such financial assets shall not be derecognized.
If the Company does not transfer or retain nearly all of the risks and remunerations related to the ownership of financial assets, it shall deal with it according to the following situations respectively: If the Company gives up the control over such financial assets, such financial assets shall be derecognized, and the assets and liabilities generated shall be recognized; If the Company does not give up the control over such financial assets, the relevant financial assets shall be recognized according to the degree of its continuous involvement in the financial assets transferred, and the relevant liabilities shall be recognized accordingly.
(8) Offset of financial assets and financial liabilities
When the Company has the legal right to offset the recognized financial assets and financial liabilities, which is enforceable for the time being, and the Company plans to settle on a netting basis or capitalize financial assets and serve financial liabilities, any amount from netting of financial assets and financial liabilities is presented in the balance sheet. Apart from this, financial assets and financial liabilities shall be presented separately in the balance sheet and shall not offset each other
12. Measurement at fair value
Fair value refers to the price that market participants can receive by selling an asset or need to pay by transferring a liability in the orderly transactions on the measurement date.
The Company measures related assets or liabilities at fair value, assuming that the orderly transaction of selling assets or transferring liabilities is conducted in the main market of related assets or liabilities; If there is no principal market, the Company assumes that the transaction will be conducted in the most favorable market of related assets or liabilities. The main market (or the most favorable market) is the trading market that the Company can enter on the measurement day. The Company adopts the assumptions used by market participants to maximize their economic benefits when pricing the assets or liabilities.
The fair value of financial assets or financial liabilities in an active market (if any) is determined by the Company at the price quoted in the active market. If there is no financial instrument in an active market, its fair value is determined by the Company via valuation technique.
When measuring non-financial assets at fair value, the ability of market participants to apply the assets for the best purpose to generate economic benefits or the ability to sell the assets to other market participants for the best purpose to generate economic benefits shall be considered.
The Company adopts the valuation technology which is applicable in the current situation and supported by sufficient available data and other information, and gives priority to the relevant observable input values. The unobservable input values are used only when the relevant observable input values are unavailable or impracticable.
For assets and liabilities measured or disclosed at fair value in financial statements, the fair value level is determined according to the lowest level input value which is of great significance to fair value measurement as a whole: The first-level input value is the unadjusted quotation of the same assets or liabilities that can be obtained on the measurement date in an active market; The second-level input value is directly or indirectly observable input value of related assets or liabilities except the first-level input value; The third-level input value is the unobservable input value of related assets or liabilities.
On each balance sheet date, the Company reassesses the assets and liabilities recognized in the financial statements that are continuously measured at fair value to determine whether there is a conversion between the fair value measurement levels.
13. Inventories
(1) Classification of inventory
The Company’s inventories are classified as raw material, work in progress, finished goods, goods dispatched, materials entrusted for processing, low-value consumables, packaging materials, development costs, etc.
(2) Determination of cost
The Company's inventories are valued at actual cost on acquisition. The raw material and merchandise inventory are priced according to the weighted average method when it is delivered.
(3) Basis for determination and method of calculation for inventory falling price reserves
On the balance sheet date, inventory is measured at cost or net realizable value (whichever is lower). If the net realizable value is lower than its cost, the provision for inventory depreciation shall be made. The net realizable value is the amount obtained by deducting the estimated incurred cost till completion, estimated selling expenses and the relevant taxes and dues from the estimated selling price of inventory. In determining net realizable value of an inventory, based on obtained proof, the Group considers the purpose of the inventory and the impact of any matters occurring after the balance sheet date. The Company usually provides for inventory write-down on an individual inventory item basis. At the balance sheet date, if the factors that previously caused a write-down of inventory value have ceased to exist, the provision for inventory write-down shall be reversed to the extent of the amount previously recognized.
(4) Inventory system of inventory
The inventory system of the Company adopts a perpetual inventory system.
(5) Amortization of low-value consumables and packaging materials
The Company expenses low-value consumables using the one-time write-off method upon issuance. Packaging materials for turnover are amortized using the one-time write-off method.
14. Long-term equity investments
Long-term equity investments include equity investments in subsidiaries, associates, and joint ventures. Where the Company can exercise significant influence over the investee, the investee is an associate of the Company.
(1) Determination of initial investment cost
For the long-term equity investment formed by business merger: For the long-term equity investment obtained through the business combination under the common control, the share of book value in the consolidated financial statement of the owner’s equity which the final control party has obtained from the merged party on the merger date shall be taken as the investment cost; For the long-term equity investment obtained through the business combination under the non-common control, the merger cost shall be taken as the investment cost of long-term equity investment.
For the long-term equity investment obtained by other means: For the long-term equity investment obtained through cash payment, the purchase price actually paid shall be taken as the initial investment cost; For the long-term equity investment obtained through issuance of equity securities, the fair value of the equity securities issued shall be taken as the initial investment cost.
(2) Method of subsequent measurement and recognition of profit and loss
The Company’s investment in subsidiaries shall be subject to accounting by using the cost method unless the investment meets the criteria for held for sale, and the investment in associates and joint ventures shall be subject to accounting by using the equity method.
For long-term equity investments measured according to the cost method, except for actual price paid when the investment is obtained or the cash dividends or profits that are included in the consideration that has been declared but not yet paid, the cash dividend or profit declared by the invested entity will be recognized as the investment income, and included into the current profits and losses.
When the equity method is adopted for calculation of the long-term equity investment, if the initial investment cost of long-term equity investment is more than the share of fair value of the identifiable net assets of the invested unit that shall be enjoyed at the time of investment, the investment cost of long-term equity investment shall not be adjusted; If the initial investment cost is less than the share of fair value of the identifiable net assets of the invested unit that shall be enjoyed at the time of investment, the book value of long-term equity investment shall be adjusted, and the difference shall be included into the current profits and losses. When the equity method is adopted, according to the share of the net profit and loss and other comprehensive income realized by the invested entity, the investment income and other comprehensive income shall be recognized respectively, and adjusts the book value of the long-term equity investment; The book value of the long-term equity investment is reduced correspondingly in accordance with the portion of the profits or cash dividends declared and distributed by the invested entity; For changes in owner’s equity other than net profit and loss, other comprehensive income and profit distribution of the invested entity, the book value of long-term equity investment is adjusted and included in capital reserves (other capital reserves). When confirming the share of net profit and loss of the invested entity, based on the fair value of various identifiable assets of the invested entity when the investment is made, the net profit of the invested entity is recognized after adjustment in accordance with the accounting policies and accounting periods of the Company.
In the case of being able to exert a significant influence on the invested unit or implement joint control (but not constitute control) due to investment increase and other reasons, the sum of the fair value of the equity originally held and the new investment cost on the date of conversion shall be taken as the initial investment cost calculated according to the equity method. For equity investments that were originally classified as non‑trading equity instruments measured at fair value with changes recognized in other comprehensive income, the cumulative fair value changes previously recognized in other comprehensive income relating to them are transferred to retained earnings when they are subsequently accounted for under the equity method.
If, due to the disposal of part of an equity investment or for other reasons, joint control of or significant influence over an investee is lost, the remaining equity interest after the disposal shall be accounted for, from the date on which joint control or significant influence is lost, in accordance with Accounting Standards for Business Enterprises No. 22 - Recognition and Measurement of Financial Instruments, and the difference between its fair value and carrying amount shall be recognized in profit or loss for the current period. Other comprehensive income recognized by the original equity investment due to the adoption of the equity method is calculated on the same basis as the invested entity's direct disposal of related assets or liabilities when the equity method is terminated. Other changes in equity related to original equity investments are transferred to current profit or loss.
If the Company loses control over an investee due to the disposal of part of its equity investment and the remaining equity can be used upon disposal to exercise joint control or significant influence over the investee, the equity method shall be used for accounting instead and the remaining equity shall be deemed to be accounted and adjusted by using the equity method when it is acquired. If the remaining equity upon disposal cannot be used to exercise joint control or significant influence over the investee, the accounting treatment shall be carried out in accordance with the provisions of Accounting Standards for Business Enterprises No. 22 - Recognition and Measurement of Financial Instruments, and the difference between the fair value and the book value when the control is deprived of shall be included in the current profits and losses.
If, due to additional capital injections by other investors, the Company’s shareholding percentage decreases and the Company thereby loses control but can still exercise joint control over or exert significant influence on the investee, the Company shall, based on the new shareholding percentage, recognize the portion of the investee’s net asset increase resulting from the capital increase that the Company is entitled to, and shall include in current profit or loss the difference between that amount and the original carrying amount of the long‑term equity investment corresponding to the portion of the shareholding percentage to be transferred; thereafter, the Company shall, under the new shareholding percentage, make adjustments by treating the investment as having been accounted for using the equity method from the date of acquisition.
For the unrealized profits and losses from the internal transaction incurred between the Company and the associates or joint ventures, the part that belongs to the Company shall be calculated according to the shareholding proportion, and the investment profits and losses shall be recognized on the basis of offset. However, if the unrealized loss from the internal transaction between the Company and the invested unit belongs to the impairment loss of the assets transferred, the offset shall not be conducted.
(3) Criteria for judging joint control and significant influence
Joint control is the contractually agreed sharing of control of an arrangement, and exists only when requiring the unanimous consent of the parties sharing control before making decisions about the relevant activities of the arrangement. When determining whether joint control exists, first determine whether the arrangement is collectively controlled by all the parties or by a combination of the parties, and then determine whether decisions about the arrangement's relevant activities require the unanimous consent of those parties that collectively control the arrangement. If all parties, or a group of parties, must act in concert to determine the relevant activities of an arrangement, those parties are considered to collectively control the arrangement; if there exists a combination of two or more parties that can collectively control an arrangement, joint control does not exist. When assessing whether there is joint control, protective rights are not taken into account.
Significant influence refers to the investor’s right to participate in an invested entity's financial and business decision-making, but not to control or jointly control the formulation of these policies with other parties. In determining whether the investor can exert significant influence over the investee, the investor considers the voting rights held directly or indirectly in the investee, as well as the impact of exercisable potential voting rights held by the investor and other parties, assuming their conversion into equity interests in the investee. This includes the effects of warrants, share options, and convertible corporate bonds issued by the investee.
When the Company directly or indirectly via subsidiaries owns more than 20% (20% inclusive) but less than 50% of the voting shares of the invested unit, it will be generally regarded as having a significant influence on the invested unit, except there is a clear evidence proving that the Company cannot participate in the production and business decision-making thereby not having a significant influence on the invested unit under this situation; Generally, when the Company owns less than 20% (exclusive) of the voting shares of the invested unit, it will be regarded as having no significant influence on the invested unit, except there is a clear evidence proving that the Company can participate in production and business decision-making thereby having a significant influence on the invested unit under this situation.
(4) Impairment test method and impairment provision accrual method
For investments in subsidiaries, associates and joint ventures, the method of providing for asset impairment is set out in Note 20 of Section V of the financial report.
15. Fixed assets
(1) Recognition criteria
Fixed assets of the Company mean the tangible assets held for the production of goods, provision of labor services, leasing or management, and with a useful life exceeding one fiscal year.
Only when the economic benefits related to such fixed assets are likely to flow into the enterprise, and the cost of such fixed assets can be reliably measured, the fixed assets can be recognized.
The fixed assets of the Company shall be initially measured at the actual cost at the time of obtaining.
Subsequent expenditures related to fixed assets shall be included in the cost of the fixed assets when it is probable that the related economic benefits will flow to the Company and their costs can be measured reliably; routine repair expenses of fixed assets that do not meet the capitalization criteria for subsequent expenditures shall, when incurred, be charged to current profit or loss or to the cost of the related asset based on the beneficiary. For the replaced parts, derecognize their carrying amount.
(2) Depreciation method
| Categories | Depreciation method | Depreciable life (years) | Ratio of remaining value (%) | Yearly depreciation (%) |
| Houses and buildings | Straight-line method | 7 -70 | 5 | 13.57-1.36 |
| General equipment | Straight-line method | 5 -10 | 5 | 19.00-9.50 |
| Dedicated equipment | Straight-line method | 5 -15 | 5 | 19.00-6.33 |
| Means of transport | Straight-line method | 5 -7 | 5 | 19.00-13.57 |
16. Projects under construction
The cost of construction in progress of the Company is determined at the actual construction expense, including various necessary construction expenditures incurred during the period of construction, capitalizable borrowing costs and other related expenses before the project reaches the predetermined conditions for use.
Construction in progress shall be transferred to fixed assets when it has reached the working condition for its intended use. The method for making impairment provisions for construction in progress is set out in Note 20 of Section V of the financial report.
17. Borrowing costs
(1) Criteria for recognition of capitalized borrowing costs
If the borrowing costs incurred by the Company can be directly attributed to the acquisition or production of assets that meet the capitalization requirements, they are capitalized and included in the relevant asset costs; Other borrowing costs, when incurred, are recognized as expenses according to the amount incurred, and included in the current profits and losses. Capitalization of borrowing costs begins when the following three conditions are fully satisfied:
① expenditures for the assets (including cash paid, transferred non-currency assets or expenditure for holding debt liability for the acquisition, construction or production of assets qualified for capitalization) have been incurred;
② borrowing costs have been incurred;
③ acquisition, construction or production that are necessary to enable the asset reach its intended usable or saleable condition have commenced.
(2) Capitalization period of borrowing costs
When the assets eligible for capitalization for acquisition and construction or production of the Company reach the estimated serviceable or marketable condition, the capitalization of borrowing costs shall be stopped. The borrowing costs incurred after the assets eligible for capitalization reach the estimated serviceable or marketable condition shall be recognized as expense according to the incurred amount at the time of occurrence and included into the current profits and losses.
If the assets eligible for capitalization are interrupted abnormally in the acquisition and construction or production process, and the interruption time lasts for more than 3 months continuously, the capitalization of borrowing costs shall be suspended; The capitalization of borrowing costs during the normal interruption period shall be continued.
(3) Calculation of capitalization rate and amount of borrowing costs
The amount to be capitalized is the actual interest expense incurred on the designated borrowings less any bank interest earned from unused funds of the designated borrowings or any investment income on the temporary investment of those funds. The amount to be capitalized on the general borrowings is calculated by applying a capitalization rate to the weighted average of the excess amounts of cumulative expenditures on the asset over and above the amounts of the designated borrowings. Capitalization rate is calculated and determined based on the weighted average interest rate of general loans.
During the period of capitalization, exchange differences arising from special borrowings in a foreign currency shall be fully capitalized, and exchange differences arising from general borrowings in a foreign currency shall be recognized in profits and losses.
18. Intangible assets
(1) Measurement method, useful lives and impairment test
The intangible assets of the Company shall include land use right, software, patent right, non-patented technologies, etc.
The intangible assets shall be initially measured at cost and its service life shall be analyzed and judged at the time of obtaining the intangible assets. If the useful life is limited, from the date when the intangible assets are available, the amortization method which can reflect the expected realization method of the economic benefits related to such assets shall be adopted for amortization within the expected useful life; If the expected realization method is unable to be reliably recognized, the intangible assets shall be amortized according to the straight-line method; The intangible assets with uncertain service life shall not be amortized.
The amortization method of intangible assets with limited service life is as follows:
| Category | Useful life | Basis for determining useful life | Amortization method | Notes |
| Land use right | 50 years and 70 years | According to the period stated in the certificate. | Method of line | |
| Software | 10 years | According to the estimated useful life | Method of line | |
| Patent right | 10 years | According to theestimated useful life | Method of line | |
| Non-patented technologies | 15 years | According to the estimated useful life | Method of line |
The Company shall review the useful life and amortization method of intangible assets with the limited useful life at the end of each year. If the result is different from the previous estimate, the original estimate shall be adjusted, and it shall be disposed according to the changes in accounting estimates.
If it is expected that certain intangible asset is unable to bring the future economic benefits to the enterprise on the balance sheet date, the book value of such intangible asset shall be completely transferred into the current profits and losses.
The method used to provide for impairment of intangible assets is set out in Note 20 of Section V of the financial report.
(2) Scope of R&D expenditures and related accounting treatment
The R&D expenses of the Company are the expenses directly related to its R&D activities, including: salaries and wages of R&D personnel; directly incurred expenses; depreciation expenses and long-term deferred expenses; amortization of intangible assets; design expenses; equipment commissioning and testing expenses; commissioned R&D expenses; and other expenses. The salaries of R&D personnel are allocated to R&D expenses based on project hours.
The expenses for internal research and development projects of the Company are divided into expenses in the research phase and expenses in the development phase.
Expenses in the research phase are recorded into the profits and losses for the current period when they occur.
Expenditures during the development phase can only be capitalized when they satisfy the following conditions simultaneously: It is technically feasible to finish intangible assets for use or sale; there is an intention to complete and use or sell the intangible assets; the methods for the intangible assets to generate economic benefits, including those which can prove that there is a market for the products manufactured by applying the intangible assets or that there is a market for the intangible assets themselves and that the intangible assets will be used internally, can prove their usefulness; there are sufficient technologies, financial resources and other resources that can support the development of the intangible assets, and the enterprise is able to use or sell the intangible assets; and the development expenditures of the intangible assets can be reliably measured. Development expenditures that do not meet the above conditions are recognized in profit or loss for the current period.
The research and development projects of the Company will enter the development stage after the above conditions are met, the technical and economic feasibility studies are completed, and the project is approved.
Capitalized development-stage expenditures are presented on the balance sheet as development expenditures and are transferred to
intangible assets on the date the project reaches its intended use.
19. Research and development expenses
The R&D expenses of the Company are the expenses directly related to its R&D activities, including: salaries and wages of R&D personnel; directly incurred expenses; depreciation expenses and long-term deferred expenses; amortization of intangible assets; design expenses; equipment commissioning and testing expenses; commissioned R&D expenses; and other expenses. The salaries of R&D personnel are allocated to R&D expenses based on project hours.
The expenses for internal research and development projects of the Company are divided into expenses in the research phase and expenses in the development phase.
Expenses in the research phase are recorded into the profits and losses for the current period when they occur.
Expenditures during the development phase can only be capitalized when they satisfy the following conditions simultaneously: It is technically feasible to finish intangible assets for use or sale; there is an intention to complete and use or sell the intangible assets; the methods for the intangible assets to generate economic benefits, including those which can prove that there is a market for the products manufactured by applying the intangible assets or that there is a market for the intangible assets themselves and that the intangible assets will be used internally, can prove their usefulness; there are sufficient technologies, financial resources and other resources that can support the development of the intangible assets, and the enterprise is able to use or sell the intangible assets; and the development expenditures of the intangible assets can be reliably measured. Development expenditures that do not meet the above conditions are recognized in profit or loss for the current period.
The research and development projects of the Company will enter the development stage after the above conditions are met, the technical and economic feasibility studies are completed, and the project is approved.
Capitalized development-stage expenditures are presented on the balance sheet as development expenditures and are transferred to intangible assets on the date the project reaches its intended use.
20. Partial impairment of long-term assets
The impairment of assets such as long-term equity investments in subsidiaries, associates and joint ventures, investment properties subsequently measured using the cost model, fixed assets, construction in progress, right-of-use assets, intangible assets, goodwill, etc. (excluding inventories, deferred tax assets and financial assets) shall be determined as follows:
To judge whether there is a sign of possible impairment in the assets on the balance sheet date, if there is a sign of impairment, the Company shall estimate its recoverable amount to conduct impairment test. An impairment test will be conducted every year for intangible assets whose goodwill and service life are uncertain due to a business combination, and intangible assets not yet available for their intended use, regardless of whether there are signs of impairment.
The recoverable amount is determined based on the higher of the net value of the fair value less cost of disposal and the present value of the estimated future cash flow of assets. The Company shall estimate its recoverable amount based on a single asset; for the recoverable amount of a single asset which is difficult to estimate, the recoverable amount of the assets group shall be recognized on the basis of the assets group to which such asset attributes. The identification of an asset group is based on whether the main cash inflows generated by the asset group are independent of the cash inflows of other assets or asset groups.
When the recoverable amount of assets or assets group is less than its book value, the Company shall write down its book value to the recoverable amount, with the written-down amount included into the current profits and losses, and withdraw the corresponding assets impairment provision simultaneously.
For the impairment test to goodwill, the Company shall, as of the purchasing day, allocate on a reasonable basis the book value of the goodwill formed by merger of enterprises to the relevant asset groups, or if there is a difficulty in allocation, to allocate it to the sets of asset groups. Relevant asset groups or the sets of asset groups mean those can benefit from the synergy of business combination and are not larger than the reportable segment determined by the Company.
When carrying out impairment testing, if an asset group or a combination of asset groups related to goodwill shows indications of impairment, first perform impairment testing on the asset group or combination of asset groups that do not include goodwill, calculate the recoverable amount, and recognize the corresponding impairment loss. Then an impairment test is performed on the asset group or combination of asset groups that includes goodwill, comparing its carrying amount with its recoverable amount. If the recoverable amount is lower than the carrying amount, an impairment loss on goodwill is recognized. The assets impairment loss shall not be reversed in the following accounting periods once recognized.
21. Long-term deferred expenses
The long-term deferred expenses incurred by the Company are measured at actual cost and amortized on a straight-line basis over the estimated benefit period. For long-term deferred expense items that cannot benefit future accounting periods, their amortized value shall be fully charged to profit or loss for the current period.
22. Employee compensation
(1) Accounting treatment method of short-term compensation
During the accounting period when the employees provide services, the Company shall recognize the actual employee wage, bonus and housing accumulation fund, as well as such social insurance premium as medical insurance premium, industrial injury insurance premium and maternity insurance premium paid for the employee according to the specified benchmark and proportion, as liabilities and include them into the current profits and losses or relevant assets cost.
(2) Accounting treatment of post-employment benefits
The welfare after demission plans shall include defined contribution plans and defined benefit plans. Wherein, defined contribution plans refer to that the enterprise shall not undertake any further payment obligations on the welfare after demission plans after depositing a fixed expense to the independent fund; Defined benefit plans refer to the welfare after demission plans except the defined contribution plans.
Defined contribution plans shall include basic endowment insurance, unemployment insurance, etc.
During the accounting period when the employees provide services, the amount to be deposited according to the defined contribution plans is recognized as a liability and included in the current profits and losses or related asset costs.
For the defined benefit plans, the actuarial evaluation shall be conducted by the independent actuary on the annual balance sheet date, and the cost to provide welfare by the expected accumulated welfare unit method shall be recognized. The employee compensation costs arising from the Company's defined benefit plans include the following components:
① Service cost, including current service cost, previous service cost and settlement gains or losses. Wherein, current service cost refers to the increase amount of the present value of the obligations in the defined benefit plans due to employee services during the current period; Previous service cost refers to the increase or decrease of the present value of the obligations in the defined benefit plans related to the employee services during the previous period due to the changes in the defined benefit plans.
② The net interest of the net liability or net asset in the defined benefit plans shall include the interest income of the planed assets, the interest expenses of the obligations in the defined benefit plans and the interest affected by the upper limit of assets.
③ Changes in net liability or net asset from re-measurement of defined benefit plans.
Unless other accounting standards require or permit employee benefit costs to be included in the cost of assets, the Company will recognize the above items ① and ② in profit or loss for the current period; item ③ will be recognized in other comprehensive income and will not be reclassified to profit or loss in subsequent accounting periods, and upon termination of the originally established defined benefit plan, the portions previously recognized in other comprehensive income will be fully transferred to retained earnings within equity.
(3) Accounting treatment of dismissal welfare
If the dismissal welfare is provided by the Company to employees, the employee compensation liabilities arising from the dismissal welfare shall be determined at the earliest of the following two, and included in the current profits and losses: When the Company cannot unilaterally withdraw the dismissal welfare provided due to the termination of labor relations plan or layoff proposal; When the Company determines the costs or expenses associated with the restructuring involving the payment of dismissal welfare.
For the employee’s internal retirement plan, the economic compensation before the official retirement date belongs to the dismissal welfare, and the intended payment of the wage and social insurance premium of the internal retirement employees, during the period when the employees stop providing services until the official retirement date, shall be included into the current profits and losses at one time.The economic compensation (such as normal pension) after the official retirement date shall be disposed according to the welfare after demission.
(4) Accounting treatment methods of other long-term employee benefits
Other long-term employee welfare provided by the Company for employees which complies with the conditions of defined contribution plans shall be disposed according to the above relevant provisions of defined contribution plans. For those complying with the defined benefit plans, they shall be disposed according to the above relevant provisions of defined benefit plans, but “Changes in net liability or net asset from re-measurement of defined benefit plans” of the relevant employee remuneration cost shall be included into the current profits and losses or relevant assets cost.
23. Provisions
The Company shall recognize the obligations related to contingencies as provisions, when all of the following conditions are satisfied:
(1) The obligation is a present obligation of the Company;
(2) It is probable that an outflow of economic benefits will be required to settle the obligation;
(3) The amount of the obligation can be measured reliably.
Provisions are initially measured at the best estimate of the expenditure required to settle the present obligation, taking into account factors such as risks, uncertainties and the time value of money related to contingent matters. Where the effect of the time value of money is material, the best estimate shall be determined by discounting the related future cash outflow. The Company reviews the carrying amounts of provisions at the balance sheet date and adjusts the carrying amounts to reflect the best curren estimates.
If all or part of the expenses required to pay off the provisions are expected to be compensated by a third party or other parties, the amount of compensation is recognized separately as an asset when it is basically recognized that it can be received. The amount recognized for the reimbursement shall not exceed the book value of the estimated liability.
24. Share-based payments and equity instruments
(1) Type of share-based payment
Share-based payment is classified into cash-settled share-based payment and equity-based share-based payment.
(2) Determination method of the fair value of equity instruments
The fair value of equity instruments, such as options, granted by the Company in an active market is determined by the price quoted in the active market. The fair value of granted equity instruments such as options without active market is determined by option pricing model. The selected option pricing model considers the following factors: A. The exercise price of options; B. The validity period of the option; C. The current price of the underlying shares; D. Estimated volatility of share price; E. Expected dividend of shares; F. Risk-free interest rate within the validity period of the option.
(3) Basis for determining the best estimation of feasible equity instruments
On each balance sheet date during the waiting period, the Company makes the best estimate based on the latest available follow-up information such as changes in the number of employees with feasible rights, and revises the estimated number of equity instruments with feasible rights. On the vesting date, the final estimated number of vesting rights and interests instruments shall be consistent with the actual number of vesting rights.
(4) Accounting treatment related to implementation, modification and termination of share-based payment plan
Equity-settled share-based payment is measured at the fair value of equity instruments granted to employees. If the right is exercised immediately after the grant, the relevant costs or expenses shall be included in the fair value of equity instruments on the grant date, and the capital reserve shall be increased accordingly. I If the rights can be exercised only after the services within the waiting period are completed or the specified performance conditions are met, on each balance sheet date within the waiting period, based on the best estimate of the number of equity instruments available, the services obtained in the current period shall be included in the relevant costs or expenses and capital reserve according to the fair value on the grant date of equity instruments. After the vesting date, the recognized related costs or expenses and the total owner's equity will not be adjusted.
Cash-settled share-based payment shall be measured according to the fair value of liabilities calculated and determined on the basis of shares or other equity instruments undertaken by the Company. If the right is exercised immediately after the grant, the fair value of the liabilities assumed by the Company shall be included in the relevant costs or expenses on the grant date, and the liabilities shall be increased accordingly. For cash-settled share-based payment that is feasible only after the service within the waiting period is completed or the specified performance conditions are met, on each balance sheet date within the waiting period, based on the best estimation of the feasibility and according to the fair value of the liabilities assumed by the Company, the services obtained in the current period are included in the costs or expenses and corresponding liabilities. On each balance sheet date and settlement date before the settlement of related liabilities, the fair value of liabilities shall be re-measured, and the changes shall be included in the current profits and losses.
When the Company modifies the share-based payment plan, if the fair value of the granted equity instruments is increased by modification, the increase of the services obtained shall be recognized according to the increase of the fair value of the equity instruments; If the number of granted equity instruments is increased by modification, the fair value of the increased equity instruments will be recognized as the increase in services obtained accordingly. The increase of fair value of equity instruments refers to the difference between the fair values of equity instruments before and after modification on the modification date. If the total fair value of share-based payment is reduced by modification or the terms and conditions of the share-based payment plan are modified in other ways that are unfavorable to employees, the accounting treatment of the obtained services will continue, as if with no changes unless the Company cancels some or all of the granted equity instruments.
During the waiting period, if the granted equity instruments are cancelled (except those cancelled due to non-market conditions that do not meet the feasible rights conditions), the Company will treat the cancellation of the granted equity instruments as an accelerated exercise, and immediately record the amount to be recognized in the remaining waiting period into the current profits and losses, and recognize the capital reserve at the same time. If the employee or other party can choose to meet the non-feasible right condition but fails to meet it during the waiting period, the Company will treat it as a cancellation for granting equity instruments.
25. Revenue
Disclose the accounting policies adopted for revenue recognition and measurement according to the type of business
(1) General principles
The Company recognizes the revenue when it performs its obligations under the contract, that is, when the customer obtains the control right of related goods or services.
If the contract contains two or more performance obligations, the Company, at the beginning of the contract, allocates the transaction price to each individual performance obligation according to the relative proportion of the individual selling price of the goods or services committed by each individual performance obligation. The Company measures the income according to the transaction price allocated to each individual performance obligation.
If one of the following conditions is met, it belongs to the performance obligation within a certain period of time; otherwise, it belongs to the performance obligation at a certain time point:
① The customer acquires and consumes the economic benefits arising from the Company's performance while the Company performs the contract.
② Customers can control the goods under construction during the performance of the Company.
③ The commodities produced by the Company during the performance possess have irreplaceable usage, and the Company has the right to collect payment for the performance part accumulated so far during the entire contract period.
For the performance obligations performed within a certain period of time, the Company recognizes the revenue according to the performance schedule within that period of time,. If the performance schedule cannot be reasonably determined and the costs already incurred by the Company are expected to be compensated, the Company recognizes the revenue according to the amount of the incurred costs until the performance schedule can be reasonably determined.
For the performance obligations performed at a certain point of time, the Company will recognize the revenue when the customer acquires the right of control over relevant commodities or services. While determining whether the customer has acquired the control over the commodities or services, the Company will take the following into consideration:
① The Company has the current collection right for the such commodities or services, that is, the customer has the curren payment obligation for such commodities.
② The Company has transferred the legal title of such commodities to the customer, that is, the customer already has the legal title of such commodities.
③ The Company has transferred the physical commodities to the customer, that is, the customer has possessed the physical commodities.
④ The Company has transferred the major risks and rewards of the commodity title to the customer, that is, the customer has acquired the major risks and rewards of the commodity title.
⑤ The customer has accepted the goods or services.
⑥ Other signals that the customer has acquired control over commodities.
(2) Specific methods
Sales revenue from commodities
The Company primarily sells nutrition products, aroma chemicals products, and new materials, which are performance obligations satisfied at a point in time. Domestic sales revenue is recognized when the Company delivers the product to the contractually agreed delivery location, the customer confirms acceptance, payment has been received or the right to receive payment has been obtained, and it is probable that related economic benefits will flow to the Company. For export sales settled on an FOB or CIF basis, revenue is recognized when the Company has declared the products to customs in accordance with the contract, obtained the bill of lading, and has received payment or obtained the right to receive payment, provided that it is probable that the related economic benefits will flow in; for export sales settled on a DDP basis, revenue is recognized when the Company has delivered the goods to the designated destination in the importing country and the customer has confirmed acceptance, and payment has been received or the right to receive payment has been obtained, provided that it is probable that the related economic benefits will flow in.
Different operating modes in the same kind of business lead to different revenue recognition methods and measurement methods
None
26. Contract costs
Contract costs include incremental costs incurred to obtain the contract and costs of contract performance.
Incremental cost incurred to obtain the contract refers to the cost that will not be incurred if the Company does not obtain the contract (such as sales commission, etc.). If such costs are expected to be recoverable, the Company recognizes them as costs to obtain a contract and records them as an asset. The Company recognizes other costs incurred in obtaining a contract in profit or loss when incurred, except for incremental costs that are expected to be recovered.
Costs incurred to fulfill a contract that do not fall within the scope of other enterprise accounting standards such as inventory, and simultaneously meet the following conditions, will be recognized by the company as a contract fulfillment cost and recognized as an asset:
① The cost is directly related to a current or expected contract, including direct labor, direct materials, manufacturing costs (or similar costs), costs clearly borne by customers, and other costs only incurred due to the contract;
② The costs enrich the Company's resources for future contract performance;
③ The cost is expected to be recovered.
Assets recognized as costs of obtaining a contract and assets recognized as costs of fulfilling a contract (hereinafter referred to as "assets related to contract costs") are amortized on the same basis as the recognition of revenue from the goods or services related to the asset and are charged to profit or loss for the period; if the amortization period does not exceed one year, they are expensed as incurred.
In case the book value of assets related to contract costs is higher than the difference between the two items below, the Company will accrue the impairment provision for the extra part, and recognize that part as an impairment loss:
① Estimated residual consideration to be obtained by the Company from the transfer of commodities or services related to the assets;
② The costs expected to be incurred for the transfer of the relevant goods or services.
27. Government subsidies
The government subsidies shall be recognized when the conditions attached thereto are satisfied and the subsidies can be received. The governmental subsidy of monetary assets shall be measured according to the amount received or to be received. The governmental subsidy of non-monetary assets shall be measured at the fair value; If the fair value cannot be reliably obtained, it shall be measured according to the nominal amount of RMB 1.
Governmental subsidy related to assets refers to the governmental subsidy obtained by the Company and used for acquisition and construction, or forming long-term assets by other means; otherwise, it shall be taken as the governmental subsidy related to income.
If government documents do not specify the object of subsidy, and long-term assets can be formed, the part of government subsidy corresponding to the value of assets shall be regarded as the government subsidy related to assets, and the rest as the government subsidy related to income. If it is difficult to distinguish them, the whole government subsidy shall be regarded as the government subsidy related to income.
If asset-related government subsidies are recognized as a deferred income, they shall be included in the profits and losses in stages according to a reasonable and systematic method within the use period of the relevant assets. Governmental subsidy related to income, which is used to compensate the relevant cost or loss already incurred, shall be included into the current profits and losses; Those used for compensation of the relevant cost or loss in the subsequent periods shall be included into the deferred income, and shall be included into the current profits and losses during the recognition period of the relevant cost or loss. The governmental subsidy measured at the nominal amount shall be directly included in the current profits and losses. The Company shall adopt the same method to dispose the same or similar governmental subsidy business.
Government subsidies related to daily activities shall be included in other income based on the economic substance of the transactions. Government subsidies unrelated to the daily activities are included in non-operating revenue.
When a recognized government grant must be returned: if at initial recognition it reduced the carrying amount of the related asset, adjust the asset's carrying amount; if there is a balance of related deferred income, offset that deferred income balance and recognize the excess in profit or loss; in other cases, recognize the refund directly in profit or loss.
For policy-based preferential loan interest subsidies received, when the finance department disburses the subsidy funds to the lending bank, the actual loan amount received will be recorded as the loan value. Borrowing costs will be calculated based on the loan principal and the applicable policy-based preferential interest rate. If the finance department directly disburses the interest subsidy to the Company, the interest subsidy shall be offset against borrowing costs.
28. Deferred income tax assets / deferred income tax liabilities
Income tax comprises current income tax and deferred income tax. Except for deferred tax arising from adjustments to goodwill resulting from a business combination, or deferred tax related to transactions or events recognized directly in owner's equity, all other deferred tax is recognized as income tax expense in profit or loss.
The Company recognizes deferred taxes using the balance sheet liability method based on temporary differences between the carrying amounts of assets and liabilities at the balance sheet date and their taxable bases
All taxable temporary differences shall be recognized as deferred income tax liabilities, except for the taxable temporary differences that arise from the following transactions:
(1) The initial recognition of goodwill, or the initial recognition of assets or liabilities arising from transactions that have the following characteristics: the transaction is not a business combination, and at the time of the transaction neither accounting profit nor taxable profit is affected (except for individual transactions in which the initial recognition of the assets and liabilities gives rise to equivalent taxable temporary differences and deductible temporary differences);
(2) For taxable temporary differences associated with investments in subsidiaries, associates, and joint ventures, the Company is able to control the timing of the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the foreseeable future.
For deductible temporary differences, and deductible losses and tax credits that can be carried forward to later years, the Company recognizes the resulting deferred tax assets to the extent that it is probable that taxable profits will be available in the future, unless those deductible temporary differences arise in the following transactions:
(1) The transaction is not a business combination, and at the time of the transaction neither accounting profit nor taxable profit is affected (except for individual transactions in which the initial recognition of the assets and liabilities gives rise to equivalent taxable temporary differences and deductible temporary differences);
(2) The deferred income tax assets shall be recognized if the deductible temporary differences associated with investments in subsidiaries, associates, and joint ventures simultaneously meet the following conditions: It is probable that the temporary difference will reverse in the foreseeable future and that taxable profits will be available in the future against which the temporary difference can be utilized.
On the balance sheet date, the Company measures deferred tax assets and deferred tax liabilities at the tax rates that are expected to apply to the periods when the asset is expected to be recovered or the liability is expected to be settled, and reflects on the balance sheet date the tax effects of the expected manner of recovery of the asset or settlement of the liability.
On the balance sheet date, the Company will review the carrying amount of the deferred income tax assets. If no sufficient taxable income is likely to be obtained to offset the benefits of deferred income tax assets in the future, the carrying amount of deferred income tax assets shall be written down. The amount written down shall be reversed when it is probable that sufficient taxable profit will be available.
On the balance sheet date, the deferred income tax assets and the deferred income tax liabilities will be presented by the ne amount after offsetting when the following conditions are fulfilled:
(1) The taxable entity within the Company is granted the legal rights of net settlement of current income tax assets and curren income tax liabilities;
(2) Deferred income tax assets and deferred income tax liabilities relate to income taxes levied by the same tax authority on the same taxable entity within the Company.
29. Lease
(1) Accounting treatment method for leasing by the lessee
At the commencement date of the lease term, the Company recognizes all right-of-use assets and lease liabilities, except for shortterm leases and low-value asset leases according to applicable business standards.
The accounting policies for right-of-use assets are set out in Note 30 of Section V of this financial report.
Lease liabilities are initially measured at the present value of the lease payments not yet paid as of the lease commencement date, discounted using the interest rate implicit in the lease. The incremental borrowing rate will be adopted as the discount rate if the interest rate implicit in the lease is not determinable. The lease payment includes fixed amount (and the substantially fixed amount) less the relative amount of any lease incentives enjoyed if there are lease incentives; the index or rate-based variable amount; the exercise price of a purchase option, provided that the lessee reasonably determines that it will exercise the option; the payment for exercising the option to terminate the lease, provided that it is reflected in the lease period that the lessee will exercise the option to terminate the lease; and the estimated amount to be paid according to the residual value of guarantee provided by the lessee. The interest expense of the lease liabilities during each period of the lease term will be calculated at a fixed periodic interest rate later and include it in the current profit or loss. Variable lease payments not included in the measurement of lease liabilities shall be included in the current profits and losses when they are actually incurred.
1) Short-term leases
The short-term lease refers to the lease that does not contain the purchase option and has a lease period of no more than 12 months from the lease commencement date.
The Company records the lease payments under short-term leases into the cost of the related assets or to current income or loss on a straight-line basis over the respective periods of the lease term.
For short-term leases, the Company, by category of leased asset, selects to apply the simplified approach described above to items within asset types that qualify as short-term leases.
2) Low-value asset leases
The Company records the lease payments under low-value asset leases into the cost of the related assets or to current income or loss on a straight-line basis over the respective periods of the lease term.
For leases of low-value assets, the Company selects, based on the specific circumstances of each lease, to apply the simplified approach described above.
3) Change of lease
The Company accounts for a lease change as a separate lease if the change occurs and both of the following conditions are met: ① the lease change increases the scope of the lease by adding the right to use one or more underlying assets; and ② the consideration for the lease increases by an amount and the scope of the lease increased by an extent that is commensurate with the stand-alone price for the increase in consideration and scope as adjusted for the particular circumstances of the contract.
If the lease change is not subject to accounting treatment as a separate lease, on the effective date of the lease change, the Company will re-apportion the consideration of the changed contract, re-determine the lease term, and remeasure the lease liabilities at the present value worked out according to the changed lease payment and the revised discount rate.
If the lease change results in narrower scope of lease or shorter lease term, the Company will reduce the carrying amount of the right-of-use assets accordingly, and will include relevant gain or loss from partial or full termination of the lease in the current profit or loss.
If other lease changes result in re-measurement of the lease liabilities, the Company will adjust the carrying amount of the right-ofuse assets accordingly.
(2) Accounting treatment method for leasing by the lessor
When the Company acts as a lessor, leases that substantially transfer all the risks and rewards incidental to ownership of the asset are recognized as finance leases, while leases other than finance leases are recognized as operating leases.
1) Operating lease
For operating leases, rental payments are recognized by the Company on a straight-line basis in profit or loss for each period during the lease term. The initial direct expenses related to an operating lease incurred shall be capitalized, apportioned during the lease term on the same recognition basis as rental income, and included into the current profit and loss by installments. The variable lease amount received under an operating lease, which is not included in the lease receipt, is included in the profit or loss of the current period at the time of actual occurrence.
2) Change of lease
In the case of any change to the operating lease, the Company will conduct accounting treatment with respect to the changed operating lease as a new lease as of the effective date of the change, and the lease payments received in advance or receivable with respect to the lease before the change will be taken as the lease receipts for the new lease.
The Company accounts for a finance lease change as a separate lease if the change occurs and both of the following conditions are met ① the change increases the scope of the lease by adding the right to use one or more underlying assets; and ② the consideration for the lease increases by an amount and the scope of the lease increased by an extent that is commensurate with the stand-alone price for the increase in consideration and scope as adjusted for the particular circumstances of the contract.
If changes to a finance lease are not subject to accounting treatment as a separate lease, the Company will treat the changed lease in the following circumstances: ① If assuming that the change takes effective at the lease commencement date, and the lease is classified into operating leases, the Company will, from the effective date of the lease change, consider the change as a new lease and the net lease investment prior to the effective date of the lease commencement as the carrying value of the leased asset; ② Assuming that the change takes effective at the lease commencement date, and the lease is classified into financing leases, the Company will apply the provisions of Accounting Standards for Business Enterprises No. 22 - Recognition and Measurement of Financial Instruments concerning the modification or re-negotiation of contract.
30. Right-of-use assets
(1) Conditions for recognition of right-of-use assets
Right-of-use asset refers to the Company's right, as lessee, to use the leased asset during the lease term.
On the lease commencement date, the right-of-use assets are initially measured at cost. Such cost includes: the initial measurement amount of the lease liability; lease payments made at or before the commencement date, less the portion relating to any lease incentives received; initial direct costs incurred by the Company as lessee; and an estimate of costs expected to be incurred by the Company as lessee for dismantling and removing the leased asset, restoring the site on which it is located, or restoring the leased asset to the condition required by the terms of the lease. The Company, as a lessee, recognizes and measures costs such as dismantling, restoration, and similar items in accordance with Accounting Standards for Business Enterprises No. 13 - Contingencies. Subsequent adjustments are made for any remeasurement of lease liabilities.
(2) Depreciation method of right-of-use assets
The Company shall withdraw the depreciation according to the straight-line method. If the Company, as a lessee, can reasonably determine that it will obtain ownership of the leased asset when the lease term expires, the right-of-use asset is depreciated over the remaining useful life of the leased asset. If the Company cannot reasonably determine that it will obtain the ownership of leased assets when the lease term expires, the right-of-use asset is depreciated over the shorter of the lease term and the remaining service life of the leased assets.
(3) The impairment test method for right-of-use assets and the impairment provision accrual method are set out in Note 20 of Section V of this financial report.
31. Work safety funds
The Company makes provisions for work safety funds in accordance with the Administrative Measures for the Collection and Utilization of Enterprise Work Safety Funds (C.Z. [2022] No. 136) jointly issued by the Ministry of Finance and the Ministry of
Emergency Management.
Work safety funds, when appropriated, are included in the cost of the related products or recognized in profit or loss for the curren period, and are simultaneously recorded in the “special reserve” account
When work safety funds are appropriated and utilized for expense-type expenditures, they directly reduce the special reserve. Expenditures that result in the formation of fixed assets are first accumulated in the "construction in progress" account; upon completion and attainment of the intended usable state, they are recognized as fixed assets. Concurrently, the special reserve is reduced by the cost of the fixed assets formed, and the same amount of accumulated depreciation will be recognized. These fixed assets will not be depreciated in subsequent periods.
32. Accounting treatment related to the repurchase of the Company's shares
The shares repurchased by the Company are held as treasury stock prior to cancellation or transfer, and all expenses incurred for the repurchase of shares shall be recorded as the cost of treasury stock. The consideration paid and transaction costs in a share repurchase reduce equity; gains or losses are not recognized on the repurchase, transfer, or cancellation of the Company's shares. When treasury shares are transferred, the difference between the actual proceeds received and the carrying amount of the treasury shares shall be recorded in capital reserve; if the capital reserve is insufficient to absorb the difference, surplus reserve and retained earnings shall be reduced to cover the shortfall. When treasury shares are cancelled, share capital is reduced by the par value per share and the number of shares canceled, and the difference between the carrying amount of the cancelled treasury shares and their par value will write off the capital reserve; if the capital reserve is insufficient to absorb the difference, surplus reserve and retained earnings shall be reduced to cover the shortfall.
33. Significant accounting judgments and estimates
The Company continuously evaluates the significant accounting estimates and key assumptions it uses, based on historical experience and other factors, including reasonable expectations about future events. Below are the major accounting estimates and key assumptions that may pose a significant risk of material adjustments to the carrying values of assets and liabilities in the upcoming financial year:
1) Classification of financial assets
The Company’s significant judgments in determining the classification of financial assets include analysis of the business mode and the characteristics of the contractual cash flows.
The Company establishes its business model for managing financial assets at the portfolio level by considering various factors. These include how the performance of financial assets is assessed and communicated to key management personnel, the risks influencing asset performance and their management, as well as the compensation structure for the relevant business managers. When evaluating whether the contractual cash flows of a financial asset align with a basic lending arrangement, the Company primarily considers the following key judgments: whether the principal amount may vary in timing or amount throughout the instrument’s term due to prepayment or other factors; and whether the interest reflects only the time value of money, credit risk, other fundamental lending risks, and appropriate compensation for costs and profit. For instance, it is important to determine whether the early repayment amount includes only the outstanding principal, the interest accrued on that principal, and any reasonable compensation for the early termination of the contract.
2) Measurement of expected credit loss of accounts receivable
The Company calculates expected credit losses on accounts receivable using the accounts receivable exposure to default risk and the expected credit loss rate, and determines the expected credit loss rate based on the probability of default and the loss in the event of default. When determining the expected credit loss rate, the Company relies on its internal historical credit loss experience along with other data, and adjusts the historical data to reflect current conditions and forward-looking information. When considering forward-looking information, the Company takes into account various indicators such as the risk of an economic downturn, shifts in the external market environment, technological developments, and customer conditions, among others. The Company regularly monitors and reviews the assumptions related to the calculation of expected credit losses.
3) Goodwill-impairment
The Company conducts an annual assessment to determine whether there has been any impairment of goodwill. This requires estimating the value in use of the asset group to which goodwill has been assigned. When estimating value in use, the Company needs to project the future cash flows generated by the asset group and apply a suitable discount rate to determine the present value of those cash flows.
4) Deferred income tax assets
If and to the extent that it is likely that there will be enough taxable profits to cover the losses, the Company recognizes deferred tax assets for all unused tax losses. In this case, the management has to use significant judgment to estimate the time and amount of future taxable profits and, in combination with its tax plan, to determine the amount of deferred tax assets that should be recognized.
34. Other significant accounting policies and accounting estimates
None
35. Changes in significant accounting policies and accounting estimates
(1) Changes in significant accounting policies
□ Applicable Not applicable
(2) Changes in significant accounting estimates
□ Applicable Not applicable
(3) Adjustments to related items of the financial statements at the beginning of the year of initial application of the new accounting standards (effective from 2025)
□ Applicable Not applicable
36. Others
VI. Taxation
1. Main tax categories and rates
| Tax categories | Taxation basis | Tax rate |
| VAT | Taxable amount of added value (taxable amount is the balance calculated as the following formula: taxable sales amount multiplies the applicable tax rate, then deducts the input tax allowable for deduction of the current period) | The applicable tax rates are 20%, 13%, 10%, 9%, 8%, 6%, 5%, and 19%. Exported goods benefit from the "exemption, offset, and refund" tax policy, with rebate rates ranging from 0% to 13%. Additionally, our subsidiary, Zhejiang NHU Import & Export Company Ltd., exports goods under the "tax collection first, refund later" policy, also with rebate rates between 0% and 13% |
| Urban maintenance and construction tax | Actual paid turnover tax amount | 5%, 7% |
| Corporate income tax | Taxable income | 8.25%, 15%, 16.5%, 17%, 20%, 21%, 22%, 25%, 25.5%, 34% |
| House property tax | For property tax assessed on a value basis, payment is calculated as 1.2% of the residual value after a one-time 30% deduction from the original property value; for property tax assessed on a rental basis, payment is calculated as 12% of rental income. | 1.2%, 12% |
| Education surcharge | Actual paid turnover tax amount | 3% |
| Local education surcharges | Actual paid turnover tax amount | 2% |
| Solidarity surcharge [Note] | Amount of income tax payable | 5.5% |
| Trade tax [Note] | Taxable income | 13.3% |
| Land appreciation tax | The incremental amount arising from the transfer of state-owned land use right and the buildings and structures that are constructed on the land | A four-grade progressive tax system is adopted. The rates are: 30% for appreciated value not over 50% of total deductible amount; 40% for appreciated value over 50% but not over 100% of total deductible amount; 50% forappreciated value over 100% but not over 200% of total deductible amount; and 60% for appreciated value over 200% of total deductible amount. |
[Note] This information is applicable to the subsidiaries NHU EUROPE GMBH, NHU Performance Materials GmbH,
Bardoterminal GmbH and NHU Life Science GmbH.
If there are taxable entities with different tax rates of enterprise income tax, disclose the specific information
| Name of taxable entity | Rate of income tax |
| The Company | 15% |
| Shangyu NHU Bio-Chem Co., Ltd. | 15% |
| Shandong NHU Pharmaceutical Co., Ltd. | 15% |
| Shandong NHU Amino-acids Co., Ltd. | 15% |
| Zhejiang NHU Specialty Materials Co., Ltd. | 15% |
| Heilongjiang NHU Biotechnology Co., Ltd. | 15% |
| Zhejiang NHU Pharmaceutical Co., Ltd. | 15% |
| Shandong NHU Fine Chemical Science and Technology Co., Ltd. | 15% |
| NHU (Hong Kong) Trading Co., Ltd. | Taxation is based on the territorial source principle. For profits sourced from Hong Kong, the first HKD 2,000,000 are taxed at a profits tax rate of 8.25%; subsequent profits sourced from Hong Kong are taxed at 16.5%. Profits earned outside of Hong Kong are not subject to profits tax within the region. |
| NHU EUROPE GMBH | 15% |
| NHU Performance Materials GMBH | 15% |
| Bardoterminal GmbH | 15% |
| NHU LIFE SCIENCE GmbH | 15% |
| NHU Singapore Pte. Ltd. | 17% |
| CONG TY TNHH NHU VIETNAM | 20% |
| NHU North America LLC | 21% |
| NHU Life Science North America LLC | 21% |
| NHU/Chr. Olesen Latin America A/S | 22% |
| NHU/CHR. OLESEN MEXICO SAPI DE CV | 25.5% |
| NHU/CHR. OLESEN BRASIL LTDA | 34% |
| NHU Japan Co., Ltd. | 15% |
| Other taxable entities not previously specified | 25% |
2. Tax incentives
(1) Corporate income tax incentives
① High-tech enterprise tax incentives
The Company has been officially recognized as a high-tech enterprise, as confirmed by the High-tech Enterprise Certificate (GR202333009429) issued by the Department of Science and Technology of Zhejiang Province, the Zhejiang Provincial Department of Finance, and the Zhejiang Provincial Tax Service, State Taxation Administration. As a result, the Company will benefit from high-tech enterprise tax incentives from 2023 through 2025, with a corporate income tax rate of 15% applicable in 2026 temporarily.
The subsidiary, Shangyu NHU Bio-Chem Co., Ltd., has been officially recognized as a high-tech enterprise, as confirmed by the High-tech Enterprise Certificate (GR202533006963) issued by the Department of Science and Technology of Zhejiang Province, the Zhejiang Provincial Department of Finance, and the Zhejiang Provincial Tax Service, State Taxation Administration. As a result, it will benefit from high-tech enterprise tax incentives from 2025 through 2027, with a corporate income tax rate of 15% applicable in 2026.
The subsidiary, Shandong NHU Pharmaceutical Co., Ltd., has been officially recognized as a high-tech enterprise, as confirmed by the High-tech Enterprise Certificate (GR202337003609) issued by the Department of Science & Technology of Shandong Province, the Shandong Provincial Department of Finance, and the Shandong Provincial Tax Service, State Taxation Administration. As a result, it will benefit from high-tech enterprise tax incentives from 2023 through 2025, with a corporate income tax rate of 15% applicable in 2026 temporarily.
The subsidiary, Shandong NHU Amino-acids Co., Ltd., has been officially recognized as a high-tech enterprise, as confirmed by the High-tech Enterprise Certificate (GR202437003425) issued by the Department of Science & Technology of Shandong Province, the Shandong Provincial Department of Finance, and the Shandong Provincial Tax Service, State Taxation Administration. As a result, it will benefit from high-tech enterprise tax incentives from 2024 through 2026, with a corporate income tax rate of 15% applicable in 2026 temporarily.
The subsidiary, Zhejiang NHU Specialty Materials Co., Ltd., has been officially recognized as a high-tech enterprise, as confirmed by the High-tech Enterprise Certificate (GR202433008150) issued by the Economy and Information Technology Department of Zhejiang, the Zhejiang Provincial Department of Finance, and the Zhejiang Provincial Tax Service, State Taxation Administration. As a result, it will benefit from high-tech enterprise tax incentives from 2024 through 2026, with a corporate income tax rate of 15% applicable in 2026.
The subsidiary, Heilongjiang NHU Biotechnology Co., Ltd., has been officially recognized as a high-tech enterprise, as confirmed by the High-tech Enterprise Certificate (GR202423000652) issued by the Department of Science and Technology of Heilongjiang Province, the Finance Bureau of Heilongjiang Province, and the Heilongjiang Provincial Tax Service, State Taxation Administration. As a result, it will benefit from high-tech enterprise tax incentives from 2024 through 2026, with a corporate income tax rate of 15% applicable in 2026.
The subsidiary, Zhejiang NHU Pharmaceutical Co., Ltd., has been officially recognized as a high-tech enterprise, as confirmed by the High-tech Enterprise Certificate (GR202533005415) issued by the Department of Science and Technology of Zhejiang Province, the Zhejiang Provincial Department of Finance, and the Zhejiang Provincial Tax Service, State Taxation Administration. As a result, it will benefit from high-tech enterprise tax incentives from 2025 through 2027, with a corporate income tax rate of 15% applicable in 2026.
The subsidiary, Shandong NHU Fine Chemical Science and Technology Co., Ltd., has been officially recognized as a high-tech enterprise, as confirmed by the High-tech Enterprise Certificate (GR202537002216) issued by the Department of Science & Technology of Shandong Province, the Shandong Provincial Department of Finance, and the Shandong Provincial Tax Service, State Taxation Administration. As a result, it will benefit from high-tech enterprise tax incentives from 2025 through 2027, with a corporate income tax rate of 15% applicable in 2026.
② Tax incentives for overseas enterprises
Pursuant to Chapter 112 of the Laws of Hong Kong, the Tax Ordinance, Section 14, Hong Kong adopts the territorial source principle for taxation: only profits arising in Hong Kong are subject to tax in Hong Kong, while profits arising elsewhere are not subject to Hong Kong profits tax. The subsidiary, NHU (Hong Kong) Trading Co., Ltd., calculates and pays corporate income tax at the applicable preferential tax rate.
(2) VAT preference
Pursuant to the Announcement on VAT Additional Deduction Policy for Advanced Manufacturing Enterprises (No. 43 Announcement of Ministry of Finance and State Administration of Taxation in 2023), from January 1, 2023, to December 31, 2027, advanced manufacturing enterprises are permitted to deduct an additional 5% of the current deductible input VAT from their VAT payable. The Company and its subsidiaries Shangyu NHU Bio-Chem mathrm C o.. , Ltd., Zhejiang NHU Pharmaceutical Co., Ltd., Zhejiang NHU Specialty Materials mathrm C o.. , Ltd., Shandong NHU Amino-acids mathrm C o., , Ltd., Shandong NHU Pharmaceutical mathrm C o. , Ltd., Shandong NHU Fine Chemical Science and Technology Co., Ltd., and Heilongjiang NHU Biotechnology Co., Ltd. enjoy a preferential policy of additional deduction/offset of input VAT.
VII. Notes to consolidated financial statements
1. Cash and cash equivalents
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Cash on hand | 9,176.31 | 19,519.80 |
| Bank deposits | 7,366,196,213.60 | 7,919,727,704.51 |
| Other monetary funds | 91,837,415.81 | 46,522,906.86 |
| Total | 7,458,042,805.72 | 7,966,270,131.17 |
| Including: Total amounts deposited abroad | 352,187,586.16 | 231,285,799.32 |
Other notes: Monetary funds that are subject to usage restrictions and are not classified as cash or cash equivalents are detailed in the financial report, specifically in Note 19 of Section VII, and Note 57(3)(4) of Section VII.
2. Financial assets held for trading
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Financial assets measured at fair value through profit or loss | 2,583,641,120.21 | 2,168,275,092.55 |
| Including: | ||
| Derivative financial assets | 29,965,130.86 | 13,213,250.21 |
| Principal-protected floating-yield wealth management product | 2,553,675,989.35 | 2,155,061,842.34 |
| Total | 2,583,641,120.21 | 2,168,275,092.55 |
3. Accounts receivable
(1) Disclosure by aging
Unit: RMB Yuan
| Aging | Closing book balance | Opening balance |
| Within 1 year (including 1 year) | 3,967,129,766.78 | 3,502,674,400.14 |
| 1 to 2 years | 364,550.09 | 4,695,426.61 |
| 2 to 3 years | 3,758,916.61 | 688,280.00 |
| Over 3 years | 2,770,460.98 | 2,120,460.98 |
| 3 to 4 years | 650,000.00 | 14,180.18 |
| 4 to 5 years | 14,180.18 | |
| Over 5 years | 2,106,280.80 | 2,106,280.80 |
| Total | 3,974,023,694.46 | 3,510,178,567.73 |
(2) Classification and disclosure by bad debt provision method
Unit: RMB Yuan
| Categories | Closing balance | Opening balance | ||||||||
| Book balance | Bad-debt provision | Carrying amount | Book balance | Bad-debt provision | Carrying amount | |||||
| Amount | % to total | Amount | Rate of provision | Amount | % to total | Amount | Rate of provision | |||
| Including: | ||||||||||
| Accounts receivable with provision for bad debts reserve based on portfolio | 3,974,023,694.46 | 100.00% | 204,206,992.71 | 5.14% | 3,769,816,701.75 | 3,510,178,567.73 | 100.00% | 178,743,890.46 | 5.09% | 3,331,434,677.27 |
| Total | ||||||||||
| Including: | 3,974,023,694.46 | 100.00% | 204,206,992.71 | 5.14% | 3,769,816,701.75 | 3,510,178,567.73 | 100.00% | 178,743,890.46 | 5.09% | 3,331,434,677.27 |
Provision for bad debts is made on a portfolio basis: Accounts receivable grouped by aging for bad debt provision
Unit: RMB Yuan
| Name | Closing balance | ||
| Book balance | Bad-debt provision | Rate of provision | |
| Within 1 year | 3,967,129,766.78 | 198,356,488.43 | 5.00% |
| 1-2 years | 364,550.09 | 72,910.01 | 20.00% |
| 2-3 years | 3,758,916.61 | 3,007,133.29 | 80.00% |
| Over 3 years | 2,770,460.98 | 2,770,460.98 | 100.00% |
| Total | 3,974,023,694.46 | 204,206,992.71 | |
Explanation of the basis for determining the grouping: Provision for bad debts is made based on aging groups If the provision for bad debts on accounts receivable is based on the general model of expected credit losses: □ Applicable Not applicable
(3) Provision, recovery or reversal of bad debt reserve in current period
Provision for bad debts of this period:
Unit: RMB Yuan
| Categories | Opening balance | Changes in amount of the current period | Closing balance | |||
| Provision | Recovery or reversal | Write off | Others | |||
| Provision for bad debts by portfolio | 178,743,890.46 | 25,463,102.25 | 204,206,992.71 | |||
| Total | 178,743,890.46 | 25,463,102.25 | 204,206,992.71 | |||
(4) The status of accounts receivable and contract assets in the top five of the ending balance collected according to debtors Unit: RMB Yuan
| Company name | Ending balance of accounts receivable | Ending balance of contract assets | Ending balance of accounts receivable and contract assets | Proportion of total balance of accounts receivable and contract assets at the end of the period | Ending balance of allowance for bad debts on accounts receivable and impairment provision for contract assets |
| Customer I | 386,381,331.37 | 386,381,331.37 | 9.72% | 19,319,066.57 | |
| Customer II | 158,170,660.67 | 158,170,660.67 | 3.98% | 7,908,533.03 | |
| Customer III | 150,208,538.46 | 150,208,538.46 | 3.78% | 7,510,426.92 | |
| Customer IV | 82,854,984.52 | 82,854,984.52 | 2.08% | 4,142,749.23 | |
| Customer V | 59,186,605.22 | 59,186,605.22 | 1.49% | 2,959,330.26 | |
| Total | 836,802,120.24 | 836,802,120.24 | 21.05% | 41,840,106.01 |
4. Receivables financing
(1) Financing of accounts receivable by classification
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Bank acceptance bills | 920,577,788.17 | 813,062,385.73 |
| Total | 920,577,788.17 | 813,062,385.73 |
(2) Classification and disclosure by bad debt provision method
Unit: RMB Yuan
| Categories | Closing balance | Opening balance | ||||||||
| Book balance | Bad-debt provision | Carrying amount | Book balance | Bad-debt provision | Carrying amount | |||||
| Amount | % to total | Amount | Rate of prov ision | Amount | % to total | Amount | Rate of provisi on | |||
| Including: | ||||||||||
| Provision for bad debts by portfolio | 920,577,788.17 | 100.00% | 920,577,788.17 | 813,062,385.73 | 100.00% | 813,062,385.73 | ||||
| Including: | ||||||||||
| Bank acceptance bills | 920,577,788.17 | 100.00% | 920,577,788.17 | 813,062,385.73 | 100.00% | 813,062,385.73 | ||||
| Total | 920,577,788.17 | 100.00% | 920,577,788.17 | 813,062,385.73 | 100.00% | 813,062,385.73 | ||||
Provision for bad debts by portfolio: Bank acceptance bills Unit: RMB Yuan
| Name | Opening balance | Closing balance | ||||
| Book balance | Bad-debt provision | Book balance | Bad-debt provision | Rate of provision | Reason for accrual | |
| Portfolio of bank acceptance bills | 813,062,385.73 | 920,577,788.17 | ||||
| Total | 813,062,385.73 | 920,577,788.17 | ||||
(3) Receivables financing pledged at the end of the period
Unit: RMB Yuan
| Items | Closing balance of pledged notes |
| Bank acceptance | 114,794,927.96 |
| Subtotal | 114,794,927.96 |
(4) Receivables financing endorsed or discounted by the Company at the end of the period and not yet due on the balance sheet date
Unit: RMB Yuan
| Items | Closing balance derecognized | Closing balance not yet derecognized |
| Bank acceptance | 1,346,436,608.90 | |
| Total | 1,346,436,608.90 |
5. Other receivables
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Other receivables | 261,081,058.41 | 274,052,669.41 |
| Total | 261,081,058.41 | 274,052,669.41 |
(1) Other receivables
1) Classification of other receivables according to the nature of payment
Unit: RMB Yuan
| Nature of payment | Closing book balance | Opening balance |
| Export tax rebates and other refundable taxes and fees | 222,483,228.55 | 224,201,293.87 |
| Deposits and guarantee deposits | 24,669,635.84 | 35,191,248.50 |
| Employee petty cash | 16,480,508.83 | 21,857,847.92 |
| Others | 11,812,279.05 | 6,774,582.72 |
| Total | 275,445,652.27 | 288,024,973.01 |
2) Disclosure by aging
Unit: RMB Yuan
| Aging | Closing book balance | Opening balance |
| Within 1 year (including 1 year) | 242,989,686.74 | 252,007,141.35 |
| 1 to 2 years | 3,812,781.62 | 9,833,193.36 |
| 2 to 3 years | 5,556,548.83 | 3,151,650.55 |
| Over 3 years | 23,086,635.08 | 23,032,987.75 |
| 3 to 4 years | 2,097,886.29 | 1,971,907.62 |
| 4 to 5 years | 5,518,012.48 | 7,190,484.46 |
| Over 5 years | 15,470,736.31 | 13,870,595.67 |
| Total | 275,445,652.27 | 288,024,973.01 |
3) Classification and disclosure by bad debt provision method
Applicable □ Not applicable
Unit: RMB Yuan
| Categories | Closing balance | Opening balance | ||||||||
| Book balance | Bad-debt provision | Carrying amount | Book balance | Bad-debt provision | Carrying amount | |||||
| Amount | % to total | Amount | Rate of prov ision | Amount | % to total | Amount | Rate of prov ision | |||
| Including: | ||||||||||
| Provision for bad debts by portfolio | 275,445,652.27 | 100.00% | 14,364,593.86 | 5.22% | 261,081,058.41 | 288,024,973.01 | 100.00% | 13,972,303.60 | 4.85% | 274,052,669.41 |
| Total | 275,445,652.27 | 100.00% | 14,364,593.86 | 5.22% | 261,081,058.41 | 288,024,973.01 | 100.00% | 13,972,303.60 | 4.86% | 274,052,669.41 |
Category name for bad debt provisions calculated by combination: Other receivables for which bad debt provisions are calculated by combination Unit: RMB Yuan
| Name | Closing balance | ||
| Book balance | Bad-debt provision | Rate of provision | |
| Export Refund Receivable Portfolio | 164,630,292.23 | 1,646,302.92 | 1.00% |
| Land deposit receivables portfolio | 17,354,493.50 | 173,544.94 | 1.00% |
| VAT refund receivable portfolio | 57,829,016.77 | 578,290.17 | 1.00% |
| Aging portfolio | 35,631,849.77 | 11,966,455.83 | 33.58% |
| Including: Within one year | 20,530,377.74 | 1,026,518.88 | 5.00% |
| 1-2 years | 3,812,781.62 | 762,556.33 | 20.00% |
| 2-3 years | 5,556,548.83 | 4,445,239.04 | 80.00% |
| Over 3 years | 5,732,141.58 | 5,732,141.58 | 100.00% |
| Total | 275,445,652.27 | 14,364,593.86 | |
Provision for bad debts under the general model of expected credit losses: Unit: RMB Yuan
| Bad-debt provision | First stage | Second stage | Third stage | Total |
| Expected credit losses over the next 12 months | Expected credit loss for the entire duration (no credit impairment occurred) | Expected credit loss for the entire duration (credit impairment has occurred) | ||
| Balance as at January 1, 2026 | 3,805,850.23 | 1,966,638.68 | 8,199,814.69 | 13,972,303.60 |
| The balance as of January 1, 2026 is in the current period | ||||
| -- Transferred to the second stage | -190,639.08 | 190,639.08 | ||
| -- Transferred to the third stage | -1,111,309.77 | 1,111,309.77 | ||
| Accrual in the current period | -190,554.24 | -283,411.66 | 866,256.16 | 392,290.26 |
| Balance as at June 30, 2026 | 3,424,656.91 | 762,556.33 | 10,177,380.62 | 14,364,593.86 |
Criteria for dividing each stage and the bad-debt reserves calculation and withdrawal proportion
Classification criteria for stages are as follows: Accounts with an aging period of up to one year and those undergoing individual impairment assessment are categorized as Stage I; accounts aged between one and two years fall under Stage II; and accounts exceeding two years in age are designated as Stage III.
Significant changes in the carrying amounts of items with material changes in the allowance for losses during the period □ Applicable Not applicable
4) Provision, recovery or reversal of bad debt reserve in current period
Provision for bad debts of this period:
Unit: RMB Yuan
| Categories | Opening balance | Changes in amount of the current period | Closing balance | |||
| Provision | Recovery or reversal | Charge-off or write-off | Others | |||
| Provision for bad debts by portfolio | 13,972,303.60 | 392,290.26 | 14,364,593.86 | |||
| Total | 13,972,303.60 | 392,290.26 | 14,364,593.86 | |||
5) Top five other receivables by period-end balance, aggregated by debtor
Unit: RMB Yuan
| Company name | Nature of the amounts | Closing balance | Aging | Ratio in the total ending balance of other receivables | Ending balance of bad debt provision |
| State Administration of Taxation (Export tax rebates receivable) | Export tax rebates and other refundable taxes and fees | 164,630,292.23 | Within one year | 59.77% | 1,646,302.92 |
| Servicio de Administración Tributaria | Export tax rebates and other refundable taxes and fees | 41,336,245.67 | Within one year | 15.01% | 413,362.46 |
| Shandong Weifang Binhai Economic Development Zone Fiscal Treasury Centralized Payment Center | Deposits and guarantee deposits | 17,354,493.50 | Over three years | 6.30% | 173,544.94 |
| Secretaria da Fazenda do Estado | Export tax rebates and other refundable taxes and fees | 7,996,410.60 | Within one year | 2.90% | 79,964.11 |
| Hauptzollamt Hamburg Zollamt | Export tax rebates and other refundable taxes and fees | 6,563,205.56 | Within one year | 2.38% | 65,632.06 |
| Total | 237,880,647.56 | 86.36% | 2,378,806.49 |
6. Advance payments
(1) Presentation of advance payments by age of account
Unit: RMB Yuan
Explanation of reasons why prepayments with more than 1 year's age and significant amount are not settled in time: None
| Aging | Closing balance | Opening balance | ||
| Amount | % to total | Amount | % to total | |
| Within 1 year | 295,510,045.01 | 99.60% | 177,889,226.14 | 99.68% |
| 1 to 2 years | 478,453.30 | 0.16% | 64,652.72 | 0.04% |
| 2 to 3 years | 393,211.53 | 0.13% | 200,115.95 | 0.11% |
| Over 3 years | 316,482.97 | 0.11% | 296,151.06 | 0.17% |
| Total | 296,698,192.81 | 178,450,145.87 | ||
(2) Top five ending balances of prepayments, grouped by payee
| Company name | Book balance | Ratio of total balance of prepayment |
| Supplier A | 28,601,323.42 | 9.64% |
| Supplier B | 25,000,000.00 | 8.43% |
| Supplier C | 22,989,023.22 | 7.75% |
| Supplier D | 17,437,277.20 | 5.88% |
| Supplier E | 11,515,112.60 | 3.88% |
| Subtotal | 105,542,736.44 | 35.58% |
7. Inventories
Whether the Company needs to comply with disclosure requirements of real estate industry No
(1) Inventory classification
Unit: RMB Yuan
(2) Provision for inventory write-downs and impairment provision for contract performance costs
| Items | Closing balance | Opening balance | ||||
| Book balance | Provision for inventory write-down or provision for impairment of contract fulfillment costs | Carrying amount | Book balance | Provision for inventory write-down or provision for impairment of contract fulfillment costs | Carrying amount | |
| Raw material | 459,814,614.91 | 995,589.29 | 458,819,025.62 | 335,723,544.36 | 930,697.19 | 334,792,847.17 |
| Work in process | 1,039,813,134.36 | 21,460,430.43 | 1,018,352,703.93 | 1,074,700,853.53 | 37,815,736.83 | 1,036,885,116.70 |
| Merchandise inventory | 2,944,347,658.26 | 118,188,866.79 | 2,826,158,791.47 | 3,142,414,991.50 | 199,598,446.21 | 2,942,816,545.29 |
| Goods dispatched | 271,932,445.61 | 2,383,203.87 | 269,549,241.74 | 202,341,534.78 | 2,337,354.64 | 200,004,180.14 |
| Work in process - outsourced | 1,504,782.46 | 893,791.28 | 610,991.18 | 11,563,462.74 | 1,068,326.66 | 10,495,136.08 |
| Packaging | 23,318,817.56 | 23,318,817.56 | 19,714,407.90 | 19,714,407.90 | ||
| Low value consumables | 172,430,670.76 | 172,430,670.76 | 104,041,234.15 | 104,041,234.15 | ||
| Total | 4,913,162,123.92 | 143,921,881.66 | 4,769,240,242.26 | 4,890,500,028.96 | 241,750,561.53 | 4,648,749,467.43 |
Unit: RMB Yuan
| Items | Opening balance | Increased amount in the current period | Decreased amount in the current period | Closing balance | ||
| Provision | Others | Reversed or charged-off | Others | |||
| Raw material | 930,697.19 | 64,892.10 | 995,589.29 | |||
| Work in process | 37,815,736.83 | 3,841,703.30 | 20,197,009.70 | 21,460,430.43 | ||
| Merchandise inventory | 199,598,446.21 | 23,202,408.55 | 104,611,987.97 | 118,188,866.79 | ||
| Goods dispatched | 2,337,354.64 | 2,997,710.58 | 2,951,861.35 | 2,383,203.87 | ||
| Work in process - outsourced | 1,068,326.66 | 174,535.38 | 893,791.28 | |||
| Total | 241,750,561.53 | 30,106,714.53 | 127,935,394.40 | 143,921,881.66 | ||
The specific criteria used to determine the net realizable value, along with the explanations for any reversals or write-offs of inventory impairment provisions during the current period
| Items | The specific criteria used to determine the net realizable value | The explanations for any reversals or write-offs of inventory impairment provisions during the current period |
| Raw material | The net realizable value is calculated by taking the estimated selling price of the finished goods and subtracting the estimated costs to complete, selling expenses, and applicable taxes | Reversal of inventory write-down provision: The net realizable value of inventory for which inventory write-down provisions were made in previous periods has increased; write-off of inventory write-down provision: During the current period, inventory for which write-down provisions were made at the beginning of the period has been consumed/sold/scrapped |
| Work in process | ||
| Merchandise inventory | The net realizable value is determined by subtracting the estimated selling expenses and related taxes from the estimated selling price of the finished products. | |
| Goods dispatched | ||
| Work in process - outsourced | The net realizable value is calculated by taking the estimated selling price of the finished goods and subtracting the estimated costs to complete, selling expenses, and applicable taxes |
Accrual standard of provision for inventory obsolescence by portfolio: None
8. Other current assets
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Prepaid VAT or input VAT pending deduction | 66,014,773.54 | 34,481,204.44 |
| Deferred service fees | 11,863,665.02 | 14,539,548.75 |
| Deferred insurance expense | 7,436,052.58 | 4,306,345.86 |
| Advance payment of enterprise income tax | 534,863.03 | |
| Prepaid rent fees | 967,808.27 | 1,175,757.55 |
| Total | 86,282,299.41 | 55,037,719.63 |
9. Other equity instrument investments
Unit: RMB Yuan
| Project name | Closing balance | Opening balance | Gains included in other comprehensive income in the current period | Losses included in other comprehensive income in the current period | Gains included in other comprehensive income at the end of the current period | Losses included accumulated in other comprehensive income at the end of the current period | Dividend income recognized in the current period | Reasons for designation as financial assets measured at fair value through other comprehensive income |
| Zhejiang Second | 7,790,147.55 | 7,790,147.55 | ||||||
| Pharma Co., Ltd. | ||||||||
| Shanghai NewMargin Yongjin Equity Enterprise (Limited Partnership) | 52,336,000.00 | -37,680,000.00 | 2,948,000.00 | 14,656,000.00 | ||||
| Total | 60,126,147.55 | -37,680,000.00 | 2,948,000.00 | 22,446,147.55 |
Derecognition in the current period: None
Other notes: The above investments are investments that the Company plans to hold long-term for strategic purposes, and the Company has designated them as financial assets measured at fair value with changes recognized in other comprehensive income.
10. Long-term equity investments
Unit: RMB Yuan
| Invested entity | Opening balance (Carrying amount) | Opening balance of impairment provision | Increase or decrease in the current period | Closing balance (Carrying amount) | Closing balance of impairment provision | |||||||
| Additional investment | Investment decrease | Recognized investment gain and loss under equity method | Other comprehensive income adjustments | Other changes in equity | Declared payment of cash dividends or profits | Provision for impairment reserve | Others | |||||
| I. Joint ventures | ||||||||||||
| Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | 418,125,357.72 | 116,968,195.93 | 29,858,295.39 | 564,951,849.04 | ||||||||
| Subtotal | 418,125,357.72 | 116,968,195.93 | 29,858,295.39 | 564,951,849.04 | ||||||||
| II. Associates | ||||||||||||
| Envalior NHU Engineering Materials (Zhejiang) Co., Ltd. | 45,409,060.43 | 8,930,489.80 | -2,894,464.62 | 51,445,085.61 | ||||||||
| Zhejiang Chunhui Environmental Protection Energy Co., Ltd. | 338,826,562.59 | 22,409,394.80 | 40,660.57 | 361,276,617.96 | ||||||||
| Zhejiang Saiya Chemical | 128,424,631.98 | 5,297,279.26 | 215,392.31 | 133,937,303.55 | ||||||||
| Materials Co., Ltd. | ||||||||||||
| CysBio ApS | 26,800,937.20 | -106,505.66 | -830,856.51 | 1,271.61 | 25,864,846.64 | |||||||
| Shandong Bin'an Vocational Training School Co., Ltd. | 3,166,062.22 | -563,800.93 | 2,602,261.29 | |||||||||
| Anhui Yingna Weixun Technology Co., Ltd. | 4,597,937.29 | -83,657.83 | 4,514,279.46 | |||||||||
| Subtotal | 547,225,191.71 | 35,883,199.44 | -830,856.51 | -2,637,140.13 | 579,640,394.51 | |||||||
| Total | 965,350,549.43 | 152,851,395.37 | -830,856.51 | 27,221,155.26 | 1,144,592,243.55 | |||||||
The recoverable amount is determined based on the net of fair value less disposal costs. □ Applicable Not applicable The recoverable amount is determined based on the present value of estimated future cash flows.
□ Applicable Not applicable
11. Fixed assets
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Fixed assets | 19,538,428,936.53 | 20,298,898,673.14 |
| Total | 19,538,428,936.53 | 20,298,898,673.14 |
(1) Status of fixed assets
Unit: RMB Yuan
| Items | Houses and buildings | General equipment | Dedicated equipment | Means of transport | Total |
| I. Original carrying amount: | |||||
| 1. Opening balance | 8,517,300,588.34 | 296,134,157.46 | 23,713,366,626.36 | 30,649,382.48 | 32,557,450,754.64 |
| 2. Amount increased in the current period | 13,082,760.98 | 23,940,570.00 | 358,439,560.99 | 762,870.21 | 396,225,762.18 |
| (1) Purchase | 1,839,140.68 | 21,656,187.65 | 45,822,598.40 | 762,870.21 | 70,080,796.94 |
| (2) Transfer from construction in progress | 11,243,620.30 | 2,284,382.35 | 312,616,962.59 | 326,144,965.24 | |
| 3. Decreased amount in the | 16,904,812.26 | 6,210,010.96 | 45,196,594.62 | 2,019,982.94 | 70,331,400.78 |
| current period | |||||
| (1) Disposal or scrapping | 16,904,812.26 | 6,210,010.96 | 45,196,594.62 | 2,019,982.94 | 70,331,400.78 |
| 4. Ending balance | 8,513,478,537.06 | 313,864,716.50 | 24,026,609,592.73 | 29,392,269.75 | 32,883,345,116.04 |
| II. Accumulated depreciation | |||||
| 1. Opening balance | 1,544,055,823.99 | 208,942,747.91 | 10,429,581,602.74 | 14,905,696.36 | 12,197,485,871.00 |
| 2. Amount increased in the current period | 109,593,470.54 | 14,758,354.99 | 994,435,863.55 | 2,415,350.92 | 1,121,203,040.00 |
| (1) Provision | 109,593,470.54 | 14,758,354.99 | 994,435,863.55 | 2,415,350.92 | 1,121,203,040.00 |
| 3. Decreased amount in the current period | 372,495.07 | 5,913,326.36 | 27,811,596.99 | 679,593.56 | 34,777,011.98 |
| (1) Disposal or scrapping | 372,495.07 | 5,913,326.36 | 27,811,596.99 | 679,593.56 | 34,777,011.98 |
| 4. Ending balance | 1,653,276,799.46 | 217,787,776.54 | 11,396,205,869.30 | 16,641,453.72 | 13,283,911,899.02 |
| III. Impairment Provision | |||||
| 1. Opening balance | 20,975,435.81 | 7,078.55 | 40,083,696.14 | 61,066,210.50 | |
| 2. Amount increased in the current period | |||||
| (1) Provision | |||||
| 3. Decreased amount in the current period | 61,930.01 | 61,930.01 | |||
| (1) Disposal or scrapping | 61,930.01 | 61,930.01 | |||
| 4. Ending balance | 20,975,435.81 | 7,078.55 | 40,021,766.13 | 61,004,280.49 | |
| IV. Carrying amount | |||||
| 1. Carrying amount at the end of the period | 6,839,226,301.79 | 96,069,861.41 | 12,590,381,957.30 | 12,750,816.03 | 19,538,428,936.53 |
| 2. Carrying amount at the beginning of period | 6,952,269,328.54 | 87,184,331.00 | 13,243,701,327.48 | 15,743,686.12 | 20,298,898,673.14 |
(2) Fixed assets temporarily idle
Unit: RMB Yuan
| Items | Original carrying amount | Accumulated depreciation | Depreciation reserves | Carrying amount | Notes |
| Houses and buildings | 171,222,489.21 | 61,625,562.52 | 18,591,263.96 | 91,005,662.73 | |
| General equipment | 16,581.19 | 13,835.89 | 1,916.23 | 829.07 | |
| Dedicated equipment | 465,330,770.49 | 365,543,618.69 | 943,670.69 | 98,843,481.11 | |
| Other devices | 43,071.25 | 33,683.29 | 9,387.96 | ||
| Total | 636,612,912.14 | 427,216,700.39 | 19,536,850.88 | 189,859,360.87 |
(3) Fixed assets leased out through operating leases
Unit: RMB Yuan
| Items | Closing carrying amount |
| Houses and buildings | 27,794,593.54 |
(4) Fixed assets for which title certificates have not been obtained
Unit: RMB Yuan
| Items | Carrying amount | Reasons for not completing the title certificate |
| Houses and buildings | 554,681,952.52 | The relevant procedures have not yet been completed |
| Total | 554,681,952.52 |
(5) Impairment testing of fixed assets
□ Applicable Not applicable
12. Construction in progress
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Construction in progress | 1,006,512,957.55 | 745,117,350.86 |
| Total | 1,006,512,957.55 | 745,117,350.86 |
(1) Conditions of construction in progress
Unit: RMB Yuan
| Items | Closing balance | Opening balance | ||||
| Book balance | Depreciation reserves | Carrying amount | Book balance | Depreciation reserves | Carrying amount | |
| New materials industry chain project | 468,842,005.69 | 468,842,005.69 | 183,041,766.17 | 183,041,766.17 | ||
| Methionine integratedupgrade project | 943,887.42 | 943,887.42 | 80,059,496.68 | 80,059,496.68 | ||
| Workshop 615 1,500-ton aldehyde-series production switching project | 79,928,124.42 | 79,928,124.42 | ||||
| 20,000-ton-per-year glufosinate-ammonium process and legalization project | 43,217,681.54 | 43,217,681.54 | 52,444,438.35 | 52,444,438.35 | ||
| Workshop 663 technological transformation project | 30,909,141.70 | 30,909,141.70 | 28,245,872.53 | 28,245,872.53 | ||
| CH phase II major production engineering project | 43,202,621.11 | 43,202,621.11 | 24,294,749.08 | 24,294,749.08 | ||
| Integration project for fluoroalkanes and plant alcohols | 20,473,131.25 | 20,473,131.25 | 21,521,655.66 | 21,521,655.66 | ||
| Linalool series products capacity expansion project | 252,511.54 | 252,511.54 | 17,291,367.93 | 17,291,367.93 | ||
| Other sporadic projects | 404,966,011.00 | 6,294,033.70 | 398,671,977.30 | 264,583,913.74 | 6,294,033.70 | 258,289,880.04 |
| Total | 1,012,806,991.25 | 6,294,033.70 | 1,006,512,957.55 | 751,411,384.56 | 6,294,033.70 | 745,117,350.86 |
(2) Increase or decrease of significant construction in progress in current period
Unit: RMB Yuan
| Project name | Budget (RMB'0,000) | Opening balance | Increased amount in the current period | Amount transferred to fixed assets in current period | Other decreased amount in the current period | Closing balance | The proportion of total project input to the budget | Project progress | Accumulated amount of interest capitalization | Including: Amount of interest capitalization in the current period | Interest capitalization rate for the current period | Capital source |
| New materials industry chain project | 403,624.00 | 183,041,766.17 | 285,800,239.53 | 468,842,005.70 | 26.91% | 16,022,465.50 | 7,567,338.87 | 2.67% | Others | |||
| Methionine integrated upgrade project | 25,138.70 | 80,059,496.68 | 5,235,437.39 | 84,351,046.65 | 943,887.42 | 100.00% | Others | |||||
| Workshop 615 1,500-ton aldehyde-series production switching project | 11,687.27 | 79,928,124.42 | 5,496,278.41 | 85,424,402.83 | 100.00% | Others | ||||||
| Total | 440,449.97 | 343,029,387.27 | 296,531,955.33 | 169,775,449.48 | 469,785,893.12 | 16,022,465.50 | 7,567,338.87 |
(3) Provision for impairment of construction in progress in the current period
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance | Reasons for provision |
| Other sporadic projects | 6,294,033.70 | 6,294,033.70 | |||
| Total | 6,294,033.70 | 6,294,033.70 | -- |
(4) Impairment testing of construction in progress
Applicable Not applicable
13. Right-of-use assets
(1) Status of right-of-use assets
Unit: RMB Yuan
| Items | Houses and buildings | Total |
| I. Original carrying amount | ||
| 1. Opening balance | 16,966,176.34 | 16,966,176.34 |
| 2. Amount increased in the current period | 1,600,260.16 | 1,600,260.16 |
| 3. Decreased amount in the current period | ||
| 4. Ending balance | 18,566,436.50 | 18,566,436.50 |
| II. Accumulated depreciation | ||
| 1. Opening balance | 7,849,458.47 | 7,849,458.47 |
| 2. Amount increased in the current period | 2,172,801.55 | 2,172,801.55 |
| (1) Provision | 2,172,801.55 | 2,172,801.55 |
| 3. Ending balance | 10,022,260.02 | 10,022,260.02 |
| III. Carrying amount | ||
| 1. Carrying amount at the end of the period | 8,544,176.48 | 8,544,176.48 |
| 2. Carrying amount at the beginning of period | 9,116,717.87 | 9,116,717.87 |
(2) Impairment testing of the right-of-use assets
□ Applicable Not applicable
14. Intangible assets
(1) Status of intangible assets
Unit: RMB Yuan
| Items | Land use rights | Patent right | Non-patented technologies | Software | Total |
| I. Original carrying amount | |||||
| 1. Opening balance | 2,776,434,384.64 | 42,772,999.92 | 106,804,273.83 | 110,460,904.09 | 3,036,472,562.48 |
| 2. Amount increased in the current period | 1,072,677,433.57 | 11,534,389.34 | 1,084,211,822.91 | ||
| (1) Purchase | 1,072,677,433.57 | 6,400,802.96 | 1,079,078,236.53 | ||
| (2) Transfer from construction in progress | |||||
| (3) Transfer to inventories | 5,133,586.38 | 5,133,586.38 | |||
| 3. Decreased amount in the current period | 6,215,754.79 | 6,215,754.79 | |||
| (1) Disposal | 6,215,754.79 | 6,215,754.79 | |||
| 4. Ending balance | 3,849,111,818.21 | 36,557,245.13 | 106,804,273.83 | 121,995,293.43 | 4,114,468,630.60 |
| II. Accumulated amortization | |||||
| 1. Opening balance | 368,751,262.88 | 14,537,023.90 | 23,020,636.25 | 40,089,748.05 | 446,398,671.08 |
| 2. Amount increased in the current period | 29,782,782.06 | 129,292.89 | 5,286,879.61 | 5,873,656.39 | 41,072,610.95 |
| (1) Provision | 29,782,782.06 | 129,292.89 | 5,286,879.61 | 5,873,656.39 | 41,072,610.95 |
| 3. Ending balance | 398,534,044.94 | 14,666,316.79 | 28,307,515.86 | 45,963,404.44 | 487,471,282.03 |
| III. Carrying amount | |||||
| 1. Carrying amount at the end of the period | 3,450,577,773.27 | 21,890,928.34 | 78,496,757.97 | 76,031,888.99 | 3,626,997,348.57 |
| 2. Carrying amount at the beginning of period | 2,407,683,121.76 | 28,235,976.02 | 83,783,637.58 | 70,371,156.04 | 2,590,073,891.40 |
At the end of this period, the proportion of intangible assets formed through internal research and development of the Company to the balance of intangible assets is 0.00%.
(2) Impairment testing of intangible assets
Applicable ☑ Not applicable
15. Goodwill
(1) Original carrying amount of goodwill
Unit: RMB Yuan
| The name of the invested unit or items forming goodwill | Opening balance | Increase in the current period | Decrease in the current period | Closing balance | ||
| Formed by business combination | Foreign currency translation reserves | Disposal | Other decreases | |||
| Bardoterminal GmbH | 2,367,819.24 | -134,671.43 | 2,233,147.81 | |||
| NHU/Chr.Olese n Latin America A/S | 3,622,704.97 | 3,622,704.97 | ||||
| Total | 5,990,524.21 | -134,671.43 | 5,855,852.78 | |||
(2) Impairment provision for goodwill
Unit: RMB Yuan
| The name of the invested unit or items forming goodwill | Opening balance | Increase in the current period | Decrease in the current period | Closing balance | ||
| Provision | Foreign currency translation reserves | Disposal | Other decreases | |||
| Bardoterminal GmbH | 2,367,819.24 | -134,671.43 | 2,233,147.81 | |||
| Total | 2,367,819.24 | -134,671.43 | 2,233,147.81 | |||
(3) Information about the asset group or combination of asset groups of goodwill
| Name | Composition and Basis of the Asset Group or Portfolio to Which It Belongs | Operating Division and Basis | Consistency with Previous Years |
| Bardoterminal GmbH | For an independently accounted overseas warehousing and logistics company, the management will recognize it as a single asset group from the date of acquisition | Independent warehousing and logistics company | Yes |
| NHU/Chr. Olesen | For sales entities with independent | Independent sales entity | Yes |
| Latin America A/S | accounting overseas, the management identifies them as a single asset group from the time of acquisition |
Changes in an asset group or a combination of asset groups: None
(4) Specific methods for determining the recoverable amount
The recoverable amount is determined based on the net of fair value less disposal costs.
Applicable Not applicable
The recoverable amount is determined based on the present value of estimated future cash flows.
Applicable ☑ Not applicable
16. Long-term deferred expenses
Unit: RMB Yuan
| Items | Opening balance | Increased amount in the current period | Amortized amount in the current period | Other decreased amount | Closing balance |
| Renovation costs | 1,242,479.65 | -33,191.99 | 778,111.54 | 431,176.12 | |
| Catalyst expenses | 18,234,620.78 | 4,585,868.53 | 13,648,752.25 | ||
| Total | 19,477,100.43 | -33,191.99 | 5,363,980.07 | 14,079,928.37 |
17. Deferred income tax assets / deferred income tax liabilities
(1) Non-offset deferred income tax assets
Unit: RMB Yuan
| Items | Closing balance | Opening balance | ||
| Deductible temporary differences | Deferred tax assets | Deductible temporary differences | Deferred tax assets | |
| Provision for impairment of assets | 99,902,023.24 | 16,086,033.08 | 109,470,361.07 | 17,528,759.54 |
| Unrealized profit from internal transaction | 112,089,294.51 | 19,090,170.17 | 93,256,153.83 | 13,988,423.06 |
| Deferred income | 143,438,204.97 | 21,515,730.75 | 166,211,235.01 | 24,931,685.24 |
| Sales rebates | 20,616,580.75 | 3,092,487.11 | 45,143,439.52 | 6,771,515.93 |
| Lease liabilities | 2,428,007.47 | 364,201.12 | 2,603,650.85 | 390,547.63 |
| Changes in fair value of trading financial instruments and derivative financial instruments | 6,243.72 | 1,560.93 | ||
| Total | 378,480,354.66 | 60,150,183.16 | 416,684,840.28 | 63,610,931.40 |
(2) Non-offset deferred income tax liabilities
Unit: RMB Yuan
| Items | Closing balance | Opening balance | ||
| Taxable temporary difference | Deferred income tax liabilities | Taxable temporary difference | Deferred income tax liabilities | |
| Full pre-tax deduction for fixed assets | 1,261,441,756.90 | 189,233,990.74 | 1,368,856,067.79 | 205,351,881.78 |
| Fair value of other equity instruments investment at the end of the period | 34,416,000.00 | 5,162,400.00 | 42,336,000.00 | 6,350,400.00 |
| Right-of-use assets | 6,451,630.53 | 967,744.58 | 7,940,001.94 | 1,191,000.29 |
| Changes in fair value of trading financial instruments and derivative financial instruments | 312,250.00 | 78,062.50 | ||
| Total | 1,302,309,387.43 | 195,364,135.32 | 1,419,444,319.73 | 212,971,344.57 |
(3) Deferred income tax assets or liabilities presented by netting after offset
Unit: RMB Yuan
| Items | Amount of deferred income tax assets and liabilities mutually-offset end of the period | Ending balance of deferred income tax assets or liabilities after offset | Amount of deferred income tax assets and liabilities mutually-offset beginning of the period | Opening balance of deferred income tax assets or liabilities after offsetting |
| Deferred income tax assets | 55,120,022.25 | 5,030,160.91 | 60,918,480.41 | 2,692,450.99 |
| Deferred income tax liabilities | 55,120,022.25 | 140,244,113.07 | 60,918,480.41 | 152,052,864.16 |
(4) Details of unrecognized deferred income tax assets
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Deductible temporary differences | 15,906,871.54 | 1,194,450,604.18 |
| Deductible loss | 3,508,448,767.45 | 3,640,655,005.58 |
| Total | 3,524,355,638.99 | 4,835,105,609.76 |
(5) The deductible loss of unrecognized deferred income tax assets will expire in the following years
Unit: RMB Yuan
| Year | Closing balance | Opening balance | Notes |
| 2026 | 12,470,639.45 | 12,470,639.45 | |
| 2027 | 36,168,974.24 | 36,109,953.27 | |
| 2028 | 92,988,113.65 | 92,988,113.65 | |
| 2029 | 110,355,923.56 | 157,453,878.38 | |
| 2030 | 282,808,253.54 | 287,710,194.39 | |
| 2031 | 127,844,426.90 | 171,759,808.89 | |
| 2032 | 673,528,324.10 | 686,611,544.78 | |
| 2033 | 555,758,039.41 | 550,583,877.97 | |
| 2034 | 427,465,559.54 | 500,973,611.00 | |
| 2035 | 456,486,651.56 | 479,287,801.45 | |
| Non-offsettable losses of overseas companies | 732,573,861.50 | 664,705,582.35 | |
| Total | 3,508,448,767.45 | 3,640,655,005.58 |
18. Other non-current assets
Unit: RMB Yuan
| Items | Closing balance | Opening balance | ||||
| Book balance | Depreciation reserves | Carrying amount | Book balance | Depreciation reserves | Carrying amount | |
| Emission trading rights fee | 12,474,645.36 | 12,474,645.36 | 10,488,933.12 | 10,488,933.12 | ||
| Coal quota payment | 67,546,800.00 | 67,546,800.00 | 65,263,600.00 | 65,263,600.00 | ||
| Certificate of deposit of large amount | 415,629,000.00 | 415,629,000.00 | 411,144,444.44 | 411,144,444.44 | ||
| Prepaid land transfer payment | 518,405,000.00 | 518,405,000.00 | ||||
| Prepaid for long-term asset funds | 673,946,242.18 | 673,946,242.18 | 471,339,952.22 | 471,339,952.22 | ||
| Total | 1,169,596,687.54 | 1,169,596,687.54 | 1,476,641,929.78 | 1,476,641,929.78 | ||
19. Assets with restricted ownership or use rights
Unit: RMB Yuan
| Items | End of the period | Beginning of the period | ||||||
| Book balance | Carrying amount | Type of restriction | Restriction situations | Book balance | Carrying amount | Type of restriction | Restriction situations | |
| Cash and bank balances | 61,825,034.41 | 61,825,034.41 | Pledged | Guarantee deposit of bank acceptance bills, etc. | 46,418,753.27 | 46,418,753.27 | Pledged | Guarantee deposit of bank acceptance bills, etc. |
| Fixed assets | 98,344,608.36 | 75,698,163.27 | Mortgage | Mortgaged for bank borrowings | 102,070,345.08 | 79,042,144.12 | Mortgage | Mortgaged for bank borrowings |
| Intangible assets | 108,525,632.40 | 85,879,187.31 | Mortgage | Mortgaged for bank borrowings | 10,794,997.29 | 10,794,997.29 | Mortgage | Mortgaged for bank borrowings |
| Receivables financing | 114,794,927.96 | 114,794,927.96 | Pledged | Establish bankacceptance bill pledge | 135,353,157.67 | 135,353,157.67 | Pledged | Establish bankacceptance bill pledge |
| Total | 383,490,203.13 | 338,197,312.95 | 294,637,253.31 | 271,609,052.35 | ||||
20. Short-term borrowings
(1) Classification of short-term loans
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Guaranteed borrowing | 26,470,505.77 | 6,604,793.50 |
| Credit loans | 935,561,772.22 | 668,567,888.87 |
| Total | 962,032,277.99 | 675,172,682.37 |
21. Financial liabilities held for trading
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Financial liabilities held for trading | 1,663,300.90 | |
| Including: | ||
| Financial liabilities classified as measured at fair value, with changes recognized in profit or loss | 1,663,300.90 | |
| Including: Derivative financial liabilities | 1,663,300.90 | |
| Total | 1,663,300.90 |
22. Notes payable
Unit: RMB Yuan
| Type | Closing balance | Opening balance |
| Bank acceptance bills | 43,197,229.37 | 70,054,101.63 |
| Total | 43,197,229.37 | 70,054,101.63 |
23. Accounts Payable
(1) Presentation of accounts payable
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Materials and labor payments | 1,374,755,480.43 | 1,040,052,507.44 |
| Payment for engineering and equipment | 514,776,101.15 | 740,255,257.64 |
| Total | 1,889,531,581.58 | 1,780,307,765.08 |
24. Other payables
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Other payables | 96,098,501.09 | 131,685,145.99 |
| Total | 96,098,501.09 | 131,685,145.99 |
(1) Other payables
1) Presentation of other payables by nature of the payment
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Accrued and unpaid expenses | 35,633,532.02 | 77,784,423.40 |
| Deposits and guarantee deposits | 36,405,806.40 | 30,090,146.97 |
| Temporary receipts payable | 4,952,835.29 | 13,548,987.92 |
| Others | 19,106,327.38 | 10,261,587.70 |
| Total | 96,098,501.09 | 131,685,145.99 |
25. Contract liabilities
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Advances from customers | 351,344,836.57 | 294,819,090.20 |
| Total | 351,344,836.57 | 294,819,090.20 |
26. Employee benefits payable
(1) Presentation of employee benefits payable
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance |
| I. Short-term employee benefits | 511,515,144.15 | 1,186,429,425.24 | 1,390,003,383.23 | 307,941,186.16 |
| II. Post-employment benefits - defined contribution plans | 96,793,564.13 | 96,793,564.13 | ||
| III. Dismissal welfare | 2,835,729.03 | 2,835,729.03 | ||
| Total | 511,515,144.15 | 1,286,058,718.40 | 1,489,632,676.39 | 307,941,186.16 |
(2) Presentation of short-term compensation
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance |
| 1. Salaries, bonuses, allowances and subsidies | 494,168,073.67 | 1,031,124,478.39 | 1,233,891,886.36 | 291,400,665.70 |
| 2. Employee welfare fee | 57,726,545.59 | 57,726,545.59 | ||
| 3. Social insurance premium | 56,357,367.92 | 56,357,367.92 | ||
| Incl.: Medical insurance premium | 47,612,461.20 | 47,612,461.20 | ||
| Industrial injury insurance premium | 5,023,315.72 | 5,023,315.72 | ||
| Maternity insurance premium | 99.96 | 99.96 | ||
| 4. Housing provident fund | 37,411,234.93 | 37,411,234.93 | ||
| 5. Labor union expenditure and employee education expenses | 17,347,070.48 | 3,809,798.41 | 4,616,348.43 | 16,540,520.46 |
| Total | 511,515,144.15 | 1,186,429,425.24 | 1,390,003,383.23 | 307,941,186.16 |
(3) Presentation of defined contribution plans
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance |
| 1. Basic endowment insurance | 92,896,267.63 | 92,896,267.63 | ||
| 2. Unemployment insurance expense | 3,897,296.50 | 3,897,296.50 | ||
| Total | 96,793,564.13 | 96,793,564.13 |
27. Taxes and fees payable
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| VAT | 84,310,856.32 | 116,722,251.38 |
| Corporate income tax | 410,973,109.91 | 476,673,438.77 |
| Individual income tax | 3,385,769.32 | 16,171,313.03 |
| Urban maintenance and construction tax | 6,164,102.74 | 10,415,102.16 |
| House property tax | 9,976,702.40 | 20,982,936.57 |
| Land use tax | 10,596,636.04 | 20,379,197.51 |
| Educational surcharge (local education surcharge) | 4,627,498.89 | 7,944,401.51 |
| Stamp duty | 432,588.63 | 180,237.73 |
| Total | 530,467,264.25 | 669,468,878.66 |
28. Non-current liabilities due within one year
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Long-term loans due within one year | 2,744,932,425.31 | 3,164,135,175.76 |
| Lease liabilities due within one year | 496,124.73 | 1,278,697.73 |
| Total | 2,745,428,550.04 | 3,165,413,873.49 |
29. Other current liabilities
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Short-term bonds payable | 503,204,520.55 | |
| Output VAT to be transferred | 33,838,891.89 | 32,397,758.57 |
| Sales rebates | 25,600,653.97 | 66,960,592.67 |
| Total | 562,644,066.41 | 99,358,351.24 |
Changes in short-term bonds payable:
Unit: RMB Yuan
| Name | Denomination | Coupon rate | Release date | Bond term | Amount | Opening balance | Issued | Interest accrued at face value | Excess discount amortization | Repayment | Closing balance | Default |
| Zhejiang NHU Company Ltd. technology innovation bond in the first phase of 2026 | 500,000,000.00 | 1.57% | February 1st,2026 | 270天 | 500,000,000.00 | 500,000,000.00 | 500,000,000.00 | 3,204,520.55 | 503,204,520.55 | No | ||
| Total | 500,000,000.00 | 500,000,000.00 | 500,000,000.00 | 3,204,520.55 | 503,204,520.55 |
30. Long-term loans
(1) Classification of long-term borrowings
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Mortgage loan | 6,913,122.89 | 19,737,123.37 |
| Credit loans | 3,163,250,227.59 | 4,167,441,445.65 |
| Total | 3,170,163,350.48 | 4,187,178,569.02 |
31. Lease liabilities
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| Outstanding lease payment | 3,128,476.17 | 3,380,508.75 |
| Unamortized financing costs | -820,689.31 | -880,325.09 |
| Total | 2,307,786.86 | 2,500,183.66 |
32. Deferred income
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance | Cause of formation |
| Government subsidies | 899,431,748.59 | 25,128,500.00 | 81,533,952.31 | 843,026,296.28 | Government grants related to assets received by the Company are amortized according to the depreciation schedule of the corresponding assets |
| Government subsidies | 6,576,000.00 | 1,398,784.26 | 5,177,215.74 | Revenue-related government grants received by the Company are amortized to match the actual expenses incurred | |
| Total | 906,007,748.59 | 25,128,500.00 | 82,932,736.57 | 848,203,512.02 |
33. Share capital
Unit: RMB Yuan
| Items | Opening balance | Increase or decrease in the change (+,-) | Closing balance | ||||
| Issue of new shares | Bonus shares | Conversion of capital reserve into shares | Others | Subtotal | |||
| Total shares | 3,073,421,680.00 | 3,073,421,680.00 | |||||
34. Capital surplus
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance |
| Capital premium (Share premium) | 2,854,024,919.08 | 33,790,775.87 | 2,887,815,694.95 | |
| Other capital reserve | 281,658,334.41 | 1,745,052.06 | 283,403,386.47 | |
| Total | 3,135,683,253.49 | 35,535,827.93 | 3,171,219,081.42 |
Other explanations, including the increase and decrease in the current period and the explanation of the reasons for the changes:Other capital reserve increased by RMB 1,745,052.06 in the period, due to increases in the special reserves of the Company's associates Zhejiang Chunhui Environmental Protection Energy Co., Ltd., Zhejiang Saiya Chemical Materials Co., Ltd. And Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd.,resulting in a change in the Company's share of net assets. On January 23,2026, the 21,454.310 shares of company stock held in the company's repurchase special securities accoun were transferred to the "Zhejiang NHU Co., Ltd. - Fifth Phase Employee Stock Ownership Plan" special securities account through non trading transfer, reducing treasury stocks by RMB 485,188,983.03 and increasing capital reserves by RMB 33,790,775.87.
35. Treasury stocks
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance |
| Treasury stock | 556,161,195.70 | 485,188,983.03 | 70,972,212.67 | |
| Total | 556,161,195.70 | 485,188,983.03 | 70,972,212.67 |
Other notes, including changes during the period and explanations of the reasons for the changes: The increase in treasury shares during the period was due to the Company repurchasing part of the publicly held shares, intended to be used to implement the equity incentive plan or the employee stock ownership plan.
36. Other comprehensive income
Unit: RMB Yuan
| Items | Opening balance | Amount incurred in the current period | Closing balance | |||||
| Amount incurred before income tax in the current period | Less: Included in other comprehensive income for the previous period and transferred in profit or loss for the current period | Less: Included in other comprehensive income for the previous period and transferred in retained earnings for the current period | Less: Income tax expense | Attributable to the parent company after tax | Attributable to minority shareholders after tax | |||
| I. Other comprehensive income that cannot be reclassified into profit or loss | 35,985,600.00 | 35,985,600.00 | ||||||
| Changes in the fair value of investments in other equity instruments | 35,985,600.00 | 35,985,600.00 | ||||||
| II. Other comprehensive income that will be reclassified into profit or loss | 31,757,896.72 | -34,098,912.83 | -15,384,368.68 | -18,714,544.15 | 16,373,528.04 | |||
| Including: other comprehensive income under the equity method that can be reclassified to profit or loss | 506,954.43 | 506,954.43 | ||||||
| Translation differences of financial | 31,250,942.29 | -34,098,912.83 | -15,384,368.68 | -18,714,544.15 | 15,866,573.61 | |||
| statements denominated in foreign currency | ||||||||
| Total other comprehensive incomes | 67,743,496.72 | -34,098,912.83 | -15,384,368.68 | -18,714,544.15 | 52,359,128.04 | |||
37. Special reserves
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance |
| Safety production expense | 162,056,373.58 | 69,820,553.97 | 55,218,410.20 | 176,658,517.35 |
| Total | 162,056,373.58 | 69,820,553.97 | 55,218,410.20 | 176,658,517.35 |
Other explanations, including the increase and decrease in the current period and the explanation of the reasons for the changes: In accordance with the Administrative Measures for the Collection and Utilization of Enterprise Work Safety Funds, hazardous goods production and storage enterprises shall base the extraction on the actual operating revenue of the previous year, using a progressive decreasing rate method to extract monthly on average according to the following standards: 1) For operating revenue not exceeding RMB 10 million, extract at 4.5%; 2) For the portion of operating revenue exceeding RMB 10 million up to RMB 100 million, extract at 2.25%; 3) For the portion of operating revenue exceeding RMB 100 million up to RMB 1 billion, extract at 0.55%; 4) For the portion of operating revenue exceeding RMB 1 billion, extract at 0.2%.
In accordance with the Administrative Measures for the Collection and Utilization of Enterprise Work Safety Funds, the power production and supply enterprises shall base the extraction on the actual operating revenue of the previous year, adopting a progressive decreasing rate method to extract monthly on average according to the following standards: 1) For operating revenue not exceeding RMB 10 million, extract at 3%; 2) For the portion of operating revenue exceeding RMB 10 million up to RMB 100 million, extract at 1.5%; 3) For the portion of operating revenue exceeding RMB 100 million up to RMB 1 billion, extract at 1%; 4) For the portion of operating revenue exceeding RMB 1 billion up to RMB 5 billion, extract at 0.8%; 5) For the portion of operating revenue exceeding RMB 5 billion up to RMB 10 billion, extract at 0.6%; 6) For the portion of operating revenue exceeding RMB 10 billion, extract at 0.2%.
38. Surplus reserves
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance |
| Statutory surplus reserves | 1,545,453,678.00 | 1,545,453,678.00 | ||
| Total | 1,545,453,678.00 | 1,545,453,678.00 |
Explanation of surplus reserves, including the increase and decrease in the current period and the explanation of the reasons for the change:
In accordance with the Company Law of the People's Republic of China and the Articles of Association, the Company shall set aside 10% of the parent company's net profit as a statutory surplus capital reserve; when the accumulated statutory surplus capital reserve reaches 50% of the registered capital, no further statutory surplus capital reserve need be set aside.
39. Undistributed profits
Unit: RMB Yuan
| Items | Current period | Prior period |
| Undistributed profits at the end of the last period before adjustment | 25,377,456,895.81 | 21,375,740,194.12 |
| Undistributed profits at the beginning of the period after adjustment | 25,377,456,895.81 | 21,375,740,194.12 |
| Plus: net profit attributable to owners of the parent company in the current period | 4,010,733,454.55 | 6,764,199,225.29 |
| Less: Dividends payable on common stock | 2,456,226,718.40 | 2,762,482,523.60 |
| Undistributed profits at the end of the period | 26,931,963,631.96 | 25,377,456,895.81 |
40. Operating revenue and operating cost
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period | ||
| Revenue | Cost | Revenue | Cost | |
| Main business | 13,077,825,612.26 | 7,308,975,788.97 | 11,072,628,572.89 | 5,996,026,761.47 |
| Other business | 51,474,648.63 | 14,699,671.84 | 28,004,263.89 | 10,340,595.62 |
| Total | 13,129,300,260.89 | 7,323,675,460.81 | 11,100,632,836.78 | 6,006,367,357.09 |
| Including: with customers Revenue from contracts | 13,126,313,081.89 | 7,323,301,008.77 | 11,097,016,365.52 | 6,006,031,204.71 |
Breakdown of the operating revenue and operating cost: Unit: RMB Yuan
| Classification of contracts | Operating revenue | Operating cost |
| Business Type | ||
| Including: | ||
| Nutrition | 8,805,591,681.68 | 4,678,820,058.46 |
| Aroma chemicals | 2,022,263,282.57 | 1,032,127,702.98 |
| New materials | 1,165,989,510.74 | 784,932,943.49 |
| Others | 1,132,468,606.90 | 827,420,303.84 |
| Subtotal | 13,126,313,081.89 | 7,323,301,008.77 |
| Classified according to operation regions | ||
| Including: | ||
| Domestic | 5,454,479,328.97 | 3,430,296,825.49 |
| Overseas | 7,671,833,752.92 | 3,893,004,183.28 |
| Subtotal | 13,126,313,081.89 | 7,323,301,008.77 |
| Classification by timing of goods transfer | ||
| Including: | ||
| Revenue recognized at a point in time | 13,126,313,081.89 | 7,323,301,008.77 |
| Subtotal | 13,126,313,081.89 | 7,323,301,008.77 |
| By sales channel | ||
| Including: | ||
| Direct selling | 9,949,165,905.05 | 5,550,738,905.46 |
| Agent sales | 3,177,147,176.84 | 1,772,562,103.31 |
| Subtotal | 13,126,313,081.89 | 7,323,301,008.77 |
Information related to the transaction price allocated to remaining performance obligations: At the end of the reporting period, the amount of income corresponding to the obligations under the contract that have been signed but have not been performed or have not been completely performed is RMB 3,625,468,392.22. Of this amount, RMB 3,625,468,392.22 is expected to be recognized as revenue in 2026.
41. Taxes and surcharges
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Urban maintenance and construction tax | 50,368,259.68 | 39,551,225.95 |
| Education surcharge | 38,752,322.82 | 31,641,245.23 |
| House property tax | 22,261,080.14 | 22,065,671.62 |
| Land use tax | 24,408,489.99 | 23,618,662.08 |
| Vehicle and vessel use tax | 30,281.63 | 18,249.52 |
| Stamp duty | 9,742,543.54 | 7,240,307.89 |
| Environmental protection tax | 1,506,080.65 | 1,965,289.57 |
| Water resource tax | 33,472.00 | 37,970.20 |
| Total | 147,102,530.45 | 126,138,622.06 |
42. Administrative expenses
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Employee compensation | 159,066,799.27 | 169,842,730.77 |
| Depreciation expense and amortization of intangible assets | 56,755,272.16 | 57,537,198.65 |
| Office expenses and travel expenses | 25,793,927.39 | 24,292,173.92 |
| Business entertainment expenses | 10,553,178.69 | 8,226,105.71 |
| Consulting fee | 9,889,172.71 | 12,834,499.47 |
| Insurance expenses | 11,706,197.12 | 9,121,780.69 |
| Others | 18,827,283.34 | 27,763,916.53 |
| Total | 292,591,830.68 | 309,618,405.74 |
43. Sales expenses
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Employee compensation | 47,169,548.77 | 37,142,722.42 |
| Sales commission | 19,177,714.24 | 28,787,391.62 |
| Office expenses and travel expenses | 13,369,693.37 | 12,935,899.47 |
| Advertising and promotion expenses, and business entertainment expenses | 8,022,007.56 | 7,271,760.73 |
| Others | 1,248,106.00 | 2,464,632.41 |
| Total | 88,987,069.94 | 88,602,406.65 |
44. R & D expenses
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Employee compensation | 254,986,435.45 | 243,369,740.34 |
| Direct input | 273,425,309.24 | 194,855,941.97 |
| Depreciation expense and amortization of intangible assets | 43,724,074.06 | 45,699,299.17 |
| Outsourcing expenses | 8,883,018.87 | 7,801,144.90 |
| Office expenses and travel expenses | 224,352.55 | 4,910,364.40 |
| Others | 24,484,887.47 | 26,087,072.40 |
| Total | 605,728,077.64 | 522,723,563.18 |
45. Financial expenses
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Interest expenses | 77,290,550.93 | 112,615,701.07 |
| Less: interest income | 33,892,368.94 | 39,620,525.39 |
| Exchange gains and losses (“-” for gains) | 201,340,238.14 | -261,991,904.62 |
| Others | 13,064,708.28 | 10,898,031.47 |
| Total | 257,803,128.41 | -178,098,697.47 |
46. Other income
Unit: RMB Yuan
| Sources of other incomes | Amount incurred in the current period | Amount incurred in the previous period |
| Government grants related to assets | 82,932,736.57 | 68,463,990.57 |
| Government grants related to income | 36,014,059.37 | 51,815,263.87 |
| Refund of service charges for withholding and paying personal income tax | 1,810,694.88 | 1,485,876.64 |
| Total | 120,757,490.82 | 121,765,131.08 |
47. Gain from changes in fair value
Unit: RMB Yuan
| Sources of income from changes in fair values | Amount incurred in the current period | Amount incurred in the previous period |
| Trading Financial Assets | 7,437,903.65 | 16,328,109.27 |
| Including: fair value change income from derivative financial instruments | 7,437,903.65 | 16,328,109.27 |
| Financial liabilities held for trading | 58,556,088.18 | -123,188,493.71 |
| Including: Gains from changes in the fair value of financial liabilities classified as measured at fair value through profit or loss | 58,556,088.18 | -123,188,493.71 |
| Total | 65,993,991.83 | -106,860,384.44 |
48. Investment income
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Return on long-term equity investments measured by the equity method | 152,851,395.37 | 24,632,875.74 |
| Investment income from disposal of trading (held-for-trading) financial assets | 35,312,041.25 | -19,871,951.63 |
| Including: Financial assets classified as at fair value through profit or loss | 4,076,535.85 | -581,571.44 |
| Including: Financial liabilities classified as at fair value through profit or loss | 31,235,505.40 | -19,290,380.19 |
| Income of bank financial products and | 16,602,412.40 | 8,184,998.28 |
| structural deposits | ||
| Interest on discounted bills | -267,359.89 | |
| Dividend income from investment in other equity instruments during the holding period | 5,292,000.00 | |
| Total | 204,498,489.13 | 18,237,922.39 |
49. Credit impairment losses
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Accounts receivables bad debt losses (“-” for losses) | -32,588,767.26 | 10,931,120.90 |
| Other receivables bad debt losses (“-” for losses) | -1,689,750.93 | -3,317,979.51 |
| Total | -34,278,518.19 | 7,613,141.39 |
50. Asset impairment losses
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Losses from inventory write-downs and impairment losses on contract fulfillment costs (“-” for losses) | -29,423,561.32 | -33,272,405.82 |
| Total | -29,423,561.32 | -33,272,405.82 |
51. Income from disposal of assets
Unit: RMB Yuan
| Source of income from asset disposal | Amount incurred in the current period | Amount incurred in the previous period |
| Gains from disposal of non-current assets (“-” for losses) | 1,251,350.66 | -1,582,139.69 |
| Total | 1,251,350.66 | -1,582,139.69 |
52. Non-operating income
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period | Amount included in current non-recurring gains and losses |
| Compensation income | 1,423,403.03 | 689,062.82 | 1,423,403.03 |
| Others | 765,764.21 | 529,530.08 | 765,764.21 |
| Total | 2,189,167.24 | 1,218,592.90 | 2,189,167.24 |
53. Non-operating expenses
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period | Amount included in current non-recurring gains and losses |
| External donation | 1,897,281.80 | 157,421.42 | 1,897,281.80 |
| Loss of damage and scrapping of non-current assets | 36,557,884.36 | 392,406.59 | 36,557,884.36 |
| Others | 8,600,946.83 | 2,448,868.23 | 8,600,946.83 |
| Total | 47,056,112.99 | 2,998,696.24 | 47,056,112.99 |
54. Income tax expense
(1) Income tax expense statement
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Current income tax expense | 680,189,197.19 | 618,501,260.17 |
| Deferred income tax expense | -10,891,950.28 | -10,594,464.32 |
| Total | 669,297,246.91 | 607,906,795.85 |
(2) Adjustment process of accounting profit and income tax expenses
Unit: RMB Yuan
| Items | Amount incurred in the current period |
| Total profits | 4,697,344,460.14 |
| Income tax expense calculated at statutory/applicable tax rate | 704,601,669.02 |
| Influence of different tax rates applied to subsidiaries | 9,424,779.57 |
| Influence of adjusting income tax in previous periods | 24,840,698.12 |
| Influence of non-taxable income | -26,666,163.74 |
| Influence of non-deductible costs, expenses and losses | 6,390,991.19 |
| Influence of deductible temporary differences or deductible losses of unrecognized deferred income tax assets in this period | 40,432,189.88 |
| Tax impact of additional deduction for research and development expenses (indicated with "-" | -89,726,917.13 |
| Income tax expenses | 669,297,246.91 |
55. Other comprehensive income
See Note 36 of Section VII of the financial report for details.
56. Cash flow statement items
(1) Cash relating to operating activities
Other cash receipts relating to operating activities
Unit: RMB Yuan
| Items | Current period cumulative | Preceding period comparative |
| Interest income from bank deposits | 34,303,334.57 | 46,489,138.86 |
| Government grants received | 39,922,197.95 | 46,323,276.36 |
| Recovery of temporary loans, deposits, and guarantee deposits | 65,245.00 | 86,687.91 |
| Net amount received from other items and transactions | 31,901,658.40 | 11,931,434.37 |
| Total | 106,192,435.92 | 104,830,537.50 |
Other cash paid related to operating activities Unit: RMB Yuan
| Items | Current period cumulative | Preceding period comparative |
| Cash payments for research and development | 18,756,282.66 | 23,435,352.94 |
| Office expenses and travel expenses | 19,979,929.10 | 17,645,221.94 |
| Advertising and promotion expenses, and business entertainment expenses | 16,508,783.88 | 14,296,751.97 |
| Sales commission | 30,487,691.74 | 36,152,773.52 |
| Insurance expenses | 11,684,890.84 | 7,687,775.66 |
| Payment of land deposit | 207,370,000.00 | |
| Other expenses and net amount of transactions | 89,829,603.67 | 219,548,408.27 |
| Total | 187,247,181.89 | 526,136,284.30 |
(2) Cash flows relating to investing activities
Other cash received from investing activities
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Redemption of wealth management products and certificates of deposit | 2,251,950,000.00 | 2,150,000,000.00 |
| Total | 2,251,950,000.00 | 2,150,000,000.00 |
Other cash paid related to investment activities
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Purchase of wealth management products, large-denomination certificates of deposit, and structured deposits | 2,550,000,000.00 | 2,651,950,000.00 |
| Deposit futures investment funds | 20,000,000.00 | |
| Total | 2,570,000,000.00 | 2,651,950,000.00 |
(3) Cash relating to financing activities
Other cash received from financing activities
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Transfer of treasury stock | 518,979,758.90 | |
| Total | 518,979,758.90 |
Other cash payments related to financing activities
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Payment of bank financing fees | 414,172.14 | 245,325.87 |
| Share repurchase | 309,134,899.57 | |
| Total | 414,172.14 | 309,380,225.44 |
Changes in various liabilities generated from financing activities
Applicable □ Not applicable
Unit: RMB Yuan
| Items | Opening balance | Increase in the current period | Decrease in the current period | Closing balance | ||
| Changes in cash | Non-cash changes | Changes in cash | Non-cash changes | |||
| Short-term borrowings | 675,172,682.37 | 901,087,666.65 | 2,248,799.99 | 616,476,871.02 | 962,032,277.99 | |
| Long-term borrowings | 7,351,313,744.78 | 891,300,000.00 | 578,547.48 | 2,328,096,516.47 | 5,915,095,775.79 | |
| Lease liabilities | 3,778,881.39 | 80,936.15 | 1,055,905.95 | 2,803,911.59 | ||
| Dividends payable | 2,456,226,718.40 | 2,456,226,718.40 | ||||
| Total | 8,030,265,308.54 | 1,792,387,666.65 | 2,459,135,002.02 | 5,401,856,011.84 | 6,879,931,965.37 | |
(4) Notes to cash flows reported on a net basis
| Items | Relevant facts and circumstances | Basis for net presentation | Financial impact |
| Other cash receipts relating to investing activities | Redemption of wealth management products and structured deposits | The cash flows related to the Company's investment business involve projects with quick turnover, large amounts, and short terms, covering both cash inflows and outflows. Reporting these cash flows on a net basis better illustrates their impact on the Company's payment and debt repayment capabilities, and is more helpful for evaluating the Company's payment and debt repayment abilities as well as analyzing its future cash flows. Therefore, the Company reports the related cash flows generated from the above business on a net basis. | 4,350,000,000.00 |
| Other Paid Cashes Related to Investment Activities | Purchase of wealth management products and structured deposits | The cash flows related to the Company's investment business involve projects with quick turnover, large amounts, and short terms, covering both cash inflows and outflows. Reporting these cash flows on a net basis better illustrates their impact on the Company's payment and debt repayment capabilities, and is more helpful for evaluating the Company's payment and debt repayment abilities as well as analyzing its future cash flows. Therefore, the Company reports the related cash flows generated from the above businesson a net basis. | 4,350,000,000.00 |
(5) Significant activities that do not involve cash receipts or payments in the current period but affect the enterprise’s financial position or may affect its future cash flows, together with their financial impacts
57. Supplementary information on the cash flow statement
(1) Supplementary Information for Cash Flow Statement
Unit: RMB Yuan
| Supplementary information | Amount of the current period | Amount of the previous period |
| 1. Reconciliation of net profit to cash flows from operating activities | ||
| Net profit | 4,028,047,213.23 | 3,621,495,545.25 |
| Add: provision for impairment of assets | 63,702,079.51 | 25,659,264.43 |
| Depreciation of fixed assets, depletion of oil and gas assets, and depreciation of productive biological assets | 1,121,203,040.00 | 1,115,106,727.67 |
| Depreciation of right-of-use assets | 2,172,801.55 | 1,833,329.36 |
| Amortization of intangible assets | 41,072,610.95 | 37,129,744.10 |
| Amortization of long-term deferred expenses | 3,555,411.78 | 6,793,386.10 |
| Losses on disposal of fixed assets, intangible assets, and other long-term assets (-" for income) | -1,251,350.66 | 1,582,139.69 |
| Loss on retirement of fixed assets (-" for income) | 33,578,711.96 | |
| Losses on changes in fair value (-" for income) | -65,993,991.83 | 106,860,384.44 |
| Financial expenses (-" for income) | 176,262,679.95 | -145,534,087.33 |
| Investment loss (-" for income) | -204,498,489.13 | -18,237,922.39 |
| Decrease in deferred income tax assets (-" for increase) | -3,460,748.24 | -19,028,941.15 |
| Increase in deferred income tax liabilities ( “-” for decrease) | 17,607,209.25 | 8,434,476.83 |
| Decrease in inventory (-" for increase) | -22,662,094.96 | -468,703,390.51 |
| Decrease of operating receivable items (-" for increase) | -708,273,835.15 | -313,836,326.44 |
| Increase in operational payables (-" for decrease) | -840,916,965.27 | -716,826,527.74 |
| Others | ||
| Net cash flows from operating activities | 3,640,144,282.94 | 3,242,727,802.31 |
| 2. Material investing and financing activities not involving cash receipt and payment | ||
| Conversion of debt into capital | ||
| Convertible corporate bonds due within one year | ||
| Fixed assets under finance lease | ||
| 3. Net changes in cash and cash equivalents: | ||
| Ending balance of cash | 7,396,217,771.31 | 5,508,745,188.26 |
| Less: Opening balance of cash | 7,819,707,489.01 | 5,521,452,666.47 |
| Add: Ending balance of cash equivalents | ||
| Less: Opening balance of cash equivalents | ||
| Net increase of cash and cash equivalents | -423,489,717.70 | -12,707,478.21 |
(2) Composition of cash and cash equivalents
Unit: RMB Yuan
| Items | Closing balance | Opening balance |
| I. Cash | 7,396,217,771.31 | 7,819,707,489.01 |
| Including: cash on hand | 9,176.31 | 19,519.80 |
| Bank deposits that can be used for payment at any time | 7,366,196,213.60 | 7,819,579,040.64 |
| Other monetary funds that can be used for payment at any time | 30,012,381.40 | 108,928.57 |
| II. Cash and cash equivalents at the end of the period | 7,396,217,771.31 | 7,819,707,489.01 |
| Including: Cash and cash equivalents with restricted use by the parent company or a subsidiary of the group | 352,187,586.16 | 231,285,799.32 |
(3) Situations where the scope of use is restricted but still listed as cash and cash equivalents
Unit: RMB Yuan
| Items | Amount of the current period | Amount of the previous period | Reasons for still being classified as cash and cash equivalents |
| Cash and bank balances | 352,187,586.16 | 231,285,799.32 | Monetary funds deposited overseas |
| Total | 352,187,586.16 | 231,285,799.32 |
(4) Monetary funds that do not belong to cash and cash equivalents
Unit: RMB Yuan
| Items | Amount of the current period | Amount of the previous period | Reasons for not being classified as cash and cash equivalents |
| Cash and bank balances | 0.00 | 100,143,888.89 | Large-denomination certificates of deposit and interest |
| 12,939,755.86 | 38,900,815.38 | Deposit for bank acceptance | |
| 3,883,550.00 | 4,117,750.00 | Deposit for customs duty | |
| 3,498,310.00 | 1,714,764.00 | Deposit for letter of guarantee | |
| 1,064,122.78 | 1,063,853.85 | Deposit for water charges | |
| 19,750,000.00 | 370,073.49 | Deposit for letters of credit | |
| 1,885.57 | 221,221.57 | Deposit for emission rights | |
| 18,500.00 | 25,500.00 | Deposit for ETC | |
| 0.00 | 4,774.98 | Long-suspended account balance | |
| 852,203.92 | 0.00 | Wage guarantee deposit for project engineering labor | |
| 595,346.15 | 0.00 | futures margin | |
| 19,221,359.13 | 0.00 | Deposit investment funds | |
| 1.00 | 0.00 | Deposit on the Yipaike platform | |
| Total | 61,825,034.41 | 146,562,642.16 |
58. Foreign currency monetary items
(1) Foreign currency monetary items
Unit: RMB Yuan
| Items | Ending foreign currency balance | Converted exchange rate | Converted RMB balance at the end of the period |
| Cash and bank balances | 676,341,424.49 | ||
| Including: USD | 65,896,817.96 | 6.810900 | 448,816,637.44 |
| EUR | 23,283,525.32 | 7.767100 | 180,845,469.51 |
| HKD | 713,076.73 | 0.868550 | 619,342.79 |
| JPY | 61,046,238.00 | 0.042045 | 2,566,689.08 |
| GBP | 131,637.27 | 9.014500 | 1,186,644.17 |
| BRL | 18,637,057.01 | 1.316400 | 24,533,821.85 |
| MXN | 11,609,747.40 | 0.389681 | 4,524,097.98 |
| SGD | 579,851.25 | 5.260500 | 3,050,307.50 |
| PLN | 59,601.43 | 1.812119 | 108,004.88 |
| VND | 15,617,996,522.00 | 0.000259 | 4,045,061.10 |
| TRY | 41,461,018.55 | 0.145808 | 6,045,348.19 |
| Accounts receivable | 2,808,639,410.46 | ||
| Including: USD | 310,989,994.06 | 6.810900 | 2,118,121,750.54 |
| EUR | 60,214,104.15 | 7.767100 | 467,688,968.34 |
| GBP | 2,334,216.66 | 9.014500 | 21,041,796.08 |
| BRL | 152,585,309.56 | 1.316400 | 200,863,301.50 |
| VND | 3,566,000,000.00 | 0.000259 | 923,594.00 |
| Other receivables | 68,211,100.95 | ||
| Including: USD | 61,391.05 | 6.810900 | 418,128.30 |
| EUR | 2,150,120.44 | 7.767100 | 16,700,200.47 |
| HKD | 31,700.00 | 0.868550 | 27,533.04 |
| JPY | 16,946,280.00 | 0.042045 | 712,506.34 |
| BRL | 6,506,107.03 | 1.316400 | 8,564,639.29 |
| MXN | 106,216,788.06 | 0.389681 | 41,390,664.19 |
| SGD | 54,721.20 | 5.260500 | 287,860.87 |
| PLN | 3,174.11 | 1.812119 | 5,751.87 |
| VND | 27,000,000.00 | 0.000259 | 6,993.00 |
| TRY | 664,048.47 | 0.145808 | 96,823.58 |
| Short-term borrowings | 26,456,085.80 | ||
| Including: USD | 2,433,496.64 | 6.810900 | 16,574,302.27 |
| EUR | 1,119,654.57 | 7.767100 | 8,696,469.01 |
| DKK | 1,140,628.13 | 1.039177 | 1,185,314.52 |
| Accounts payable | 445,671,030.02 | ||
| Including: USD | 6,908,520.90 | 6.810900 | 47,053,245.00 |
| EUR | 27,454,483.52 | 7.767100 | 213,241,718.95 |
| JPY | 754,795.00 | 0.042045 | 31,735.36 |
| BRL | 137,267,171.72 | 1.316400 | 180,698,504.85 |
| MXN | 8,065,337.45 | 0.389681 | 3,142,908.76 |
| DKK | 29.40 | 1.039177 | 30.55 |
| CHF | 50,880.60 | 8.422799 | 428,557.07 |
| VND | 3,014,215,124.00 | 0.000259 | 780,681.72 |
| TRY | 2,013,934.52 | 0.145808 | 293,647.76 |
| Other payables | 46,646,134.31 | ||
| Including: USD | 3,712,670.89 | 6.810900 | 25,286,630.16 |
| EUR | 2,632,198.90 | 7.767100 | 20,444,552.08 |
| HKD | 41,079.00 | 0.868550 | 35,679.17 |
| BRL | 546,000.00 | 1.316400 | 718,754.40 |
| SGD | 18,682.68 | 5.260500 | 98,280.24 |
| PLN | 9,631.13 | 1.812119 | 17,452.75 |
| CHF | 2,969.00 | 8.422799 | 25,007.29 |
| VND | 6,281,136.00 | 0.000259 | 1,626.81 |
| TRY | 124,488.43 | 0.145808 | 18,151.41 |
| Long-term borrowings | 7,366,283.15 | ||
| Including: USD | |||
| EUR | 948,395.56 | 7.767100 | 7,366,283.15 |
| HKD | |||
| Non-current liabilities that mature within one year | 7,844,476.39 | ||
| Including: USD | 12,799.73 | 6.810900 | 87,177.68 |
| EUR | 961,662.00 | 7.767100 | 7,469,324.92 |
| HKD | 106,563.99 | 0.868550 | 92,556.15 |
| BRL | 148,448.53 | 1.316400 | 195,417.64 |
(2) Explanation of overseas operating entities, including for important overseas operating entities, the main overseas operating places, bookkeeping base currency and selection basis shall be disclosed, and the reasons for changes in bookkeeping base currency shall also be disclosed.
Applicable Not applicable
59. Lease
(1) The Company acts as the lessee
Applicable □ Not applicable
Variable lease payments not included in the measurement of lease liabilities
□ Applicable Not applicable
Lease expenses for simplified treatment of short-term leases or low-value asset leases
Applicable □ Not applicable
1) For related information on right-of-use assets, see Note 13 of Section VII of the financial report.
2) The details on accounting policies for short-term leases and low-value asset leases of the Company are set out in Note 29 of Section V of this financial report. The amounts of short-term lease expenses and low-value asset lease expenses recognized in the current profit or loss are as follows:
Unit: RMB Yuan
| Items | Amount of the current period | Amount at the same period last year |
| Short-term lease expenses | 2,502,954.96 | 865,262.56 |
| Total | 2,502,954.96 | 865,262.56 |
3) Profit or loss of the current period, and cash flows related to the lease
Unit: RMB Yuan
| Items | Amount of the current period | Amount at the same period last year |
| Interest charges on lease liabilities | 70,338.10 | 65,137.59 |
| Total cash outflows related to the leases | 3,265,314.23 | 1,795,192.45 |
4) For the analysis of the maturity profile of lease liabilities and the related liquidity risk management, see Note 1 of item XII of the financial report.
(2) The Company acts as the lessor
Operating lease as a lessor
Applicable □ Not applicable
Unit: RMB Yuan
| Items | Lease income | Including: Income related to variable lease payments not included in rental receipts |
| Lease income | 2,981,065.53 | |
| Total | 2,981,065.53 |
Financial lease as a lessor □ Applicable Not applicable
Undiscounted lease receipts for each of the next five years
Applicable □ Not applicable
Unit: RMB Yuan
| Items | Undiscounted lease receipts for each year | |
| Closing balance | Opening balance | |
| First Year | 1,880,218.11 | 1,371,619.12 |
| Second Year | 623,853.21 | |
| Third Year | 293,577.98 | |
| Total undiscounted lease receipts after five years | 1,880,218.11 | 2,289,050.31 |
(3) Profit or loss on sales of finance leases recognized as a producer or distributor
Applicable ☑ Not applicable
VIII. Research and development expenses
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Employee compensation | 254,986,435.45 | 243,369,740.34 |
| Direct input | 273,425,309.24 | 194,855,941.97 |
| Depreciation expense and amortization of intangible assets | 43,724,074.06 | 45,699,299.17 |
| Outsourcing expenses | 8,883,018.87 | 7,801,144.90 |
| Office expenses and travel expenses | 224,352.55 | 4,910,364.40 |
| Others | 24,484,887.47 | 26,087,072.40 |
| Total | 605,728,077.64 | 522,723,563.18 |
| Including: expensed R&D expenditures | 605,728,077.64 | 522,723,563.18 |
IX. Changes in the scope of consolidation
1. Changes in the scope of consolidation due to other reasons
Explain changes in the scope of consolidation caused by other reasons (for example, newly established subsidiaries, liquidated subsidiaries, etc.) and the related details:
(1) Increase in the scope of consolidation
| Name of companies | Equity acquisition method | Equity acquisition date | Capital contribution | Capital contribution proportion (%) |
| NHU Life Science North America LLC | Establishment | January 28, 2026 | USD 150,000 | 100.00% |
(2) Decrease of consolidation scope
| Name of companies | Equity disposal method | Equity acquisition date | Disposal of daily net assets | Disposal of daily net profit |
| Shandong Xinshuang'an Biotechnology Co., Ltd. | Deregistration | January 30, 2026 | RMB 98,918.40 | RMB -67.99 |
X. Interests in other entities
1. Interests in subsidiaries
(1) Composition of enterprise group
| Name of subsidiary | Registered capital | Main place of business | Registration place | Business nature | Holding proportion | Acquisition method | |
| Direct | Indirect | ||||||
| NHU (Hong Kong) Trading Co., Ltd. | USD2,400,000.00 | Hong Kong, China | Hong Kong, China | Business | 100.00% | Establishment | |
| Shandong NHU Amino-acids Co., Ltd. | RMB1,100,000,000.00 | Weifang, Shandong | Weifang, Shandong | Manufacturing industry | 100.00% | Establishment | |
List significant subsidiaries; the materiality criteria are set out in Note 5 of Section V of the financial report.
2. Rights and interests in joint ventures or associates
(1) Summary financial information of insignificant (immaterial) joint ventures or associates
Unit: RMB Yuan
| Items | Ending balance/amount incurred in current period | Beginning balance/amount incurred in previous period |
| Joint ventures: | ||
| Total carrying amount of investment | 564,951,849.04 | 418,125,357.72 |
| The total of the following items calculated according to the shareholding ratio | ||
| --Net profit | 145,667,271.39 | -15,076,323.59 |
| --Total comprehensive income | 145,667,271.39 | -15,076,323.59 |
| Associates: | ||
| Total carrying amount of investment | 568,684,576.58 | 547,225,191.71 |
| The total of the following items calculated according to the shareholdingratio | ||
| --Net profit | 40,676,371.27 | 38,312,710.19 |
| --Total comprehensive income | 40,676,371.27 | 38,312,710.19 |
XI. Government subsidies
1. Government subsidies recognized based on receivable amounts at the end of the reporting period
□ Applicable Not applicable
Reasons for not receiving the expected amount of government subsidies at the anticipated time
□ Applicable Not applicable
2. Liability items involving government subsidies
Applicable □ Not applicable
Unit: RMB Yuan
| Accounting items | Opening balance | Amount of new subsidies in the current period | Amount included in non-operating revenue of the current period | Amount transferred in other income in the current period | Other variations in the current period | Closing balance | Asset-related/income-related |
| Deferred income | 899,431,748.59 | 25,128,500.00 | 81,533,952.31 | 843,026,296.28 | Asset-related | ||
| 6,576,000.00 | 1,398,784.26 | 5,177,215.74 | Related to income | ||||
| Total | 906,007,748.59 | 25,128,500.00 | 82,932,736.57 | 848,203,512.02 |
3. Government subsidies included in current profit and loss
Applicable □ Not applicable
Unit: RMB Yuan
| Accounting items | Amount incurred in the current period | Amount incurred in the previous period |
| Government grants included in other income | 118,946,795.94 | 120,279,254.44 |
XII. Risks related to financial instruments
1. Various types of risks arising from financial instruments
The Company's major financial instruments include cash and cash equivalents, notes receivable, accounts receivable, receivables financing, other receivables, other current assets, financial assets held for trading, investments in other equity instruments, notes payable, accounts payable, other payables, short-term borrowings, financial liabilities held for trading, non-current liabilities due within one year, long-term borrowings, and lease liabilities. Detailed information on the various financial instruments has been disclosed in the related notes. Risks related to the financial instruments and the Company’s risk management policy used for reducing these risks are described as follows. The Company’s management governs and monitors these exposures to ensure that these risks are controlled within the limited scope.
(1) Risk management goals and policies
The main risks arising from the Company's financial instruments are credit risk, liquidity risk, and market risk (including exchange rate risk, interest rate risk, and commodity price risk).
The Company’s risk management aims to reach proper balance between risks and benefits, to minimize the negative impact of risks on the Company's operating results, and to maximize the interests of shareholders and other equity investors. Based on these risk management goals, the Company’s basic strategy for risk management is to determine and analyze various risks faced by the Company, establish an appropriate risk tolerance bottom line and conduct risk management, and supervise various risks in a timely and reliable manner to control the risks within a limited scope.
The Company has formulated risk management policies to identify and analyze the risks it faces. These risk management policies clearly specify particular risks and cover a wide range of areas, including market risk, credit risk, and liquidity risk management. The Company regularly assesses changes in the market environment and in its operating activities to determine whether to update its risk management policies and systems. The Company's Internal Audit Department conducts periodic reviews of risk management controls and procedures, and reports the review results to the Audit Committee of the Company.
The Company manages financial instrument risks by appropriately diversifying its investments and business portfolio. It also mitigates risks concentrated in a single industry, specific region, or particular counterparty by implementing targeted risk management policies.
1) Credit risk
Credit risk refers to the risk that a counterparty's failure to perform its contractual obligations will cause the Company to incur financial loss.
The Company oversees credit risk through the classification of its portfolio. Credit risk mainly arises from bank deposits, notes receivable, accounts receivable, and other receivables.
The Company's bank deposits are primarily held with reputable financial institutions that have high credit ratings. The Company expects that there are no significant credit risks associated with these bank deposits.
For notes receivable, accounts receivable, and other receivables, the Company has established policies to control credit risk exposure. The Company assesses customers' creditworthiness based on their financial condition, credit records, and other factors, such as current market conditions, and sets the corresponding credit terms accordingly. The Company will regularly monitor customers' credit records. For those with less favorable credit records, the Company will implement measures such as sending written collection notices, reducing credit terms, or discontinuing credit arrangements to maintain overall credit risk within manageable limits.
The debtors of the Company's accounts receivable are customers distributed across different industries and regions. The Company continuously assesses the creditworthiness of accounts receivable and, when appropriate, purchases credit guarantee insurance.
The maximum credit risk exposure of the Company is the carrying amount of the financial assets in the balance sheet. The Company has not provided any other guarantees that could potentially expose it to credit risk.
Accounts receivable from the top five customers represented 19.54% of the Company’s total accounts receivable (compared to 18.51% in 2025). Additionally, other receivables from the top five companies accounted for 86.32% of the Company’s total other receivables (compared to 83.54% in 2025).
2) Liquidity risk
Liquidity risk refers to the risk of shortage of funds when the Company fulfills its obligation to settle by delivering cash or other financial assets.
When managing liquidity risk, the Company maintains and monitors cash and cash equivalents the management deem sufficient to meet the Company's operating needs and to reduce the impact of cash flow fluctuations. To control such risk, the Company applies various financing methods, such as bill settlement and bank loans, in appropriate combination of long-term and short-term financing ways to optimize the financing structure and keep the balancing between financing sustainability and flexibility. The Company has obtained lines of credit from several commercial banks to satisfy its working capital demand and capital expenditure. As of the end of the period, the Company’s financial liabilities are categorized based on the maturities of the undiscounted remaining contractual cash flows as follows (Unit: RMB Yuan):
| Items | Closing balance | |||
| Within one year | One to three years | Three years or more | Total | |
| Financial liabilities: | ||||
| Bank loans | 3,334,376,783.83 | 3,082,434,213.49 | 676,313,419.45 | 7,093,124,416.77 |
| Notes payable | 43,197,229.37 | 43,197,229.37 | ||
| Accounts payable | 1,889,531,581.58 | 1,889,531,581.58 | ||
| Other payables | 96,098,501.09 | 96,098,501.09 | ||
| Lease liabilities | 496,124.73 | 714,285.69 | 2,652,285.72 | 3,862,696.14 |
| Total financial liabilities | 5,363,700,220.60 | 3,083,148,499.18 | 678,965,705.17 | 9,125,814,424.95 |
At the end of the previous year, the Company’s financial liabilities are categorized based on the maturities of the undiscounted remaining contractual cash flows as follows (Unit: RMB Yuan):
| Items | Balance at the end of the previous year | |||
| Within one year | One to three years | Three years or more | Total | |
| Financial liabilities: | ||||
| Bank loans | 3,980,899,147.47 | 3,784,283,730.64 | 536,333,678.12 | 8,301,516,556.23 |
| Notes payable | 70,054,101.63 | 70,054,101.63 | ||
| Accounts payable | 1,780,307,765.08 | 1,780,307,765.08 | ||
| Other payables | 131,685,145.99 | 131,685,145.99 | ||
| Lease liabilities | 1,421,784.44 | 714,285.72 | 2,652,285.72 | 4,788,355.88 |
| Total financial liabilities | 5,964,367,944.61 | 3,784,998,016.36 | 538,985,963.84 | 10,288,351,924.81 |
The financial liabilities presented in the table above represent undiscounted contractual cash flows and may therefore differ from the carrying amounts reported on the balance sheet.
3) Market risk
Market risk of financial instruments refers to the risk that the fair value or future cash flow of financial instruments will fluctuate due to market price changes, including interest rate risk, exchange rate risk and other price risks.
① Interest rate risk
Interest rate risk refers to the risk that the fair value or future cash flow of financial instruments will fluctuate due to changes in market interest rates. Interest rate risk can arise from both recognized interest-bearing financial instruments and unrecognized instruments, such as certain loan commitments.
The Company's interest rate risk arises primarily from long-term bank loans and other long-term interest-bearing debts. Floatingrate financial liabilities expose the Company to cash flow interest rate risk, while fixed-rate financial liabilities expose the Company to fair value interest rate risk. The Company determines the relative proportions of fixed-rate and floating-rate contracts based on the prevailing market conditions at the time, and maintains an appropriate portfolio of fixed and floating rate instruments through regular reviews and monitoring.
The Company closely monitors the effects of interest rate fluctuations on its overall interest rate risk. The Company has not yet implemented a formal interest rate hedging policy. However, management is responsible for monitoring interest rate risk and will consider hedging significant interest rate risks as necessary. An increase in interest rates will raise the cost of newly incurred interest-bearing debts and the Company's outstanding interest expenses on floating-rate interest-bearing debts, significantly adversely affecting the Company's financial performance. Management will make timely adjustments based on the latest market conditions, which may include arrangements for interest rate swaps to reduce interest rate risk.
As of June 30, 2026, the Company's bank borrowings bearing interest at floating rates amounted to RMB 5,011,708,469.43 (December 31, 2025: RMB 5,685,241,467.24). Assuming other variables remain constant, an interest rate change of 50 basis points would not have a material impact on the Company's total profit and shareholders' equity.
For financial instruments held at the balance sheet date that expose the Company to fair value interest rate risk, the effects on net profit and shareholders' equity in the above sensitivity analysis assume a change in interest rates at the balance sheet date and reflect the impact of remeasuring those financial instruments using the new rates. For floating-rate non-derivative instruments held as of the balance sheet date that expose the Company to cash flow interest rate risk, the impact on net profit and shareholders equity shown in the sensitivity analysis reflects the estimated annual effect of the specified interest rate changes on interest expense or income. The analysis for the previous year was based on the same assumptions and methods.
② Exchange rate risk
Exchange rate risk refers to the risk that the fair value or future cash flow of financial instruments will fluctuate due to the change of foreign exchange rate. Exchange rate risk can occur with financial instruments that are denominated in currencies different from the functional currency.
The Company's principal operations are located in China, and its primary business is settled in RMB. However, the foreigncurrency assets and liabilities already recognized by the Company and future foreign-currency transactions (the currencies in which such foreign-currency assets, liabilities and transactions are denominated are primarily the U.S. dollar, the euro and the Japanese yen) continue to be exposed to foreign exchange risk.
For details of the Company's foreign-currency monetary assets and liabilities at the end of the reporting period, see Note 58 of Section VII of the financial report.
The Company closely monitors the impact of exchange rate fluctuations on its exchange rate risk. The Company consistently monitors the volume of the Group's foreign currency transactions, as well as its foreign currency assets and liabilities, to effectively manage and minimize foreign exchange risk. To mitigate this risk, the Company may engage in forward foreign exchange contracts or currency swap agreements as hedging strategies.
③ Other price risks
Other price risk refers to the risk of volatility resulting from market price fluctuations beyond exchange rate and interest rate risks. These fluctuations may stem from factors specific to individual financial instruments or their issuers, as well as from factors affecting all comparable financial instruments traded in the market. Other price risks may arise from changes in commodity prices, stock market indices, equity instrument prices, and other risk variables.
The Company closely monitors the impact of price fluctuations on the price risk of its investments in equity securities. Management is responsible for monitoring other price risks and will, if necessary, consider maintaining a diversified portfolio of equity securities to mitigate the price risk associated with equity investments.
2. Hedging
(1) The Company conducts hedging activities for risk management.
Applicable □ Not applicable
1) During this period, the Company carried out foreign exchange hedge activities, using forward foreign exchange contracts and other derivative contracts as hedge instruments; some of the expected foreign-currency cash flows related to anticipated purchase and sale transactions were designated as the hedged items, in order to mitigate the risk that fluctuations in foreign exchange market prices would cause variability in the Company's expected future cash flows from those anticipated purchases and sales.
2) During this period, the Company conducted foreign exchange hedge transactions, using derivative contracts such as forward foreign exchange contracts as hedging instruments, and designated certain foreign currency deposits as hedged items, thereby mitigating the risk the Company bears of fluctuations in its existing foreign currency deposits due to movements in foreign exchange market prices.
3) During this period, the Company carried out raw material futures hedging business, using raw material futures contracts as hedging tools to cope with fluctuations in bulk raw material prices and ensure business stability.
(2) The Company conducts qualified hedging activities and applies hedge accounting.
Applicable Not applicable
(3) The Company engages in hedging activities for risk management purposes and expects to achieve its risk management objectives, but has not applied hedge accounting.
Applicable Not applicable
| Items | Reasons for not applying hedge accounting | Impact on financial statements |
| Foreign exchange swap contract | The Company widely uses foreign exchange forward contracts and other instruments globally to manage foreign exchange risk related to the conversion between currencies such as the USD, EUR, RMB, and JPY. Because there is a certain offsetting relationship in exchange rate fluctuations between different currencies, this can to some extent achieve the same effect as hedge accounting; therefore, hedge accounting has not been applied. | Derivative financial assets: RMB 29,965,130.86Derivative financial liabilities: RMB 633,860.90Investment income: RMB 35,495,335.97Income from changes in fair value: RMB 60,205,247.49 |
| Raw material futures contracts | The Company continuously purchase or sell, dynamically adjust futures positions, and manage the overall net risk exposure, rather than individual, identifiable hedged items. The standard requires a formal written designation of the corresponding relationship between the hedging instrument and the specific hedged item at the beginning of the hedging process. Rolling, batch, and combination exposures are difficult to match on a transaction by transaction basis, making it impossible to complete thedesignation of the hedging relationship. | Investment income: RMB -182,990.00Income from changes in fair value: RMB -1,029,440.00 |
3. Financial assets
(1) Classification of transfer method
Applicable □ Not applicable
Unit: RMB Yuan
| Transfer method | Nature of transferred financial assets | Amount of transferred financial assets | Derecognition situation | Basis for determining derecognition |
| Notes endorsed, discount | Receivables financing | 1,346,436,608.90 | Recognition terminated | It has transferred almost all of its risks and rewards |
| Total | 1,346,436,608.90 |
(2) Financial assets with termination of recognition due to transfer
Applicable □ Not applicable
Unit: RMB Yuan
| Items | Transfer method of financial assets | Amount of financial assets with termination of recognition | Gains or losses related to termination recognition |
| Receivables financing | Endorsement and discount | 1,346,436,608.90 | -267,359.89 |
| Total | 1,346,436,608.90 | -267,359.89 |
(3) Transferred financial assets with continuing involvement
Applicable Not applicable
XIII. Disclosure of fair value
1. The ending fair value of assets and liabilities measured at fair value
Unit: RMB Yuan
| Items | Ending fair value | |||
| The first level of fair value measurement | The second level of fair value measurement | The third level of fair value measurement | Total | |
| I. Continuous fair value measurement | -- | -- | -- | -- |
| (I) Trading financial assets | 2,583,641,120.21 | 2,583,641,120.21 | ||
| 1. Financial assets measured at fair value through profit and loss | 2,583,641,120.21 | 2,583,641,120.21 | ||
| (1) Derivative financial assets | 29,965,130.86 | 29,965,130.86 | ||
| (2) Structured deposits | 2,553,675,989.35 | 2,553,675,989.35 | ||
| (II) Receivables financing | 920,577,788.17 | 920,577,788.17 | ||
| (III) Other equity instrument investments | 22,446,147.55 | 22,446,147.55 | ||
| Total amount of assets measured at fair value on a continuous basis | 2,583,641,120.21 | 943,023,935.72 | 3,526,665,055.93 | |
| (IV) Trading financial liabilities | 1,663,300.90 | 1,663,300.90 | ||
| Including:derivative financial liabilities | 1,663,300.90 | 1,663,300.90 | ||
| Total amount of liabilities measured at fair value on a continuous basis | 1,663,300.90 | 1,663,300.90 | ||
| II. Non-recurring Fair Value Measurements | -- | -- | -- | -- |
2. Qualitative and quantitative information on the valuation techniques and important parameters used in recurring and non-recurring second-level fair value measurement items
The derivative financial assets measured at second-level fair value held by the Company are forward foreign exchange contracts. The Company determines their fair value by discounting to present value the difference between the contractual settlement exchange rate specified in the forward foreign exchange contracts and the market forward exchange quotation at the balance sheet date, using the expected yield
3. Qualitative and quantitative information on the valuation techniques and important parameters used in recurring and non-recurring third-level fair value measurement items
(1) The Company's receivables financing measured at fair value using third-level inputs consists of bank acceptance bills, which have low credit risk and short remaining maturities, and the Company determines their fair value based on their face value.
(2) The other equity instrument investments measured at fair value through third-level held by the Company are equity interests in non-listed companies. For investments in unlisted equity instruments, the Company comprehensively considers the use of the market approach, the discounted cash flow method and other methods to estimate fair value. If the operating environment, operating conditions, and financial condition of the investee Zhejiang Second Pharma Co., Ltd. and Shanghai NewMargin Yongjin Equity Enterprise (Limited Partnership) have not undergone significant changes, the Company measures the investments at cost as a reasonable estimate of fair value. The investee, Shanghai NewMargin Yongjin Equity Enterprise (Limited Partnership), is measured at a reasonable estimate of fair value based on the audited fund report.
XIV. Related parties and related transactions
1. Information about the parent company of the Company
| Parent company name | Registration place | Business nature | Registered capital | Shareholding ratio of parent company to the Company | Proportion of parent company's voting rights to the Company |
| NHU Holding Group Co., Ltd. | Xinchang, Zhejiang | Manufacturing industry | RMB 120,000,000 | 50.08% | 50.08% |
Explanation of the parent company of the Company: The ultimate controller of the enterprise is Hu Baifan.
2. Information on subsidiaries of the Company
Details of the Company's subsidiaries are set out in Note 3(1) of Section XVIII of the financial report.
3. Information on joint ventures and associates of the Company
Details of the Company's joint ventures and associates are set out in Note 10 of Section VII of the financial report.
Information about other joint ventures or associates that have related transactions with the Company in the current period, or have a balance resulting from related transactions with the Company in the previous period is as follows:
| Name of joint ventures and associates | Relationship with the Company |
| Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | Joint ventures of the Company |
| Zhejiang Chunhui Environmental Protection Energy Co., Ltd. | Associates of the Company |
| Envalior NHU Engineering Materials (Zhejiang) Co., Ltd. | Associates of the Company |
| Zhejiang Saiya Chemical Materials Co., Ltd. | Associates of the Company |
| CysBio ApS | Associates of the Company |
| Shandong Bin'an Vocational Training School Co., Ltd. | Associates of the Company |
| Anhui Yingna Weixun Technology Co., Ltd. | Associates of the Company |
4. Information of other related parties
| Name of other related parties | Relationship between other related parties and the Company |
| Beijing Front Pharma CO., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Zhejiang Asen Pharmaceutical Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Zhejiang Deli Equipment Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Fuyuan Pharmaceutical Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Weifang Hecheng Real Estate Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Qionghai Heyue Property Service Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Qionghai Boao Heyue Hotel Management Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Shaoxing Heyue Property Services Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Zhejiang Jingshi Real Estate Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Shaoxing Yuexiu Education Development Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Shaoxing Jinghe Hotel Management Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Shaoxing Shangyu Hecheng Real Estate Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Zhejiang Yuexiu University | Under the common control of NHU Holding Group Co., Ltd. |
| Changbai Mountain Protection and Development Zone Heyue Real Estate Development Co., Ltd. | Under the common control of NHU Holding Group Co., Ltd. |
| Heilongjiang Haotian Corn Development Co., Ltd. | Minority shareholders of subsidiaries |
| Beijing Front Pharma CO., Ltd. Cangzhou Branch | Branch of Beijing Front Pharma CO., Ltd. |
| Shaoxing Heyue Property Services Co., Ltd. Shangyu Branch | Branch of Shaoxing Heyue Property Services Co., Ltd. |
Other remarks:
Customer II holds 25% equity in NHU EUROPE GMBH, a subsidiary controlled by the Company's subsidiary NHU Singapore Pte. Ltd. As a precaution, the Company discloses the transactions and outstanding balances between Customer II and the subsidiary NHU EUROPE GMBH in the related party transaction section.
5. Related party transactions
(1) Related transactions for the purchase and sale of goods and the provision and receipt of services
Statement of purchases of goods and acceptance of services(I)
Unit: RMB Yuan
| Related parties | Related transaction content | Amount incurred in the current period | Approved transaction limit | Exceed the transaction limit or not | Amount incurred in the previous period |
| Zhejiang Saiya Chemical Materials Co., Ltd. | Purchasing goods | 125,930,371.86 | 230,000,000.00 | No | 111,801,148.68 |
| Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | Purchasing goods | 337,883,700.13 | 793,000,000.00 | No | |
| Zhejiang Deli Equipment Co., Ltd. | Purchasing goods | 74,531,732.72 | 177,000,000.00 | No | 8,320,553.16 |
| Shaoxing Jinghe Hotel Management Co., Ltd. | Catering and accommodation services | 680,858.69 | 3,450,000.00 | No | 764,004.04 |
| Shaoxing Heyue Property Services Co., Ltd. Shangyu Branch | Property management services | 285,498.80 | 188,264.15 | ||
| Qionghai Boao Heyue Hotel Management Co., Ltd. | Catering and accommodation services | 16,193.00 | 2,288.00 | ||
| Zhejiang Asen Pharmaceutical Co., Ltd. | Purchasing goods | 115,126.59 | 54,785.84 | ||
| Fuyuan Pharmaceutical Co., Ltd. | Purchasing goods | 4,500.00 | |||
| Total | 539,447,981.79 | 1,203,450,000.00 | 121,131,043.87 |
Statement of purchases of goods and acceptance of services(II) Unit: RMB Yuan
| Related parties | Related transaction content | Amount incurred in the current period | Amount incurred in the previous period |
| Zhejiang Chunhui Environmental Protection Energy Co., Ltd. | Purchase of steam | 57,863,728.41 | 48,597,383.90 |
| Acceptance of services | 2,036,000.79 | 437,189.89 | |
| Heilongjiang Haotian Corn Development Co., Ltd. | Purchasing goods | 56,008,761.63 | 20,125,109.65 |
| CysBio ApS | Consulting service fee | 427,405.68 | |
| Shandong Bin'an Vocational Training School Co., Ltd. | Training fees | 366,801.88 | 56,940.57 |
| Total | 116,702,698.39 | 69,216,624.01 |
Statement of sales of goods/provision of services Unit: RMB Yuan
| Related parties | Related transaction content | Amount incurred in the current period | Amount incurred in the previous period |
| Envalior NHU Engineering Materials (Zhejiang) Co., Ltd. | Sales of goods | 55,352,733.90 | 74,760,442.59 |
| Hazardous waste disposal fee | 5,676.60 | 4,961.85 | |
| Water and electricity charges | 801,907.38 | 857,110.29 | |
| Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | Sales of goods | 2,484,792.93 | |
| Provision of services | 465,000.00 | ||
| Fuyuan Pharmaceutical Co., Ltd. | Sales of goods | 1,409,292.04 | 398,230.09 |
| Zhejiang Deli Equipment Co., Ltd. | Sales of goods | 589,492.03 | |
| Heilongjiang Haotian Corn Development Co., Ltd. | Steam sales | 4,425,024.13 | |
| Zhejiang Second Pharma Co., Ltd. | Sales of goods | 2,814.16 | |
| Beijing Front Pharma CO., Ltd. | Testing fee | 1,654,867.23 | 391,509.43 |
| Beijing Front Pharma CO., Ltd. Cangzhou Branch | Provision of services | 75,471.70 | |
| Testing fee | 171,698.11 | ||
| Subtotal | 63,899,485.25 | 79,951,539.21 |
(2) Related‑party lease information
The Company acts as the lessor:
Unit: RMB Yuan
| Name of lessee | Types of leased assets | Lease income recognized in current period | Lease income recognized in last period |
| Envalior NHU Engineering Materials (Zhejiang) Co., Ltd. | Land use right and buildings | 549,803.22 | 316,724.37 |
| Zhejiang Jingshi Real Estate Co., Ltd. | Land use right and buildings | 112,171.26 | 69,357.80 |
| NHU Holding Group Co., Ltd. | Land use right and buildings | 13,400.92 | 13,400.92 |
| Weifang Hecheng Real Estate Co., Ltd. | Land use right and buildings | 5,142.86 | 5,142.86 |
The Company acts as the lessee:
Unit: RMB Yuan
| Name of lessor | Types of leased assets | Lease expenses for short- term leases and leases of low- value assets accounted for using the simplified approach (if applicable) | |
| Amount incurred in the current period | Amount incurred in the previous period | ||
| NHU Holding Group Co., Ltd. | Land use right and buildings | 342,290.74 | |
(3) Remuneration of key management personnel
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Remuneration of key management personnel | 7,637,102.36 | 7,181,369.40 |
(4) Other related‑party transactions
During this period, the subsidiary NHU EUROPE GMBH sold goods to Customer II in the amount of RMB 112,830,549.16; the accounts receivable balance at the end of the period was RMB 56,155,303.71.
6. Receivables and payables of related parties
(1) Accounts receivable
Unit: RMB Yuan
| Project name | Related parties | Closing balance | Opening balance | ||
| Book balance | Bad-debt provision | Book balance | Bad-debt provision | ||
| Accounts receivable | Envalior NHU Engineering Materials (Zhejiang) Co., Ltd. | 42,708,999.02 | 2,135,449.95 | 47,131,641.33 | 2,356,582.07 |
| Heilongjiang Haotian Corn Development Co., Ltd. | 978,120.00 | 48,906.00 | |||
| Subtotal | 43,687,119.02 | 2,184,355.95 | 47,131,641.33 | 2,356,582.07 | |
| Other receivables | Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | 2,514,698.55 | 125,734.93 | ||
| Other receivables | Zhejiang Chunhui Environmental Protection Energy Co., Ltd. | 20,000.00 | 4,000.00 | 20,000.00 | 4,000.00 |
| Subtotal | 20,000.00 | 4,000.00 | 2,534,698.55 | 129,734.93 | |
| Other non-current assets | Zhejiang Deli Equipment Co., Ltd. | 1,377,500.00 | 67,685,510.00 | ||
| Subtotal | 1,377,500.00 | 67,685,510.00 | |||
(2) Payable items
Unit: RMB Yuan
| Project name | Related parties | Closing book balance | Opening balance |
| Accounts payable | Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | 369,696,529.64 | 237,385,884.16 |
| Zhejiang Chunhui Environmental Protection Energy Co., Ltd. | 11,649,326.70 | 12,472,492.16 | |
| Zhejiang Deli Equipment Co., Ltd. | 15,219,814.90 | 10,680,005.30 | |
| CysBio ApS | 1,023,018.50 | ||
| Heilongjiang Haotian Corn Development Co., Ltd. | 863,384.97 | 575,475.87 | |
| Zhejiang Saiya Chemical Materials Co., Ltd. | 82,985,135.06 | 258,119.47 | |
| Zhejiang Second Pharma Co., Ltd. | 6,408.00 | 6,408.00 | |
| Subtotal | 480,420,599.27 | 262,401,403.46 | |
| Contract liabilities (tax-inclusive) | Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | 125,660,377.36 | 223,396,226.42 |
| Zhejiang Deli Equipment Co., Ltd. | 14,700.89 | ||
| Subtotal | 125,675,078.25 | 223,396,226.42 | |
| Other payables | Zhejiang Deli Equipment Co., Ltd. | 3,740.00 | |
| Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | 1,650.00 | ||
| Shaoxing Jinghe Hotel Management Co., Ltd.Wanyi Branch | 110,500.96 | ||
| Subtotal | 110,500.96 | 5,390.00 | |
| Total | 606,206,178.48 | 485,803,019.88 |
XV. Commitments and Contingencies
1. Important commitments
Significant commitments existing at the balance sheet date
(1) Forward foreign exchange contracts
According to the ISDA 2002 MASTER AGREEMENT signed with Bank of China (Hong Kong) Limited, the ISDA 2002 MASTER AGREEMENT signed with DBS Bank (China) Limited, the Global Capital Markets Transactions and related transaction application forms signed with HSBC Bank (China) Company Limited, Hangzhou Branch, the Zheshang Bank Customer Foreign Exchange Trading Master Agreement signed with China Zheshang Bank Co., Ltd., Shanghai Branch, and the NAFMII Master Agreement and supplementary agreement (No. Y161136) signed with Bank of China Limited, Zhejiang Branch, as of June 30, 2026, the Company's outstanding forward foreign exchange contracts that have not been settled are as follows:
| Currency | Forms of foreign exchange settlement and sale | Notional amount | Agreed exchange rate range | Weighted average agreed exchange rate | Settlement month |
| USD | Foreign exchange settlement | 156,393,697.10 | 6.7375 - 6.7956 | 6.7740 | July 2026 |
| Foreign exchange settlement | 111,729,039.61 | 6.7252 - 6.7880 | 6.7632 | August 2026 | |
| Foreign exchange settlement | 76,087,494.70 | 6.7130 - 6.7710 | 6.7298 | September 2026 | |
| Foreign exchange settlement | 56,535,590.06 | 6.6980 - 6.7510 | 6.7325 | October 2026 | |
| Foreign exchange settlement | 30,973,552.25 | 6.6830 - 6.7415 | 6.7237 | November 2026 | |
| Foreign exchange settlement | 15,528,220.24 | 6.6786 - 6.7226 | 6.6991 | December 2026 | |
| Foreign exchange settlement | 18,480,000.00 | 6.7035 - 6.7045 | 6.7038 | January 2027 | |
| EUR | Foreign exchange settlement | 26,526,000.00 | 7.8790 - 8.0110 | 8.0004 | July 2026 |
| Foreign exchange settlement | 46,838,600.00 | 7.8360 - 8.0243 | 7.9934 | August 2026 | |
| Foreign exchange settlement | 3,005,200.00 | 7.7240 - 7.8696 | 7.8389 | September 2026 | |
| Foreign exchange settlement | 6,580,900.00 | 7.7150 - 7.9100 | 7.8008 | October 2026 | |
| Foreign exchange settlement | 11,607,600.00 | 7.7862 - 7.8531 | 7.8345 | November 2026 | |
| Foreign exchange settlement | 23,022,600.00 | 7.7005 - 7.8940 | 7.8471 | December 2026 | |
| Foreign exchange settlement | 18,022,700.00 | 7.6855 - 7.8375 | 7.7639 | January 2027 |
(2) Issued letters of guarantee not yet expired As of June 30, 2026, the various unexpired letters of guarantee issued by the Company and its subsidiaries are as follows:
| Issuing bank | Applicant unit | Letter of guarantee type | Letter of guarantee amount | Opening conditions |
| Bank of China Limited Xinchang Sub-Branch | Zhejiang NHU Co., Ltd. | Performance guarantee | USD 99,614.00 | Use of bank credit facilities |
| Performance guarantee | USD 7,075.00 | Use of bank credit facilities | ||
| China Merchants Bank Limited Weifang Sub-Branch | Shandong NHU Fine Chemical Science and Technology Co., Ltd. | Payment guarantee | CNY 1,119,300.00 | Margin deposit CNY 111,930.00 |
| China Merchants Bank Limited Weifang Sub- Branch | Shandong NHU Fine Chemical Science and Technology Co., Ltd. | Payment guarantee | CNY 2,379,010.00 | Margin deposit CNY 237,901.00 |
(3) Issued letters of credit that have not yet expired
As of June 30, 2026, the letters of credit issued by the Company and its subsidiaries that have not yet matured are as follows:
| Issuing bank | Applicant unit | Letter of credit balance | Opening conditions |
| Industrial and Commercial Bank of China Limited TEDA Sub-Branch | Tianjin NHU Materials Technology Co., Ltd. | EUR 2,057,000.00 | Use of bank credit facilities |
| USD 2,252,000.00 | Use of bank credit facilities | ||
| Bank of China Limited Xinchang Sub- Branch | The Company | JPY 180,000,000.00 | Use of bank credit facilities |
| USD 354,320.00 | Use of bank credit facilities | ||
| CNY 100,000,000.00 | Use of bank credit facilities | ||
| CNY 50,000,000.00 | Use of bank credit facilities | ||
| Bank of China Limited Shangyu Sub-Branch | Zhejiang NHU Specialty Materials Co., Ltd. | JPY 425,000,000.00 | Margin deposit CNY 19,750,000.00 |
| Industrial and Commercial Bank of China Limited Xinchang Sub-Branch | The Company | CNY 50,000,000.00 | Use of bank credit facilities |
| China Construction Bank Corporation Xinchang Sub-branch | CNY 450,000,000.00 | Use of bank credit facilities | |
| CNY 50,000,000.00 | Use of bank credit facilities |
(4) "Bill Pool" business
The Company and its subsidiaries, including Shangyu NHU Bio-Chem Co., Ltd., Zhejiang NHU Pharmaceutical Co., Ltd., Zhejiang NHU Specialty Materials Co., Ltd., Shaoxing Yuchen New Materials Co., Ltd., Shandong NHU Pharmaceutical Co., Ltd., Shandong NHU Amino-acids Co., Ltd., Heilongjiang NHU Biotechnology Co., Ltd., Shandong NHU Fine Chemical Science and Technology Co., Ltd., Heilongjiang Xinhao Thermal Power Co., Ltd., Xinchang NHU Vitamins Co., Ltd., Zhejiang VYS Animal Nutrition and Health Co., Ltd., and NHU Import & Export Company Ltd., have signed and entered into the Bill Pool Business Cooperation Agreement with China Zheshang Bank Co., Ltd. The Company uses asset pool pledges or bill pool pledges as collateral and opens a bill pool margin account, paying margin at a certain proportion. The specific amount of the margin has not been agreed upon. As of June 30, 2026, the balance of the Company's pledged bank acceptance bills was RMB 114,794,927.96, and RMB 12,939,755.86 was deposited as margin in the bill pool at China Zheshang Bank Co., Ltd. (5) As of June 30, 2026, there are no other commitments that should be disclosed by the Company.
2. Contingencies
(1) Even if the Company does not have important contingencies to be disclosed, it shall also state so There are no important contingencies that the Company needs to disclose.
3. Others
As of June 30, 2026, there are no other contingencies that should be disclosed by the Company.
XVI. Events after Balance Sheet Day
1. Profit distribution
The Board of Directors of the Company proposes: As of July 31, 2026,using the existing total share capital, after deducting the shares in the repurchase special account, as the base of 3,073,421,680 shares [Note], distribute to all shareholders a cash dividend of RMB 2.00 for every 10 shares (tax-inclusive), issue 0 bonus shares (tax-inclusive), and not convert capital reserve into share capital.
[Note] As of July 31, 2026, the Company’s total share capital is 3,073,421,680 shares, including 4,704,282 shares in the repurchase-dedicated securities account. According to the “Rules on Share Repurchase of Listed Companies”, shares in the special account for repurchase of listed companies carry no right of profit distribution and conversion of capital reserve into share capital. If the Company’s total share capital changes due to the conversion of convertible bonds, share repurchase, exercise of equity incentives, refinancing, and listing of new shares, etc., before the implementation of the profit distribution proposal, the total distribution will be adjusted accordingly based on the same distribution ratio.
This proposal is subject to review and approval by the General Meeting of Shareholders.
2. Progress of implementation of the employee stock ownership plan
Pursuant to proposals related to employee stock ownership plan including the Fifth Phase of Employee Stock Ownership Plan (Draft) ofZhejiang NHU Co., Ltd. and Summary deliberated and approved by the 16th Meeting of the Ninth Session of the Board of Directors and the 11th Meeting of the Ninth Session of the Board of Supervisors dated December 10, 2025 and the Third Extraordinary General Meeting of 2025 dated December 26, 2025, the Company agreed to implement the fifth phase of employee stock ownership plan.
On January 26, 2026, the Company received the Securities Transfer Registration Confirmation issued by the Shenzhen Branch o China Securities Depository and Clearing Corporation Limited, and the 21,454,310 shares held in the Company's repurchasededicated securities account were transferred on January 23, 2026 via non-trading transfer to the "Zhejiang NHU mathrm C o., Ltd. - Fifth Employee Stock Ownership Plan" dedicated securities account, representing 0.6981% of the Company's share capital, at a transfer price of RMB 24.19 per share.
As of now, the Company's fifth employee stock ownership plan has completed its purchases. The lock-up period for the shares obtained under the fifth employee stock ownership plan is 12 months, calculated from the date the Company announces that the last tranche of the target shares has been registered and transferred to this plan’s name, i.e., January 27, 2026 - January 26, 2027. The term of the target shares obtained under this shareholding plan is 24 months, calculated from the date the Company announces that the registration and transfer of the last target share into the name of this plan.
3. Explanation of other events after the balance sheet date
Except for the matters described above, as of the date these financial statements were authorized for issue, the Company had no other material events after the balance sheet date.
XVII. Other Important Matters
1. Segment information
(1) Basis for determining reportable segments and accounting policies
1) Segment reporting
According to the Company's internal organizational structure, management requirements and internal reporting system, the Company's operating business is divided into two reportable segments. These reporting segments are determined based on the financial information required for the Company's day-to-day internal management. The Group's management regularly reviews the operating results of these reportable segments to determine the allocation of resources to them and to assess their performance. The Company's reportable segments include:
① Pharmaceutical and chemical segment, producing and selling nutritional products and aroma chemicals;
② Other segment, production and sale of new materials, others;
Segment reporting information is disclosed based on the accounting policies and measurement bases adopted by each segment when reporting to management; these accounting policies and measurement bases are consistent with those used in the preparation of the financial statements.
(2) Financial information of the reportable segments
Unit: RMB Yuan
| Items | Pharmaceutical chemicals | Others | Inter-segment eliminations | Total |
| Operating revenue | 12,333,751,691.26 | 1,179,235,190.63 | 383,686,621.00 | 13,129,300,260.89 |
| Including: Revenue arising from contracts with customers | 12,333,751,691.26 | 1,176,248,011.63 | 383,686,621.00 | 13,126,313,081.89 |
| Operating cost | 6,903,638,200.70 | 803,723,881.11 | 383,686,621.00 | 7,323,675,460.81 |
| Total assets | 41,956,582,912.40 | 5,180,695,555.07 | 452,046,966.71 | 46,685,231,500.76 |
| Total Liabilities | 10,072,385,555.56 | 2,030,928,967.94 | 452,046,966.71 | 11,651,267,556.79 |
2. Other
Details of the Company's subsidiaries are set out in Note 14&15 of Section V of the financial report.
XVIII. Notes on Main Items in Financial Statements of the Parent Company
1. Accounts receivable
(1) Disclosure by aging
Unit: RMB Yuan
| Aging | Closing book balance | Opening balance |
| Within 1 year (including 1 year) | 1,163,192,878.20 | 1,149,760,310.62 |
| Total | 1,163,192,878.20 | 1,149,760,310.62 |
(2) Classification and disclosure by bad debt provision method
Unit: RMB Yuan
| Categories | Closing balance | Opening balance | ||||||||
| Book balance | Bad-debt provision | Carrying amount | Book balance | Bad-debt provision | Carrying amount | |||||
| Amount | % to total | Amount | Rate of provi sion | Amount | % to total | Amount | Rate of prov ision | |||
| Including: | ||||||||||
| Accounts receivable with provision for bad debts reserve based on portfolio | 1,163,192,878.20 | 100.00% | 58,159,643.91 | 5.00% | 1,105,033,234.29 | 1,149,760,310.62 | 100.00% | 57,488,015.53 | 5.00% | 1,092,272,295.09 |
| Total | 1,163,192,878.20 | 100.00% | 58,159,643.91 | 5.00% | 1,105,033,234.29 | 1,149,760,310.62 | 100.00% | 57,488,015. 53 | 5.00% | 1,092,272,295.09 |
Provision made on a collective basis using age analysis method: Unit: RMB Yuan
| Name | Closing balance | ||
| Book balance | Bad-debt provision | Rate of provision | |
| Within 1 year | 1,163,192,878.20 | 58,159,643.91 | 5.00% |
| Total | 1,163,192,878.20 | 58,159,643.91 | |
If the provision for bad debts on accounts receivable is based on the general model of expected credit losses:
□ Applicable Not applicable
(3) Provision, recovery or reversal of bad debt reserve in current period
Provision for bad debts of this period:
Unit: RMB Yuan
Unit: RMB Yuan
| Categories | Opening balance | Changes in amount of the current period | Closing balance | |||
| Provision | Recovery or reversal | Write off | Others | |||
| Provision for bad debts by portfolio | 57,488,015.53 | 671,628.38 | 58,159,643.91 | |||
| Total | 57,488,015.53 | 671,628.38 | 58,159,643.91 | |||
(4) Details of the accounts receivable and contract assets in the top five of the ending balance, grouped by debtor
Unit: RMB Yuan
| Company name | Ending balance of accounts receivable | Ending balance of accounts receivable and contract assets | Proportion of total balance of accounts receivable and contract assets at the end of the period | Ending balance of allowance for bad debts on accounts receivable and impairment provision for contract assets |
| Customer 1 | 847,522,350.34 | 847,522,350.34 | 72.86% | 42,376,117.52 |
| Customer 2 | 156,123,444.65 | 156,123,444.65 | 13.42% | 7,806,172.23 |
| Customer 3 | 31,924,166.84 | 31,924,166.84 | 2.74% | 1,596,208.34 |
| Customer 4 | 13,809,000.00 | 13,809,000.00 | 1.19% | 690,450.00 |
| Customer 5 | 10,978,000.00 | 10,978,000.00 | 0.94% | 548,900.00 |
| Total | 1,060,356,961.83 | 1,060,356,961.83 | 91.15% | 53,017,848.09 |
2. Other receivables
| Items | Closing balance | Opening balance |
| Other receivables | 227,803,286.35 | 476,588,831.47 |
| Total | 227,803,286.35 | 476,588,831.47 |
(1) Other receivables
1) Classification of other receivables according to the nature of payment
Unit: RMB Yuan
| Nature of payment | Closing book balance | Opening balance |
| Interbank borrowings | 203,605,250.01 | 448,209,083.34 |
| Deposits and guarantee deposits | 13,282,510.50 | 13,272,472.50 |
| Refund of tax for export | 18,171,029.29 | 30,199,388.70 |
| Employee petty cash | 4,923,784.23 | 5,958,784.23 |
| Others | 2,570,916.08 | 4,567,180.89 |
| Total | 242,553,490.11 | 502,206,909.66 |
2) Disclosure by aging
Unit: RMB Yuan
| Aging | Closing book balance | Opening balance |
| Within 1 year (including 1 year) | 223,913,952.67 | 483,399,289.58 |
| 1 to 2 years | 1,727,201.59 | 4,555,904.23 |
| 2 to 3 years | 2,914,270.00 | 566,162.85 |
| Over 3 years | 13,998,065.85 | 13,685,553.00 |
| 3 to 4 years | 590,073.32 | 325,560.47 |
| 4 to 5 years | 48,000.00 | |
| Over 5 years | 13,359,992.53 | 13,359,992.53 |
| Total | 242,553,490.11 | 502,206,909.66 |
3) Classification and disclosure by bad debt provision method
Unit: RMB Yuan
| Categories | Closing balance | Opening balance | ||||||||
| Book balance | Bad-debt provision | Carrying amount | Book balance | Bad-debt provision | Carrying amount | |||||
| Amount | % to total | Amount | Rate of provision | Amount | % to total | Amount | Rate of provision | |||
| Including: | ||||||||||
| Provision for bad debts by portfolio | 242,553,490.11 | 100.00% | 14,750,203.76 | 6.08% | 227,803,286.35 | 502,206,909.66 | 100.00% | 25,618,078.19 | 5.10% | 476,588,831.47 |
| Including: | ||||||||||
| Total | 242,553,490.11 | 100.00% | 14,750,203.76 | 6.08% | 227,803,286.35 | 502,206,909.66 | 100.00% | 25,618,078.19 | 5.1O% | 476,588,831.47 |
Category name for bad debt provisions calculated by combination: Other receivables for which bad debt provisions are calculated by combination Unit: RMB Yuan
| Categories | Closing balance | ||
| Book balance | Provision for bad debts | Provision proportion | |
| Land deposit receivable portfolio | 12,518,762.50 | 125,187.63 | 1.00% |
| Export Refund Receivable Portfolio | 18,171,029.29 | 181,710.29 | 1.00% |
| Ages | 211,863,698.32 | 14,443,305.84 | 6.82% |
| Within 1 year (inclusive) | 205,742,923.38 | 10,287,146.17 | 5.00% |
| 1-2 years | 1,727,201.59 | 345,440.32 | 20.00% |
| 2-3 years | 2,914,270.00 | 2,331,416.00 | 80.00% |
| Over 3 years | 1,479,303.35 | 1,479,303.35 | 100.00% |
| Total | 242,553,490.11 | 14,750,203.76 | |
Description for basis of determining the combination:
Provision for bad debts under the general model of expected credit losses:
Unit: RMB Yuan
| Bad-debt provision | First stage | Second stage | Third stage | Total |
| Expected credit losses over the next 12 months | Expected credit loss for the entire duration (no credit impairment occurred) | Expected credit loss for the entire duration (credit impairment has occurred) | ||
| Balance as at January 1, 2026 | 23,087,176.56 | 911,180.85 | 1,619,720.78 | 25,618,078.19 |
| The balance as of January 1, 2026 is in the current period | ||||
| -- Transferred to the second stage | -86,360.08 | 86,360.08 | ||
| -- Transferred to the third stage | -582,854.00 | 582,854.00 | ||
| Accrual in the current period | -12,406,772.39 | -69,246.61 | 1,608,144.57 | -10,867,874.43 |
| Balance as at June 30, 2026 | 10,594,044.09 | 345,440.32 | 3,810,719.35 | 14,750,203.76 |
Criteria for dividing each stage and the bad-debt reserves calculation and withdrawal proportion
Accounts with an aging period of up to one year are categorized as Stage I; accounts aged between one and two years fall under Stage II; and accounts exceeding two years in age are designated as Stage III
Significant changes in the carrying amounts of items with material changes in the allowance for losses during the period □ Applicable Not applicable
4) Details of the top five other receivables by period-end balance, aggregated (grouped) by debtor
Unit: RMB Yuan
| Company name | Nature of the amounts | Closing balance | Aging | Ratio in the total ending balance of other receivables | Ending balance of bad debt provision |
| Shandong NHU Fine Chemical Science and Technology Co., Ltd. | Interbank borrowings | 150,099,166.69 | Within 1 year | 61.88% | 7,504,958.33 |
| Shaoxing Nayan Material Technology Co., Ltd. | Interbank borrowings | 40,310,000.00 | Within 1 year | 16.62% | 2,015,500.00 |
| State Administration of Taxation (Export tax rebatesreceivable) | Refund of tax for export | 18,171,029.29 | Within 1 year | 7.49% | 908,551.46 |
| Zhejiang NHU Pharmaceutical Co., Ltd. | Interbank borrowings | 13,196,083.32 | Within 1 year | 5.44% | 659,804.17 |
| Shandong Weifang Binhai Economic and Technological Development Zone Treasury Centralized Payment Center | Land bond | 12,518,762.50 | Over 5 year | 5.16% | 125,187.63 |
| Total | 234,295,041.80 | 96.59% | 11,214,001.59 |
3. Long-term equity investments
Unit: RMB Yuan
| Items | Closing balance | Opening balance | ||||
| Book balance | Depreciation reserves | Carrying amount | Book balance | Depreciation reserves | Carrying amount | |
| Investments in subsidiaries | 12,894,909,150.12 | 12,894,909,150.12 | 12,054,909,150.12 | 12,054,909,150.12 | ||
| Investments in associates and joint ventures | 930,742,746.46 | 930,742,746.46 | 761,549,857.60 | 761,549,857.60 | ||
| Total | 13,825,651,896.58 | 13,825,651,896.58 | 12,816,459,007.72 | 12,816,459,007.72 | ||
(1) Investment in subsidiaries
Unit: RMB Yuan
| Invested entity | Opening balance (Carrying amount) | Opening balance of impairment provision | Increase or decrease in the current period | Closing balance (Carrying amount) | Closing balance of impairment provision | |||
| Additional investment | Investment decrease | Provision for impairment reserve | Others | |||||
| Xinchang NHU Vitamins Co., Ltd. | 229,407,990.15 | 70,000,000.00 | 299,407,990.15 | |||||
| Zhejiang NHU Import & Export Co., Ltd. | 13,500,000.00 | 13,500,000.00 | ||||||
| Zhejiang VYS Animal Nutrition and HealthCo., Ltd. | 5,000,000.00 | 5,000,000.00 | ||||||
| Shangyu NHU Bio-Chem Co., Ltd. | 414,100,091.44 | 414,100,091.44 | ||||||
| NHU (Hong Kong) Trading Co., Ltd. | 16,406,160.00 | 16,406,160.00 | ||||||
| Zhejiang NHU Pharmaceutical Co., Ltd. | 480,000,000.00 | 480,000,000.00 | ||||||
| Zhejiang NHU Specialty Materials Co., Ltd. | 554,844,108.53 | 554,844,108.53 | ||||||
| Shandong NHU Amino-acids Co., Ltd. | 5,800,000,000.00 | 5,800,000,000.00 | ||||||
| Shandong NHU Holdings Co., Ltd. | 200,000,000.00 | 200,000,000.00 | ||||||
| Heilongjiang NHU Biotechnology Co., Ltd. | 2,300,000,000.00 | 2,300,000,000.00 | ||||||
| Shandong NHU Pharmaceutical Co., Ltd. | 586,000,000.00 | 586,000,000.00 | ||||||
| Shandong NHU Fine Chemical Science and Technology Co., Ltd. | 590,000,000.00 | 590,000,000.00 | ||||||
| NHU Singapore Pte. Ltd. | 55,650,800.00 | 55,650,800.00 | ||||||
| Tianjin NHU Materials Technology Co., Ltd. | 310,000,000.00 | 170,000,000.00 | 480,000,000.00 | |||||
| Zhejiang NHU Holdings Co., Ltd. | 500,000,000.00 | 600,000,000.00 | 1,100,000,000.00 | |||||
| Total | 12,054,909,150.12 | 840,000,000.00 | 12,894,909,150.12 | |||||
(2) Investment in associates and joint ventures
Unit: RMB Yuan
| Invested entity | Opening balance (Carrying amount) | Opening balance of impairment provision | Increase or decrease in the current period | Closing balance (Carrying amount) | Closing balance of impairment provision | |||||||
| Addit ional invest ment | Invest ment decre ase | Recognized investment gain and loss under equity method | Other comprehensive income adjustments | Other changes in equity | Declared payment of cash dividends or profits | Provision for impairment reserve | Others | |||||
| I. Joint ventures | ||||||||||||
| Ningbo Zhenhai Refining and Chemical NHU Biotechnology Co., Ltd. | 418,125,357.72 | 145,667,271.39 | 1,159,219.93 | 564,951,849.04 | ||||||||
| Subtotal | 418,125,357.72 | 145,667,271.39 | 1,159,219.93 | 564,951,849.04 | ||||||||
| II. Associates | ||||||||||||
| Zhejiang Chunhui Environmental Protection Energy Co., Ltd. | 338,826,562.59 | 22,409,394.80 | 40,660.57 | 361,276,617.96 | ||||||||
| Anhui Yingna Weixun Technology Co., Ltd. | 4,597,937.29 | -83,657.83 | 4,514,279.46 | |||||||||
| Subtotal | 343,424,499.88 | 22,325,736.97 | 40,660.57 | 365,790,897.42 | ||||||||
| Total | 761,549,857.60 | 167,993,008.36 | 1,199,880.50 | 930,742,746.46 | ||||||||
The recoverable amount is determined based on the net of fair value less disposal costs. □ Applicable Not applicable The recoverable amount is determined based on the present value of estimated future cash flows.
□ Applicable Not applicable
4. Operating revenue and operating cost
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period | ||
| Revenue | Cost | Revenue | Cost | |
| Main business | 2,309,266,771.97 | 1,770,559,469.33 | 2,272,445,803.50 | 1,608,253,690.17 |
| Other business | 29,360,785.43 | 18,552,802.71 | 16,464,550.41 | 13,097,558.26 |
| Total | 2,338,627,557.40 | 1,789,112,272.04 | 2,288,910,353.91 | 1,621,351,248.43 |
| Including: with customers Revenue from contracts | 2,337,108,362.48 | 1,788,618,094.60 | 2,287,433,972.45 | 1,620,857,070.99 |
Breakdown of the operating revenue and operating cost:
Unit: RMB Yuan
| Classification of contracts | Operating revenue | Operating cost |
| Business Type | ||
| Including: | ||
| Nutrition | 2,196,329,810.86 | 1,697,717,504.42 |
| Others | 140,778,551.62 | 90,900,590.18 |
| Classified according to operation regions | ||
| Including: | ||
| Domestic | 1,061,291,875.76 | 812,515,442.25 |
| Overseas | 1,275,816,486.72 | 976,102,652.35 |
| Classification by timing of goods transfer | ||
| Including: | ||
| Revenue recognized at a point in time | 2,337,108,362.48 | 1,788,618,094.60 |
| Total | 2,337,108,362.48 | 1,788,618,094.60 |
Information related to the transaction price allocated to remaining performance obligations: At the end of the reporting period, the amount of revenue related to contracts that have been signed but whose performance obligations have not yet been performed or have not yet been fully performed amounted to RMB 456,267,255.54, of which RMB 456,267,255.54 is expected to be recognized as revenue in 2026.
5.R&D expenses
Unit: RMB Yuan
| Items | Amount of the current period | Amount of the corresponding period of the previous year |
| Employee compensation | 84,080,356.43 | 82,725,549.50 |
| Depreciation expense and amortization of intangible assets | 10,388,784.02 | 10,733,137.45 |
| Outsourcing expenses | 8,883,018.87 | 6,077,358.50 |
| Direct input | 15,441,856.00 | 13,547,258.16 |
| Office expenses and travel expenses | 1,049,804.06 | 1,285,946.17 |
| Others | 4,664,254.54 | 10,163,538.49 |
| Total | 124,508,073.92 | 124,532,788.27 |
6. Investment incomes
Unit: RMB Yuan
| Items | Amount incurred in the current period | Amount incurred in the previous period |
| Long-term equity investment income calculated by cost method | 1,800,000,000.00 | 1,750,000,000.00 |
| Return on long-term equity investments measured by the equity method | 167,993,008.36 | 17,307,279.63 |
| Interest income from interbank lending | 3,230,192.89 | 16,565,281.42 |
| Dividend income from investment in other equity instruments during the holding period | 5,292,000.00 | |
| Income of financial products and structural deposits | 2,630,063.73 | 4,122,267.74 |
| Investment income from disposal of trading (held-for-trading) financial liabilities | -183,294.72 | |
| Total | 1,973,669,970.26 | 1,793,286,828.79 |
XIX. Supplementary Information
1. Statement of non-recurring gains and losses for the current period
Applicable □ Not applicable
Unit: RMB Yuan
| Items | Amount | Remarks |
| Loss or gain from disposal of non-current assets | -35,306,533.70 | |
| Government grants included in profit or loss (excluding those closely related to operating activities of the Company, satisfying government policies and regulations, enjoyed based on certain standards, and having a continuing impact on the Company's profit or loss) | 37,824,754.25 | |
| Gains or losses on changes in fair value of financial assets and financial liabilities held by non-financial enterprises and gains or losses arising from disposal of financial assets and financial liabilities, excluding those arising from effective hedging business related to the Company's normal operating activities | 101,306,033.08 | |
| Gains or losses on assets consigned to the third party for investment or management | 16,602,412.40 | |
| Other non-operating revenue or expenditures | -8,309,061.39 | |
| Less: Enterprise income tax affected | 20,142,157.25 | |
| Non-controlling interest affected | 178,556.56 | |
| (after tax) | ||
| Total | 91,796,890.83 | -- |
Remarks on other profit or loss satisfying the definition of non-recurring profit or loss:
□ Applicable Not applicable
The Company has no other profit or loss satisfying the definition of non-recurring profit or loss.
Remarks on defining non-recurring profit or loss listed in the “Interpretation Pronouncement on Information Disclosure Criteria for Public Companies No. 1 – Non-Recurring Profit or Loss” as recurring profit or los
□ Applicable Not applicable
2. Return on net assets and earnings per share
| Profit during the reporting period | Weighted average return on equity | Earnings per share | |
| Basic earnings per share (yuan/share) | Diluted earnings per share (yuan/share) | ||
| Net profit attributable to common shareholders of the Company | 11.39% | 1.30 | 1.30 |
| Net profit attributable to common shareholders of the Company after deducting non-recurring gains and losses | 11.12% | 1.27 | 1.27 |
3. Differences in accounting data under domestic and foreign accounting standards
(1) Differences in net profits and net assets in the financial reports disclosed pursuant to international accounting standards and Chinese accounting standards at the same time
Applicable Not applicable
(2) Differences in net profits and net assets in the financial reports disclosed pursuant to foreign accounting standards and Chinese accounting standards at the same time
Applicable ☑ Not applicable
(3) Explanation of reasons for differences in accounting data under domestic and foreign accounting standards; if the data audited by an overseas audit firm is adjusted for differences, the name of the overseas firm shall be indicated.
Applicable ☑ Not applicable
股票
板块
用户
资讯
评论 (0)